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ABSTRACT
Protein glycosylation in Helicobacter pylori is known to modify the flagellins
with pseudaminic acid (pse). This modification is required for proper flagellum
production and H pylori motility, which implicates protein glycosylation in H. pylori’s
pathogenesis. We investigated whether protein glycosylation extends beyond pse-specific
flagellin glycosylation by the use of H pylori pse biosynthesis mutants and the detection
of glycoproteins by glycoprotein-specific chemical labelling. Using these methods, we
demonstrated the presence of novel protein glycosylation in H pylori, in terms of both
the identification of membrane glycoproteins and at least two alternative glycosylation
pathways. In addition, a link between protein glycosylation and lipopolysaccharide (LPS)
biosynthesis was elucidated, in which the O-antigen ligase, WaaL, is a candidate
glycoprotein and was shown to exhibit general oligosaccharyltransferase activity.
Overall, this study highlights that protein glycosylation affects several proteins in H
pylori and has a key role in the production of multiple virulence factors.
Keywords: Helicobacter pylori, protein glycosylation, flagellins, lipopolysaccharide,
virulence factors, glycoproteins
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CHAPTER 1: Introduction
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1.1 Helicobacter pylori
Helicobacter pylori is a Gram-negative, spiral-shaped, microaerophilic bacterium
with multiple polar sheathed flagella (reviewed in [1]). Presently, H. pylori is
acknowledged as a cause of gastritis, peptic ulcer disease and gastric cancer [2].
However, at the time of its discovery, the finding of a bacterium in the stomach was
controversial, as it was believed that no microorganisms were able to survive in the acidic
stomach environment.
Dr. Robin Warren originally observed a bacterium associated with gastric biopsies
in 1979, but it was not successfully cultured until 1982 when a plate was left
serendipitously incubating over the Easter long weekend [3]. Based on its spiral-shape,
the bacterium was named Campylobacter pyloridis, but was later found not to be part of
the Campylobacter genus based on disparity of 16S rRNA sequencing and discrepancies
in morphology, cellular fatty acids, and growth characteristics. The bacterium was re
named Helicobacter pylori [4, 5], In 1985, Drs. Barry Marshall and Robin Warren
demonstrated the association of H. pylori infection with gastritis and peptic ulcer disease
when Dr. Marshall drank a culture of H. pylori and subsequently developed peptic ulcer
disease. He later cleared the infection with antibiotic treatment. Dr. Marshall’s
experiment was groundbreaking as it fulfilled Koch’s postulates and disproved the theory
that the stomach was a sterile environment [6]. As a result, Drs. Robin Warren and Barry
Marshall won the Nobel Prize in Physiology and Medicine in 2005 for the discovery of
H. pylori and its involvement in chronic gastrointestinal disease.
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1.1.1 General H. pylori characteristics
H. pylori range from 2.5pm to 5.0pm in length and are 0.5pm to 1.0pm wide [7].
Genome size varies from 1.6 to 1.73Mb [8]. A high level of genetic diversity has been
observed among H. pylori isolates, which exhibit silent nucleotide variation within genes
and limited gene clustering [9]. Up to 6-7% of encoded genes are predicted to be strainspecific. These strain-specific genes are localized to a hypervariable region that is
common amongst H. pylori strains, termed the ‘plasticity zone’ [10]. This genetic
diversity of distinct H. pylori strains is believed to be associated with the variation in the
severity and disease outcome of H. pylori infections [10, 11].
Moreover, H pylori is a slow-growing fastidious organism that requires rich,
complex media and microaerophilic conditions for growth [1, 12]. When growth
conditions are not optimal for the bacterium, such as after several sub-culturing events or
during extended growth periods, H. pylori is known to change from its spiral shape to a
coccoid form. The coccoid form is believed to be viable, but non-culturable in vitro [13].
Thus, strict growth conditions in the laboratory need to be maintained to prevent
conversion of H. pylori to its non-culturable form.
1.1.2 H. pylori prevalence and transmission
H. pylori is a ubiquitous microorganism as it is found worldwide. It is estimated
that more than half of the world’s population is affected by H. pylori, making it one of the
most common human bacterial infections [14]. Although widespread, H. pylori
prevalence demonstrates large geographic variation. In general, this variation is
associated with socioeconomic status with a higher prevalence of infection occurring in
developing countries, estimated at 74%, compared to a lower prevalence in developed

countries, estimated to be 58% [15]. It is proposed that this divergence is due to
differential rates of acquisition during the early years of life. In developing countries it is
believed that infection occurs most often during childhood years and continues
throughout life as a chronic infection. Comparatively, infection in developed countries is
thought to occur later in life, likely due to better sanitation and standards of living [16].
Despite the global pattern, variance in the prevalence of H. pylori infection within
countries is also common [16]. A recent study on H. pylori prevalence in Canadian
children from three urban cities indicated a low prevalence with an observed infection
rate of 7.1% [17]. However, prevalence in Arctic Aboriginal populations can range from
50-90%, indicating large variations in H. pylori infection rates within sub-populations of
developed countries [18, 19].
In addition to socioeconomic status, other risk factors have been documented for
H. pylori infection. In particular, age has a positive correlation with H. pylori prevalence,
with infection being more common among adults [20]. As well, genetic factors are
believed to have a role in susceptibility [21]. Overall, many factors contribute to infection
and although infection rates are declining in developed countries, due to high
seroprevalence of sub-populations and multiple risk factors, H. pylori remains a global
health burden [22].
Transmission of H. pylori remains largely uncharacterized. The only known
reservoir of H. pylori is the human stomach, despite several studies aimed at identifying
other environmental sources, such as water, food, and animal sources [23-28]. As such,
person-to-person spread is the most likely mode of transmission, with the route of
transfer proposed as either an oral-oral, oral-fecal, or gastro-oral route [16]. A recent
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study conducted on the acquisition of H pylori in rhesus macques supports the oral-oral
route of transmission as H. pylori infection rapidly spread among animals despite no
cultivation of H pylori from any environmental source [29]. Conversely, H pylori has
been detected in the gastric juice, vomitus, and stool samples of infected individuals,
suggesting spread by gastro-oral and oral-fecal routes and the potential for increased
transmission by other gastrointestinal diseases [30, 31]. Moreover, interfamilial
transmission is considered a predominant method of infection. Mother-to-child spread is
believed to be the most common, in which H. pylori isolates from children and their
mothers are identical [32, 33]. In summary, although H. pylori is common around the
world, how infection spreads between geographic locations and communities remains
largely unknown.
1.1.3 JET.pylori and disease
The majority of H. pylori infections are asymptomatic; however, infection results
in chronic inflammation of the stomach mucosa that remains life-long unless eradication
therapy is employed. Chronic gastritis ultimately leads to the erosion of the gastric
mucosa which can result in the development of severe gastrointestinal diseases including
peptic ulcer disease, gastric cancer and mucosa-associated lymphoid tissue (MALT)
lymphoma [34],
Overall, it is estimated that 6-10% of individuals infected with H. pylori will
develop gastroduodenal disease, up to 3% will develop gastric cancer and less than 0.1%
will develop MALT lymphoma [35]. In 1994, H pylori was classified as a class I
carcinogen by the International Agency for Research on Cancer (IARC) [36] and is
currently recognized as the leading infectious agent known to cause cancer [15].
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Importantly, gastric cancer remains the second leading cause of cancer-related deaths
[37], of which, 63% of cases is attributable to H. pylori infection [15]. H. pylori infection
is also associated with the development of MALT lymphoma in which 92% of cases are
thought to arise from H. pylori infection [38]. Eradication of H. pylori has been shown to
lead to regression of gastric lymphomas, indicating that treatment of H. pylori infection is
a feasible measure for the prevention of gastrointestinal disease. In fact, due to the
success of H. pylori eradication, gastric MALT lymphoma is considered the first treatable
cancer with antibiotic therapy [39, 40].
Typical treatment for H. pylori infection involves the use of triple therapies; a
combination of proton pump inhibitors and at least two antibiotics. However, high rates
of treatment failure, due to patient non-compliance from various side effects and rising
antibiotic resistance worldwide, threatens the efficacy of current treatment regimens, and
indicates the need to identify new therapeutic targets [41, 42].
While the association of H pylori with gastrointestinal diseases is well established,
more recently, a protective role of H. pylori in the progression of esophageal cancer has
been described, indicating the potential of the co-adaptation of humans with H. pylori
[43, 44]. This highlights the complexity of H. pylori infection and the host-microbe
interaction.
Overall, much remains unknown regarding the progression of H pylori infection
and its involvement in disease. The severity and disease outcome of H. pylori infection is
believed to be due to a combination of environmental, host genetic, and bacterial factors
[34], In fact, many bacterial virulence factors have been characterized and shown to
contribute to H. pylori’s pathogenesis.
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1.2 H. pylori virulence factors
In addition to host and environmental factors, various bacterial factors aid in H.
pylori’s ability to cause disease. Bacterial virulence factors aid H. pylori in all aspects of
infection; survival within the hostile gastric environment, colonization, and modulation of
host immune responses, all of which contribute to H. pylori’s ability to cause persistent
infection. A brief overview of a few of these factors related to this work is provided
below.
1.2.1 Urease
Urease is a multi-subunit enzyme produced by H. pylori that aids in its ability to
survive within the stomach by converting urea into ammonia and carbon dioxide by
products, thereby neutralizing the local pH of the stomach. The importance of urease in
H. pylori colonization was first highlighted by urease-negative mutants that were unable
to cause infection in gnotobiotic piglets [45]. Urease is highly abundant in the cell and
represents 10-15% of total bacterial proteins [46]. The enzyme is composed of two
structural subunits, UreA (~29.5 kDa) and UreB (~66 kDa), that form a hexadimer and
function in conjunction with UreE-H, which are responsible for transporting nickel for
urease activity, and Urel, which encodes a pH-gated urea channel that controls urea
concentration [47,48]. The majority of urease is cytoplasmic, where it acts to maintain
the cytoplasmic pH and the proton motive force, and thereby also reduces the acidity of
the periplasm [49]. External urease attached to the outer membrane of H. pylori has also
been observed, and is believed to neutralize the pH of the direct surrounding environment
of the bacteria [50].
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1.2.2 Adhesins
Initial colonization and persistence of infection is mediated by adherence to host
cells. H. pylori possesses several adhesins and outer membrane proteins (OMPs) that
assist in its adherence to host cells. In fact, 4% of the H. pylori genome is predicted to
encode OMPs [51]. One of the most characterized adhesins in H. pylori is the blood
group antigen binding adhesin (BabA). BabA binds fucosylated Lewis b blood group
antigens (Leb) found on the surface of gastric epithelial cells. Leb-mediated colonization
of transgenic mice expressing Leb by H. pylori was shown to result in more severe
gastritis, indicating that BabA may increase H. pylori’s pathogenesis [52]. As well, the
presence of BabA in clinical strains is associated with an increased risk of developing
duodenal ulcer disease and gastric cancer [53].
Sialic acid-binding adhesin (SabA) is another H. pylori adhesin. SabA binds the
Lewis x blood group antigen (Lex) expressed by the gastric epithelium [54], Lex
expression is induced during chronic gastritis, suggesting that H. pylori modulates host
cell glycosylation patterns to enhance its own attachment, and therefore may play a role
in the persistence of H. pylori infection [55].
As well, other less characterized adhesins that likely play a role in colonization
are AlpA/AlpB [56], HopZ [57]and OipA [51], however, their host targets have yet to be
identified.
1.2.3 Toxins
H. pylori produces a variety of factors that directly target the host and manipulate
cell functions. One of the most extensively studied toxins is CagA. CagA is a 145 kDa
protein that is translocated into host cells via a type IV secretion system of which CagA is
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the only known effector protein [58, 59]. CagA is encoded within the cag pathogenicity
island (cag PAI), a 40kb DNA insertion element encoding 27-31 genes including both
CagA and components of the bacterial type IV secretion system [60]. Both CagA and the
cag PAI are strongly associated with the development of disease. Clinical strains of H.
pylori are categorized as cagyf-positive or cagA-negative. cag4-positive strains are
considered to be more virulent and are associated with an increased risk for disease [61].
Upon translocation of CagA into host cells, CagA is believed to interact with an
estimated 20 host cellular proteins in either a non-phosphorylated or phosphorylated state
and interfere with multiple cellular pathways, including actin-cytoskeletal rearrangement,
disruption of tight junctions, induction of pro-inflammatory responses, and apoptosis
[62]. Further, translocation of CagA results in a characteristic elongation of gastric cells,
termed “the hummingbird phenotype” [58]. Based on its numerous host cell effects and
association with disease, CagA is considered a bacterial oncoprotein. In fact, transgenic
expression of CagA in mice results in gastric epithelial cell proliferation and the
production of carcinomas [63].
Another toxin linked to increased disease risk is the secreted vacuolating cytoxin
A (VacA). VacA also has multiple effects on host cells. VacA was first characterized for
its ability to induce vacuole formation in mammalian cells [64], but it is now known to
alter additional cellular functions including induction of apoptosis, membrane channel
formation, suppression of T-cell responses, and induction of pro-inflammatory cytokine
production [65],

10

1.2.4 Lipopolysaccharide (LPS)
Lipopolysaccharide (LPS) is a common outer membrane and cell-surface
component of Gram-negative bacteria. It is composed of three main components; a lipid
A moiety that acts as a hydrophobic anchor in the outer leaflet of the membrane lipid
bilayer and has endotoxic activity, a core oligosaccharide with conserved length and
sugar composition, and a variable O-antigen chain that provides serospecificity [66, 67].
LPS provides a physical barrier from host defences, including bile salts, detergents, and
antimicrobial peptides, and is involved in the maintenance of membrane stability, nutrient
transport, and host interactions [68]. The main constituents of H. pylori LPS are fucose
(Fuc), galactose (Gal) and N-acetyl-glucosamine (GlcNAc), as well as minor amounts of
glucose (Glc) and heptose (Hep) [69, 70].
While activation of the innate immune system during bacterial infection by the
components of LPS has been well established, the LPS of H. pylori exhibits unique
characteristics that aid in its ability to evade the host immune response. These
modifications are thought to reflect an adaptation of H. pylori to its ecological niche in
the human stomach, which enables persistent infection.
Firstly, the lipid A domain, commonly referred to as endotoxin due to several
well-documented immunomodulatory effects on host cells, such as septic shock [66, 67],
is underphosphorylated and contains unusual long fatty acid chains in H. pylori [71-73].
These modifications result in reduced endotoxicity, including reduced induction of
cytokines and chemokines, and lower lethality in mice, when compared to the lipid A of
other Gram-negative bacteria [74-76]. In particular, bacterial LPS is known to activate
the innate immune response via recognition by Toll-like receptor 4 (TLR-4) [76-78].
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However, in the case of H. pylori LPS, activation of TLR-4 is reduced due to the atypical
acylation and phosphorylation pattern of its lipid A domain [76]. Thus, the unusual
modifications of the lipid A moiety result in H. pylori’s LPS being less immunogenic, in
terms of its ability to activate the host immune response, and thereby aids in H. pylori’s
ability to evade the host immune response and generate persistent, chronic infections.
In addition, the O-antigen chain of H. pylori contributes to its ability to evade the
host immune response as H. pylori O-antigen mimics the human Lewis blood group
antigens found on gastric epithelial cells [79, 80], More than 80% of H. pylori strains
express type 2 Lewis antigens, Lex and Ley, whereas less than 5% express type 1 antigen
motifs, Lea and Leb [81]. Typical H. pylori type 2 O-antigen is composed of several
internal repeating Lexunits on the precursor O-antigen structure and either Lexor Ley at
the terminal position [82]. The synthesis of Leyor Lexantigens is mediated by the activity
of different fucosyltransferases (FucTs) (Figure 1) [82, 83]. A FucT with al,3-activity
glycosylates the backbone O-antigen chain creating the Lex antigen. A second FucT with
a 1,2 -activity adds a second fucose to the Lex structure generating the Ley antigen. Ley
structures cap the O-antigen and prevent further elongation of the O-antigen chain, thus,
they are only found at the terminal position. The relative activities of the FucTs required
for Lewis antigen synthesis have been shown to vary amongst H. pylori strains, which
alters the Lewis antigen production exhibited [83]. For example, the H. pylori strain
26695 has relatively lower al,2-FucT activity, which results in less conversion of Lex
structures to Ley and thereby produces O-antigen that is decorated with both Lex and Ley
antigens simultaneously [84, 85], Conversely, in other H. pylori strains,
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Figure 1: The synthesis of type 2 Lewis antigens, Ley and Lex, of H. pylori O-antigen.
Type 2 Lewis antigen synthesis is mediated by fucosyltransferases (FucTs) that modify
the O-antigen chain precursor. A FucT with al,3-activity fucosylates the O-antigen
backbone generating the Lex structure. Lex antigens are present along the O-antigen chain
and in the terminal position. Lex structures can be further modified by an additional FucT
with al,2-FucT activity to generate the Leyantigen. Ley structures terminate the Oantigen chain and prevent further elongation. Gal = galactose, GlcNAc = N-acetylglucosamine, Fuc - fucose.
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a high level of al,2-FucT activity results in the transformation of the majority of terminal
Lex structures to Ley. Indeed, monoclonal antibodies with specificity for the Lewis
antigens found on the O-antigen have been used as a serotyping system for H. pylori
isolates [86].
In addition to being a form of molecular mimicry, Lewis antigen expression is
also phase variable, which further contributes to H. pylori’s ability to escape detection by
the host immune response. Phase variability is due to slipped-strand mispairing during
transcription of a polyA-polyC tract in the 5’end and a repeat region in the 3’end of the
FucTs genes, which creates an on/off switch for FucT expression and thereby Lewis
antigen expression [87]. In fact, H. pylori Lewis antigen expression in vitro was shown to
exhibit phase variation at a rate of 0.2-0.5% in bacterial populations derived from a single
cell [88]. As a result, phase variability in the Lewis antigen decoration of H. pylori Oantigen allows H. pylori isolates to adapt to their host and evade the host immune
response.
Lastly, in addition to immune evasion, the O-antigen of H. pylori also acts as an
adhesin and binds C-type lectin DC-SIGN [89]. This interaction is believed to mediate
interactions with immune cells and induce gastric autoimmunity [82].
1.2.4.1 LPS biosynthesis
In general, three O-antigen LPS biosynthesis pathways have been described [67].
In all cases, the O-antigen is assembled on an undecaprenyl phosphate (UndP) lipid
carrier by the action of specific glycosyltransferases. Assembly of the O-antigen is
typically initiated by WecA, an UDP-GlcNAc:undecaprenyl-phosphate GlcNAc-1phosphate transferase, that acts to transfer the initiating GlcNAc from the nucleotide
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activated sugar donor (UDP-GlcNAc) to UndP [90]. The three pathways diverge in the
mechanism by which the O-antigen is assembled and translocated to the periplasm [67].
In the polymerase-dependent pathway, individual O-antigen units are assembled in the
cytoplasm and are each translocated to the periplasm by the flippase Wzx, where they are
polymerized by Wzy to form the full O-antigen. The length of the final O-antigen chain is
regulated by the chain length regulator Wzz. In the ABC transporter-dependent pathway,
the entire O-antigen is assembled in the periplasm and flipped by an ATP-dependent
transporter composed of the polypeptides Wzm and Wzt that form the membrane channel
and produce the energy to drive translocation by ATPase activity, respectively. In the
synthase-dependent LPS pathway, the entire O-antigen is also assembled in the
cytoplasm and the synthase, WbbF, is required for both glycosyltransferase activity and
translocation of the assembled O-antigen to the periplasm. In all three pathways, the fully
assembled O-antigen is attached to the lipid A core by WaaL, the O-antigen ligase.
Unlike most bacteria, the genome of H. pylori is largely unorganized. As such,
genes involved in LPS biosynthesis have been difficult to identify and characterize as
they are spread throughout the genome. Indeed, several studies have identified
glycosyltransferases involved in O-antigen assembly [82], as well as enzymes involved in
the synthesis and modification of the lipid A core [73, 91, 92], however, the enzymes
responsible for the translocation and assembly of the completed O-antigen to the lipid A
core had remained elusive until recently.
The LPS biosynthesis pathway in H. pylori was characterized during the course of
this study by Hug et al. 2010 [93]. In this study, Hug et al. 2010, demonstrated that the H.
pylori LPS biosynthesis pathway lacks several of the standard LPS enzymes from each
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model pathway; no wzx, wzt, wzm, wbbF, wzy, or wzz, could be identified. However,
homologs of WecA and WaaL were identified based on similar membrane topology to
the model enzymes from Escherichia coll As such, H. pylori possesses a distinct
mechanism for the translocation of O-antigen compared to the established pathways. In
short, similar to the canonical pathways, O-antigen assembly in H. pylori is initiated by a
WecA homolog, followed by synthesis of the complete O-antigen by specific
glycosyltransferases. The O-antigen is then flipped to the periplasm by the activity of the
newly characterized O-antigen translocase, Wzk. Wzk is a homolog of PglK, the enzyme
responsible for the translocation of the oligosaccharide intermediate during protein Nglycosylation in Campylobacter jejuni, and has not been identified in any other LPS
biosynthesis pathways. Wzk exhibits relaxed substrate specificity, which corresponds
with the ability of H. pylori to express diverse O-antigen chains with varying fucose
decoration. After the translocation of the O-antigen to the periplasm, the O-antigen ligase
or WaaL, attaches the O-antigen to the lipid A core and the completed unit is transported
to the outer membrane. Overall, the elucidation of the H. pylori LPS biosynthesis
pathway demonstrated a novel translocase involved in LPS biosynthesis. The connection
of LPS biosynthesis and protein glycosylation will be discussed further in Section 1.3.4.
1.2.5 Motility and flagella
The ability of H. pylori to transverse the viscous gastric mucus to reach the gastric
epithelium for colonization is a key component of H. pylori’s survival in the human
stomach. H. pylori has 4-6 polar flagella that work in conjunction with its spiral shape to
propel the bacterium through the gastric environment [4], Motility has been shown to be
essential for colonization as non-motile variants are unable to establish persistent
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infection and are selected against in animal infection models [94-96]. Further, greater
motility has been observed in clinical strains isolated from cases of chronic gastritis,
peptic ulceration or gastric cancer compared to strains obtained from asymptomatic
infections [97], indicating that motility is a significant factor in H. pylori’s pathogenesis.
Over 40 proteins are involved in flagellum biosynthesis and regulation in H.
pylori [98]. The overall structure of the H. pylori flagellum is similar to the type III
flagellar-export apparatus characterized in E. coli and Salmonella [99,100]. In general,
the flagellar apparatus is composed of three main elements: a basal body, hook, and
flagellar filament. The basal body comprises the integral membrane ring structure that
forms the foundation of the export channel across the periplasm, as well as the rotor of
the flagellum and the motor proteins that mediate the proton-motive force for flagellum
rotation [101,102], The hook forms a flexible junction between the basal body and the
flagellar filament. Mutation of the hook subunit protein in H. pylori, FlgE, disrupts
motility and production of the flagellar filament [103], which corresponds to the
hierarchical flagellum assembly model in most Gram-negative bacteria [104]. Both the
hook proteins and the proteins that make up the flagellar filament are secreted through the
flagellar apparatus by a type III secretion system and assemble external to the cell. The
flagellar filament of H. pylori is composed of two structural subunits, flagellin A (FlaA)
and flagellin B (FlaB), rather than just a single flagellin species as found in most
flagellated bacteria [105]. FlaB is the minor flagellin subunit and assembles adjacent to
the flagellar hook. FlaA is the major flagellin subunit and makes up the remainder of the
filament structure. The stoichiometric ratio of FlaA and FlaB is approximately ten to one.
Inactivation offlaA disrupts motility and results in the production of multiple truncated
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flagella [106]. Conversely, disruption offlaB has no apparent effect on flagellum
production but restricts motility by 30-40%. A double knockout mutation of both
flagellin genes abolishes H. pylori motility and flagellum production. As such, both
flagellin structural subunits are required for fully functional flagella and H. pylori
motility. It is proposed that the complex flagellar filament assembly by two flagellins,
rather than one subunit, relates to flagellum strength and may be an adaptation of H.
pylori to enable its movement through the viscous gastric environment.
In addition, the H. pylori flagellar filament is enclosed by a membrane sheath [4].
The sheath forms a terminal bulb at the tip of the flagellum and is an extension of the
outer membrane containing both LPS and various outer membrane proteins [107]. The
role of the flagellar sheath is incompletely understood, however, it is thought to protect
the flagellum from the acidic gastric environment, mask flagellar antigens, or act as an
adhesin [108].
The H. pylori flagellum is also unique in regards to the genetic organization of its
components and transcriptional regulation. Unlike similar flagellar systems, the flagellar
genes encoding proteins for flagellum biosynthesis and regulation are primarily unlinked
on the chromosome [98, 108-111]. Flagellum biosynthesis is controlled in a hierarchical
manner by three RNA polymerase sigma factors, a80, a54 (RpoN), and o28. In general, a80
controls housekeeping flagellar genes that encode proteins for chemotaxis and for the
basal body and motor components of the flagellum, o54 controls ‘middle’ flagellar gene
expression including the flagellar hook subunits, the minor flagellin FlaB, and the sheath,
and c28 controls Tate’ flagellar gene expression, including the major flagellin subunit
FlaA [111, 112]. The transcriptional regulation of the flagellar genes differs from other
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flagellar systems as no master regulator has been identified, however, components of the
basal body, FlhA and FlhF, downregulate flagellar gene transcription [112]. As well, the
secreted anti- a factor, FlgM, well characterized in Salmonella, is truncated and lacks a
typical N-terminal secretion sequence in H. pylori. Recently, it was proposed that FlgM
of H. pylori exerts its antagonist function on middle flagellar genes in the cytoplasm by
interacting with basal body components rather than being secreted [113,114]. In addition,
growth-phase dependent regulation has also been characterized in H. pylori for both of
the flagellin subunits and the basal body component FlhA [115].
The unique features of the H. pylori flagellum also aid in its ability to evade the
host immune response. In particular, recognition of FlaA by Toll-like receptor 5 (TLR 5)
is dramatically lower than Salmonella enterica ser. Typhimurium flagellin, which is
demonstrated by approximately 1000-fold less activation of IL-8 production by gastric
epithelial cells [116]. The low activation of the innate immune response likely aids in H.
pylori’s ability to cause life-long infection.
Lastly, the flagellin subunits of H. pylori are known to be glycosylated with the
sugar pseudaminic acid (pse). Glycosylation of both flagellin subunits is required for
proper flagellum assembly [117-119]. Disruption of flagellin glycosylation results in H
pylori that is non-motile and lack flagella - two components essential to H pylori’s
colonization and overall pathogenicity. Thus, glycosylation is a key virulence factor of H.
pylori and is presented in detail in the following section.
1.3 Protein glycosylation
Protein glycosylation is the modification of proteins by the covalent attachment of
carbohydrates. It is the most abundant polypeptide chain modification found in nature
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[120] . Two dominant forms of protein glycosylation have been characterized - N-linked
glycosylation and O-linked glycosylation. N-glycosylation occurs by covalent attachment
of the glycan to the amide nitrogen of asparagine residues. Comparatively, Oglycosylation occurs by the attachment of the glycan to the hydroxyl group of serine or
threonine residues. Other forms of glycosylation have been reported, including C-C
linkage of tryptophan residues, but are rare.
Initially, protein glycosylation was believed to be restricted to eukaryotes,
however, the phenomenon is now firmly established among all domains of life and is
known to mediate a variety of functions. In general, protein glycosylation is believed to
provide the functional diversity required to regulate cellular processes and mediate the
interaction of organisms with varying environments [121].
1.3.1 Protein glycosylation in eukaryotes
Protein glycosylation was first reported in eukaryotes [122] and is now predicted
to modify two-thirds of eukaryotic proteins [123], The role of protein glycosylation in
eukaryotes spans a variety of functions, which include mediating the immune response,
intracellular trafficking, intercellular recognition, protein folding, and protein stability
[ 121] .

N-glycosylation in eukaryotes is a co-translational process that occurs at the
consensus sequence Asn-X-Ser/Thr (where X represents any amino acid except proline)
of newly synthesized polypeptide chains in the lumen of the endoplasmic reticulum (ER)
(reviewed in [124]). In general, eukaryotic N-glycosylation occurs “en bloc”, in which
the glycan is preassembled and attached to the protein target as a unit by a dedicated
glycosylation pathway.
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The eukaryotic N-glycosylation pathway begins with the assembly of the glycan
on the cytoplasmic side of the ER membrane on a dolichol pyrophosphate lipid carrier.
The assembled glycan is then translocated to the ER lumen by an ATP-independent
“flippase” protein. The remaining biosynthetic steps occur in the ER lumen, producing a
conserved tetradecasaccharide (Glc3 Man9 GlcNAc2 ) core oligosaccharide, which is
subsequently transferred to the target protein by a conserved oligosaccharyltransferase
(OTase) [125]. The eukaryotic OTase is a multimeric, membrane-associated enzyme,
composed of at least eight protein subunits [126]. Of the subunits, Sttp3, is highly
conserved, being found in all eukaryotic organisms, and is involved in the catalytic
activity of the OTase complex [127]. In fact, the OTase responsible for bacterial Nglycosylation in C. jejuni, PglB, is homologous to Sttp3 [128] and suggests that
components of protein glycosylation systems are highly conserved. After transfer to the
target protein, the oligosaccharide becomes further modified in the ER and during
transport through the Golgi apparatus by the action of various glycosidases and
glycosyltransferases [129].
In comparison, the mechanism of O-linked glycosylation in eukaryotes is more
variable. No dedicated O-linked glycosylation pathway has been identified and no
consensus sequence for O-glycosylation sites has been observed, such that O-linked
glycosylation may occur on any exposed serine or threonine residue (reviewed in [130]).
While O-linked glycosylation in eukaryotes occurs predominantly in the Golgi apparatus
during protein maturation, O-glycosylation has also been observed in the ER.
In general, eukaryotic O-glycosylation is initiated by addition of a sugar from a
nucleotide-activated sugar, most commonly N-acetyl-galactosamine (GalNAc), by a
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specific glycosyltransferase, followed by sequential addition and elongation of the sugar
chain by the transfer of additional sugars, such as Gal, GlcNAc, Fuc, and N-acetyl neuraminic acid (NeuNAc), by dedicated glycosyltransferases [130, 131]. In yeast, Oglycosylation is initiated by addition of a single mannose from a lipid-linked carrier in the
ER, followed by further modification by the addition of other sugars in the Golgi
apparatus [131]. On the whole, O-linked glycans are smaller than the branched
oligosaccharide attached during N-glycosylation, but both forms of modifications are
similar in that they contribute to diverse roles on a variety of target proteins.
1.3.2 Protein glycosylation in prokaryotes
Protein glycosylation was originally thought to be absent in prokaryotes as they
lack the cellular compartmentalization necessary for the eukaryotic protein glycosylation
systems [124]. However, since the initial discovery of prokaryotic protein glycosylation
on the surface layers (S-layers) of Halobacterium salinarium [132], protein glycosylation
has been established as a common phenomenon in both Archaea and Bacteria.
In comparison to eukaryotic protein glycosylation that occurs on unfolded
polypeptides, prokaryotic protein glycosylation occurs on flexible surface-exposed
regions of folded proteins [133]. As well, the sugars involved in glycosylation are more
diverse. In particular, bacterial glycosylation systems make use of amino- and deoxysugars that are not found in eukaryotes [134]. As such, prokaryotic sugar biosynthesis
pathways may provide unique targets for therapeutic development.
Similar to eukaryotic glycosylation, no general function has been associated with
prokaryotic glycosylation, however, unlike eukaryotic glycosylation, where the function
of many glycoproteins has been studied in-depth, the roles of prokaryotic glycosylation
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remain largely uncharacterized. Regardless, prokaryotic glycosylation has been reported
to have a diverse array of functions, including roles in protein stability and resistance to
denaturation [135], cell competence and cellular localization [136], host colonization
[137, 138], and modulation of the immune response [139]. Most relevant to this study is
the involvement of glycoproteins in bacterial virulence, which has been widely observed
among several bacterial pathogens [140].
1.3.2.1 Bacterial N-linked glycosylation
Bacterial N-linked glycosylation is exemplified by the system characterized in C.
jejuni. To date, C. jejuni is the only bacterium with both well-characterized N-and Oglycosylation pathways, making it a model organism for the study of bacterial protein
glycosylation. Based on the pathway initially described in C. jejuni, bacterial Nglycosylation is similar to the eukaryotic protein glycosylation pathway, in which both
pathways are membrane-mediated and involve synthesis of the glycan on a lipid-linked
intermediate prior to transfer to the target protein by an OTase.
In C. jejuni, over 53 proteins are now predicted to be N-glycosylated with the
majority being localized to the periplasm or surface-associated [141-143]. Nglycosylation occurs within an extended consensus sequence compared to that of
eukaryotes and archaea, Asp/Glu-X]-Asn-X2 -Ser/Thr, where Xi and X2 are any amino
acid except for proline [144]. This sequence is required, but not sufficient for
glycosylation [145, 146]. The genes involved in C. jejuni N-glycosylation are organized
in an operon termed, pgl, for protein glycosylation, and include genes pglA-G [142] that
synthesize the sugars and assemble them into the final heptasaccharide, GalNAc2 [Glc]GalNAc3 -diacetamido bacillosamine [143]. The resulting heptasaccharide is
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subsequently flipped to the periplasm by an ATP-dependent flippase, PglK, and
transferred to an asparagine residue of a target protein by the OTase PglB [142]. Unlike
eukaryotic glycosylation, no further modification of the glycan is performed.
1.3.2.1.1 Additional N-glycosylation systems
In addition to the general N-glycosylation pathway described in C. jejuni, an Nglycosylation pathway has recently been identified in H. pullorum based on identification
of a PglB ortholog, the OTase responsible for mediating N-linked glycosylation in C.
jejuni [147]. The N-linked glycosylation system differs from C. jejuni in that a
pentasaccharide glycan is produced rather than the heptasaccharide identified in C. jejuni.
This indicates significant differences in the glycosylation machineries employed.
Interestingly, while PglB orthologs were identified in H. canadensis and H. pullorum, no
PglB ortholog was evident in the genomes of H. pylori, H. acinonychis, H mustelae, and
H. hepaticus.
Moreover, a distinct N-glycosylation pathway has been described in Haemophilus
influenzae [148-150]. N-glycosylation of H. influenzae occurs by the sequential addition
of sugars in the cytoplasm to the target protein rather than “en bloc” transfer of the
synthesized glycan in the periplasm.
These large differences in protein glycosylation machineries highlight the
diversity and complexity of bacterial protein glycosylation and imply that other protein
glycosylation pathways and mechanisms have yet to be explored.
I. 3.2.2 Bacterial O-linked glycosylation
O-linked glycosylation has also been described in several bacteria. Most common
is the observation of O-glycosylation on surface appendages, such as flagella and pili.
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The pilin subunits of Neisseria spp. [151,152] and Pseudomonas aeruginosa [153] have
been shown to be O-glycosylated. Pilin glycosylation has been implicated in virulence as
modification is required for host cell adherence and twitching motility [154, 155]. As
well, among other species, the flagellins of C. jejuni [156], H. pylori [117], and P.
aeruginosa [157] are also known to be O-glycosylated. Glycosylation of the flagellin
structural subunits is known to be required for the proper production of flagella [117,
118, 156], indicating that in addition to virulence characteristics, O-glycosylation is also
directly associated with production of bacterial virulence factors.
1.3.2.2.1 The model system: O-glycosylation of the C. jejuni flagellins
Flagellin glycosylation was originally identified in Campylobacter spp.
Glycosylation in C. jejuni was demonstrated based on the sensitivity of flagellin serospecificity to periodate oxidation and their affinity for a sialic acid-specific lectin [158].
A flagellar glycosylation locus was later identified including the genes that encode the
flagellins. Structural analysis demonstrated that the flagellins were modified with a
derivative of sialic acid, pse, a nine carbon sugar [156], However, it is now established
that the C. jejuni flagellins are modified by a variety of sugars, including pse and pse
derivatives (PseAcOAc, PseAm, PseAmOGln), as well as an acetamidino derivative of
legionaminic acid (LegAm) [156,159-161]. As well, the extent and variety of flagellin
glycosylation appears to vary from strain to strain which demonstrates the heterogeneity
in the flagellar glycosylation loci.
The C. jejuni flagellins are modified at up to 19 sites, representing up to 10% of
protein mass [156, 159, 160]. As such, glycosylation results in an observed ~10 kDa size
increase when separated by SDS-PAGE [162], The glycosylation sites are present along
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the central domain of the flagellin subunits and are surface exposed [156], suggesting that
glycosylation may be involved in the antigenic variation of the flagellar surface [158].
Although, the mechanism of flagellin O-glycosylation is largely uncharacterized,
it is speculated that a glycosyltransferase acts to modify the flagellins at the basal body of
the flagellar export apparatus, or during secretion. A recent study indicated that the
flagellar glycosylation machinery is localized to the flagellar basal body in the cytoplasm,
which supports that glycosylation occurs in the cytoplasm prior to export and that
glycosylation is independent of the flagellar regulon as it occurs separate from flagellum
assembly [163].
The biological function of flagellin glycosylation remains incompletely
understood, such that flagellin glycosylation may be required for flagellin secretion or
may mediate protein interactions [163]. Nevertheless, Campylobacter flagellin
glycosylation is known to be required for proper flagellum assembly in which mutations
of pse biosynthetic genes result in C. jejuni that is non-motile [162]. As such,
glycosylation plays a key role in C. jejuni virulence as motility is well characterized as an
essential component for C. jejuni colonization in human hosts [164].
1.3.2.2.2 General O-glycosylation systems
Until recently, O-glycosylation was thought to be restricted to single protein
targets, such as the flagellins. However, general O-glycosylation systems have now been
identified. These pathways are similar to the N-glycosylation pathway in which various
proteins are modified with a specific glycan after sugar assembly on lipid carriers by the
action of an OTase.
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The general O-glycosylation system of Neisseria spp. is a prime example [165,
166]. Originally, the pilin protein subunit, PilE, of the Type IV pilus of N. gonorrhoeae
was shown to undergo O-glycosylation at a single serine residue [167]. This
glycosylation system was demonstrated to be similar to the N-glycosylation system of C.
jejuni by interspecies complementation. The two glycosylation systems differed only by
the oligosaccharide transfer in which the OTase, PglO, rather than a PglB homolog of the
C. jejuni system, was required for the transfer of the assembled glycan to the protein
target [168]. The presence of a general glycosylation pathway was initially observed by
the immunoreactivity of multiple proteins with an antibody raised against glycosylated
PilE, which indicated the presence of a shared epitope [166]. All proteins of the N.
gonorrhoeae O-glycosylation system are believed to be periplasmic or cell surface
associated. The identification of periplasmic glycoproteins indicates that O-glycosylation
is not limited to surface exposed proteins [166],
Moreover, the O-glycosylation system of Bacteroides fragilis has also been
implicated in the glycosylation of several extracytoplasmic proteins, including some
proteins that are localized to the inner membrane [169,170]. As well, O-glycosylation in
B. fragilis has been demonstrated to modify essential proteins, such as those involved in
cell division and chromosomal segregation. The B. fragilis O-glycosylation system is
unique in that a consensus sequence has been identified; Ser/ThrAla/Ile/Leu/Met/Thr/Val. It is anticipated that over half of the extracytoplasmic proteins
of B. fragilis are glycosylated [170].
Overall, the diversity of the O-glycosylation systems identified thus far, including
the variety of protein targets based on cellular function and localization, indicate that
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glycosylation is much more widespread than previously believed and that protein
glycosylation may have significant implications for both essential cellular functions for
viability as well as in the production of bacterial virulence factors.
1.3.3 H. pylori and protein glycosylation
The flagellins, FlaA and FlaB, are the only glycoproteins fully characterized in H
pylori. The first evidence of flagellin glycosylation in H. pylori arose from
characterization of the neuA/flmD gene cluster hypothesized to be involved in protein
glycosylation [119]. In this study, the flagellins were chemically labelled with
digoxigenin (DIG)-hydrazide, indicating that they were modified via glycosylation.
Interestingly, glycosylated forms of the flagellins in the cytoplasm could not be detected,
which may indicate that glycosylation of the flagellins is likely coupled to their secretion
from the flagellar apparatus [119]. This finding remains to be further characterized.
Purified flagellins were subsequently analyzed by mass spectrometry and the
sugar substituent identified as pse, similar to C. jejuni [117]. Unlike the flagellins of C.
jejuni, the H. pylori flagellins demonstrated little heterogeneity in sugar content or sugar
distribution. This likely reflects the presence of the membrane sheath around the flagellar
filament that limits interaction with the surrounding environment. This is in contrast to
the C. jejuni flagellins, which are decorated by a variety of carbohydrates and are
believed to be involved in antigenic recognition [160, 161]. As well, the H. pylori
flagellins were both shown to be less heavily glycosylated than the C. jejuni flagellins. H
pylori FlaA was observed to be glycosylated at up to 7 sites and FlaB to be glycosylated
at up to 10 sites [117]. Comparatively, the C. jejuni flagellins are glycosylated at up to 19
sites, which is reflected in a noticeable molecular mass increase by SDS-PAGE. A similar
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molecular mass increase by SDS-PAGE is not observed with the H. pylori flagellins
[118]. Regardless, similar to C. jejuni, the glycosylation sites of the H. pylori flagellins
are located in the central core of the flagellin subunits. This suggests that flagellin
glycosylation in both species may share a similar biological role. Furthermore, a similar
set of enzymes for pse biosynthesis in C. jejuni has been described for H. pylori [171].
1.3.3.1 The requirement for pse biosynthesis in H. pylori
Our laboratory and others have demonstrated that mutants of H. pylori defective
in the enzymes required for pse biosynthesis are non-motile and lack production of proper
flagella [117-119, 162]. As motility is a requirement for H. pylori’s colonization, protein
glycosylation can be considered a key virulence factor in H. pylori’s pathogenesis.
Despite the well-established role of flagellin glycosylation in H pylori flagellum
production, the exact biological role of glycosylation remains uncharacterized.
The biosynthesis pathway for pse was initially investigated based on mutations of
sugar-nucleotide modifying enzymes [117, 119]. In particular, our laboratory
demonstrated that FlaAl exhibits UDP-GlcNAc Códehydratase/C4 reductase activity
[172, 173]. As well, HP0366 was shown to be an aminotransferase and to convert the
product of FlaAl [174]. Knockout mutants offlaAl (hp0840) and hp0366 resulted in H.
pylori that lacked proper flagella, were non-motile, and exhibited altered LPS profiles
[118, 174]. Both mutants were successfully complemented in trans with restoration of
motility and LPS production [118,174]. The entire pse biosynthesis pathway has since
been solved and is known to start with UDP-GlcNAc and result in the generation of an
activated form of pse, CMP-pse. The entire pathway has been observed in a “single pot”
reaction [171]. FlaAl and HP0366 perform the first two steps of the pse pathway as
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depicted in Figure 2. While the pse biosynthesis machinery has been fully elucidated in
H. pylori, the mechanism of O-glycosylation remains uncharacterized. However, it is
thought to require an unidentified glycosyltransferase which adds pse directly to the
flagellins, similar to the eukaryotic O-glycosylation system.
I. 3.3.2 Evidence of additional protein glycosylation in H. pylori
In H. pylori, the only accepted glycoproteins are the flagellins. However, the
observation of general glycosylation systems in related species, C. jejuni and H pullorum
[142, 147], suggest that H. pylori may also possess additional glycoproteins.
Upon investigation of the pse biosynthesis pathway, our laboratory has observed
the presence of several anomalies that indicate that both additional glycoproteins and
additional glycosylation pathways are likely present in H pylori.
Characterization of isogenic mutants of the first two steps in the pse biosynthesis
pathway, flaA 1 and hp0366, first indicated that glycosylation extends beyond the
flagellins and pse glycosylation in H. pylori. Both pse mutants, flaAl and hp0366, were
shown to be non-motile and lack flagella, as expected since pse biosynthesis is disrupted
and pse is known to be required for flagellum production [118, 174]. The flagellins from
total cell lysates of both of the pse mutants were assessed for glycosylation by chemical
labelling with DIG-hydrazide, as used commonly in the field of glycoproteomics [175].
As anticipated, the flagellins of the flaAl mutant were non-glycosylated. Comparatively,
the flagellins of the hp0366 mutant appeared glycosylated. This was surprising as pse
biosynthesis is disrupted in the mutant [174]. The observation of glycosylated flagellins
in the hp0366 mutant suggests that there exists an alternative glycosylation pathway in H.
pylori, such that there may be a branch in the pse biosynthesis pathway (Figure 2: A).
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Figure 2: Initial steps for pse biosynthesis and the proposed alternative
glycosylation pathways in H. pylori. The pse biosynthesis pathway in H. pylori has been
fully elucidated. The first two steps in the pse biosynthesis pathway are mediated by
FlaAl, a dehydratase, and HP0366, an aminotransferase, respectively. The HP0366
product is subsequently converted to CMP-pse by the remaining enzymes in the pathway
for incorporation on the flagellins. In addition to pse-glycosylation, several lines of
evidence indicate the presence of additional glycosylation pathways in H. pylori. The
demonstration of glycosylated flagellins in the hp0366 mutant, but not the flaAl mutant,
suggests that there may be an alternative glycosylation pathway that branches from the
pse pathway (A). As Well, based on glycosylation of the hp0366 flagellins and the lack of
flagellum production in the waaL mutant, a completely pse-independent glycosylation
pathway is hypothesized (B).
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Despite glycosylation of the hp0366 flagellins, the mutant was non-motile indicating that
the modification of the hp0366 flagellins is not due to the presence of an additional
aminotransferase that can complement the defect in hp0366 and that the hp0366 flagellin
glycan is distinct from pse [118]. Alternatively, the glycosylation of the hp0366 flagellins
may be due to a separate pse-independent glycosylation pathway in H. pylori (Figure 2:
B).
In addition to the surprising flagellin glycosylation of hp0366, both pse mutants
displayed altered LPS profiles [118, 174]. In comparison to WT LPS, the LPS offlaAl
exhibited a reduced O-antigen with an altered serotype, while the LPS of hp0366 was
completely O-antigen deficient. This effect on LPS production by the pse mutants was
unexpected as pse is not involved in the production of H. pylori LPS [69, 70], As well,
this effect on LPS production was not due to joint transcriptional regulation as
quantitative real-time PCR (qRT-PCR) data on the pse mutants indicated no significant
changes in the gene expression of LPS biosynthetic enzymes that would result in
decreased production of O-antigen (Creuzenet Lab, unpublished). The observation of a
defect in LPS production in the pse mutants suggests that other proteins are affected by
pse glycosylation. In particular, this finding indicated that LPS biosynthetic enzymes may
require pse glycosylation for function [175].
Moreover, the hp0366 O-antigen deficient LPS profile is reminiscent of a defect
in the WaaL, or O-antigen ligase, required for O-antigen biosynthesis. As such, the H.
pylori WaaL could require glycosylation for function. A waaL knockout mutant in H
pylori was constructed and characterized [175]. As expected, the waaL LPS profile was
O-antigen deficient, similar to hp0366. Upon characterization of the waaL mutant, it was
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observed that the mutant was non-motile and lacked production of flagella. This was not
anticipated as waaL is not involved in flagellar assembly [104]. As such, it was proposed
that waaL may be required for protein glycosylation [175]. Interestingly, the flagellins of
the waaL mutant appeared glycosylated by chemical labelling. This suggests that if waaL
is required for protein glycosylation, it acts separately from the pse glycosylation
pathway and modifies other proteins besides the flagellins (Figure 2: B). These proteins
may include other components of the flagellar apparatus, which prevent flagellum
assembly in the waaL mutant.
Furthermore, a recent study conducted by our laboratory examined the presence
of additional glycoproteins in the soluble fraction of H. pylori and their dependence on
pse biosynthesis [176]. In this study, glycoproteins were detected by chemical DIGlabelling. By this method, additional glycoproteins besides the flagellins were observed in
the soluble protein fraction of H. pylori, indicating additional pse-dependent
glycoproteins. Moreover, glycoproteins were also observed in the soluble protein
fraction offlaAl and hp0366, suggesting the presence of pse-independent glycoproteins.
This is consistent with a study that utilized a metabolic labelling approach to detect
glycoproteins, which also observed the presence of additional glycoproteins in H. pylori
[177],
In addition to the detection of both pse-dependent and pse-independent soluble
glycoproteins in H. pylori, sugars were extracted from the protein fractions containing
glycoproteins by acid hydrolysis and identified by mass spectrometry (MS). The sugars
identified from the glycoprotein fractions included pse, previously identified on the H
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pylori flagellins, as well as uncharacterized sugars in H. pylori that include pse
derivatives, bacillosamine derivatives and a legionaminic acid derivative [176].
Together, these findings indicate that protein glycosylation in H. pylori affects
proteins other than the flagellins and that multiple glycosylation pathways are likely
present. The study presented here, aims to further characterize protein glycosylation in H
pylori. In particular, the possibility of glycoproteins in the membrane fraction of H. pylori
is investigated. As well, the link between protein glycosylation and LPS biosynthesis is
further explored.
1.3.4 Similarities between protein glycosylation and LPS biosynthesis
Based on comparison of the biosynthetic pathways leading to the production of
glycolipids and glycoproteins, striking similarities can be observed. In many cases, the
biosynthesis of LPS and protein glycosylation pathways involve homologous enzymes,
which suggest a possible evolutionary connection [178].
The similarity of the two pathways can be appreciated by the number of reports
which inaccurately identify components of LPS biosynthesis for protein glycosylation
and vice versa. For instance, the pgl locus for N-glycosylation in C. jejuni was originally
identified and proposed to be required for the biosynthesis of lipooligosaccharide (LOS),
a derivative of LPS which lacks the repeating O-antigen units [179].
In particular, both LPS biosynthesis and “en bloc” N- or O- glycosylation are
membrane-mediated events which are preceded by assembly of the oligosaccharide units
on an undecaprenyl lipid carrier. This is similar to the N-glycosylation pathway in
eukaryotes in which the glycan is assembled on a dolichol lipid carrier in the ER
membrane. As well, assembly of the oligosaccharide is initiated by similar
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glycosyltransferases and in some cases the same initiating enzyme is utilized for both
pathways [178]. For example, P. aeruginosa employs the WecA homolog, WbpL, for
both LPS synthesis and pilin glycosylation [180] and the glycosyltransferase, WbpO, for
both LPS synthesis and flagellin glycosylation [181]. Moreover, some P. aeruginosa pilin
glyeans have been shown to share structural similarity to that of its O-antigen [153]. As
well, the UDP-GlcNAc/Glc-4 epimerase of C. jejuni, Gne, is involved in the production
of both the N-linked heptasaccharide for protein glycosylation and LOS [182].
In addition, both “en bloc” bacterial glycosylation and O-antigen biosynthesis
pathways require the translocation of the lipid-linked intermediate oligosaccharides to the
periplasm. Interestingly, as described, the flippase responsible for the translocation of the
O-antigen chain in H. pylori, Wzk, is a homolog of the translocase involved in C. jejuni
N-glycosylation, PglK [93]. Furthermore, the H influenzae N-glycosylation pathway was
recently shown to involve the transfer of sugar precursors previously implicated in LOS
biosynthesis [149],
Lastly, the assembled glycans are attached to their respective cell structures in the
periplasm. O-antigen is attached to lipid A by the O-antigen ligase, or WaaL, whereas the
substrate for protein glycosylation is attached to serine or threonine residues for Oglycosylation or asparagine residues for N-glycosylation by an OTase. It is believed that
WaaL ligases and O-linked OTases are evolutionarily related, whereas the origin of Nlinked OTases is likely distinct [178]. However, in all cases, OTase activity is believed to
be similar to that of WaaL ligases. In fact, the OTase responsible for N-linked protein
glycosylation in C. jejuni, PglB, was shown to be able to use O-antigen as a substrate
[183], Interestingly, a Wzy_C motif characteristic of WaaL ligases is also present in O-
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linked OTases, including PglL of N. meningitidis and PilO of P. aeruginosa, that mediate
O-linked pilin glycosylation [153, 184], Indeed, the WaaL of H. pylori exhibits the same
degree of sequence similarity to PglL as it does with known WaaLs from other species
[175]. Further, WaaL ligase activity appears to be independent of the substrate glycan
structure, suggesting the potential for WaaL to act as a ligase for a variety of substrates
[67]. In fact, it has been suggested that glycosylation of the adhesin EmaA in
Aggregatibacter actinomycetemcomitans is mediated by WaaL [185]. This may be
similar to the phenomenon observed by our laboratory, in which is it hypothesized that
the H. pylori WaaL may act as a general glycosyltransferase and modify proteins
involved in flagellar biosynthesis [175].
In general, the similarity of protein glycosylation pathways and LPS biosynthesis
in bacteria suggest that further interconnections are likely present. As such, it is
anticipated that with the increasing reports of bacterial protein glycosylation, further
involvement and overlap with the LPS biosynthesis machinery will be observed.
1.3.5 Methods to detect glycoproteins
Several methods have been developed for the study of glycoproteins. However,
the heterogeneity of glycan composition and linkage sites poses many challenges.
Furthermore, the strategy employed for glycoprotein characterization depends on the
quantity and purity of the sample. In many cases, complementary approaches are required
in order to fully characterize both the sugar composition of the glycan and the linkage site
[186]. As well, many of these methods originated from characterization of eukaryotic
glycoproteins in which the core structure and sugar components are fairly conserved. In
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the case of prokaryotic glycosylation, many glycans are composed of unique sugars,
which cannot be identified via the same methods [187].
Initial steps in identifying and characterizing glycoproteins typically begins with
separation of samples by ID SDS-PAGE or 2-dimensional gel electrophoresis (2-DE)
[186]. By ID SDS-PAGE separation, glycoprotein bands are often diffuse due to
heterogeneous glycosylation and the presence of multiple glycoforms or exhibit aberrant
migration. Similarly, by 2-DE, multiple protein spots are evident in a diagonal pattern
representing various glycoforms of differing molecular mass and isoelectric point [188].
However, in many cases, glycoproteins, especially those that are membrane associated,
are poorly represented by ID SDS-PAGE or 2-DE analysis due to poor solubility or, in
the case of the latter, difficulties with isoelectric focusing [186]. Thus, several additional
methods are utilized to enrich samples in glycoproteins and aid in their detection and
characterization.
1.3.5.1 Lectins
Lectins are non-enzymatic proteins that bind specifically to morio- or oligo
saccharides. In many cases their binding specificity has been defined. Thus, lectins serve
as a valuable tool to detect, purify, and assess the presence and structure of glycoproteins
[189]. As such, panels of lectins with known specificities have been used to detect the
presence of specific sugar epitopes [190]. Furthermore, the development of lectin affinity
chromatography matrices has allowed purification of glycoprotein pools by specific lectin
binding [186,191]. As well, the availability of lectin arrays allows for qualitative and
quantitative glycoprotein glycan profiling [192]. Nevertheless, this form of analysis
typically requires an a priori knowledge of the type of glycan expected. This information
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is not always readily available or predictable, especially in the case of bacterial
glycoproteins in which unusual sugars are the norm.
1.3.5.2 Enzymatic and chemical release of glycans
Removal of intact glycans for MS analysis can be facilitated by enzymatic
cleavage by glycosidases. The effectiveness of this approach is based on the substrate
specificity of the enzyme. As such, a prior knowledge of the type of sugar linkage is
required, as not all glycans can be released [186], Enzymatic release of N-glycans is most
common as a greater variety of enzymes have been identified with varying substrate
specificity. The most commonly used enzyme is the amidase peptide N-glycosidase F,
PNGase F, which cleaves the linkage between GlcNAc and asparagine and allows for the
broad removal of N-linked sugars [193, 194]. Conversely, the enzymes available to
cleave O-linked glycans are much more limited in substrate specificity. Thus, alternative
methods are generally used to investigate O-glycosylation. Enzymatic release can be used
in conjunction with reverse phase (RP) high performance liquid chromatography (HPLC)
[186]. This strategy allows the carbohydrate content to be estimated based on differences
in the elution profiles before and after enzymatic treatment.
Alternatively, chemical release of glycans can be employed. Hydrazinolysis
preferentially releases O-linked glycans but conditions can be adjusted for the release of
N-linked glycans as well [186, 194], However, in the case of large O-linked glycan
structures, the oligosaccharide can be sequentially degraded resulting in the release of
monosaccharide units, which complicates analysis. O-linked glycans are also commonly
released by P-elimination in alkaline conditions [194, 195]. However, chemical removal
of glycans can result in degradation.
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As well, acid hydrolysis can be employed to non-specifically cleave
monosaccharides for compositional analysis of the glycan of interest [196]. Conversely,
treatment of glycoproteins with trifluoromethanesulfonic (TFMS) acid can be used to
degrade the attached glycan, leaving the protein component intact for MS analysis [197].
1.3.5.3 Chemical labelling strategies
In order to enhance detection and subsequent analysis of glycoproteins, several
glycoprotein-specific chemical labelling strategies have been developed based on
periodic acid-Schiff staining (PAS) [198,199], This strategy enables the introduction of a
detectable label after mild oxidation of the glycan and has been employed for
glycoprotein samples in-solution or after immobilization on a membrane support [200],
Briefly, samples containing glycoproteins are treated by mild oxidation with sodium
periodate or periodic acid. Mild oxidation converts vicinal diols present on carbohydrates
to reactive aldehyde groups that specifically react with hydrazide groups at basic pH to
form a hydrazone linkage and allow incorporation of a specific tag. A variety of tags have
been developed for this purpose, including hydrazide-linked digoxigenin (DIG) that can
be detected by an anti-DIG Western blot, chromophores and fluorescent probes [201204]. For the purpose of glycoprotein detection in this study, a hydrazide-linked
derivative of biotin was utilized that can be detected by streptavidin (Figure 3).
1.3.5.4 Metabolic labelling
Metabolic labelling strategies have also been developed to detect cellular
glycoproteins. Compared to chemical labelling strategies that are conducted after cell
lysis, metabolic labelling incorporates the label during growth via supplementation of
growth media with unnatural sugars [205]. Unnatural sugar monosaccharides have been
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Figure 3: Glycoprotein-specific chemical labelling with biotin-hydrazide.
Glycoproteins can be specifically labelled in-solution or immobilized on a nitrocellulose
support by a modification of periodic acid Schiff (PAS)-staining. By this method,
glycoproteins are chemically labelled and detected by the incorporation of a specific tag,
such as biotin. Samples containing glycoproteins are treated by mild oxidation with
sodium periodate. Mild oxidation converts vicinal diols present on sugar glycans to
reactive aldehyde groups that specifically react with hydrazide groups at basic pH to form
a hydrazone linkage. This allows for specific incorporation of the biotin tag. Biotinlabelled glycoproteins can subsequently be detected by interaction with a fluorescent
conjugate of streptavidin.
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developed containing ketone, azide or thiol groups. During growth, these unnatural
sugars are converted to nucleotide-activated sugar analogs that enter normal biosynthetic
pathways, which ultimately lead to their incorporation in glycoproteins [206]. The tag can
then be selectively detected by Western blot or other methods. This technique provides
the advantage of being able to track glycosylation over time in live cells. However, the
unnatural sugar derivatives can also be incorporated into other cell structures [206],
which can interfere with the interpretation of results. This system was originally
optimized for eukaryote cells, however, metabolic labelling with azido-GlcNAc has since
been used to assess the glycoprotein content in H pylori [177]. While the results of this
study indicate that several additional glycoproteins besides the flagellins are present in H
pylori, the validity of the technique in bacteria and the specific labelling of glycoproteins
remains to be established.
1.3.5.5 Mass spectrometry analyses of glycopeptides and sugars
Most often enzymatic analysis and labelling strategies only provide preliminary
evidence of the presence of glycoproteins, the linkage site, and the glycan structure [186].
For complete characterization of the glycosylation site and the identification of the
glycan, analysis by mass spectrometry (MS) is required. In short, MS is an analytical
technique that separates sample components after ionization based on their mass to
charge ratio (m/z). MS has been particular useful in the characterization of bacterial
glycosylation in which the sugars are often unknown [187]. However, in general, MS
analysis of glycoproteins poses many more challenges than non-glycosylated proteins
[186], Firstly, glycopeptides are poorly abundant relative to non-glycosylated peptides.
This is further compounded by the existence of multiple glycoforms which results in
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lower signal intensities and less efficient ionization of glycosylated peptides. As well, MS
analysis relies on the digestion of proteins into peptides. Glycosylation can hinder protein
digestion by masking accessibility to proteinase cleavage sites, thereby limiting peptide
coverage of glycoproteins and preventing the detection of glycosylated peptides.
In order to enhance the detection of glycoproteins, previous enrichment strategies
are often required. If the carbohydrate moiety is known, purification methods such as
lectin affinity chromatography can be used. As well, for oligosaccharide analysis, initial
separation of glycans by capillary electrophoresis (CE) or HPLC is beneficial to enhance
MS sensitivity [207]. However, in the case of novel bacterial glycosylation in which the
glycan is typically unknown, crude separation techniques can often be used to enrich
samples.
Furthermore, recent improvements in MS instrumentation have allowed for
analysis of complex glycoprotein samples. Briefly, target glycoproteins are separated by
ID SDS-PAGE or 2-DE and the respective protein band or spot is excised. Glycoproteins
can subsequently be analyzed by “top down” or “bottom up” MS strategies [208], In a top
down approach to analysis, intact glycoproteins are assessed by electrospray ionization
(ESI)-MS. Low range masses often correspond to glycan ions that fragment from the
glycoprotein backbone. Comparatively, a bottom up MS approach requires glycoproteins
to be enzymatically digested into peptides and analyzed by liquid chromatography-matrix
assisted laser desorption ionization with time of flight analysis, LC-MALDI-TOF MS,
and/or by ESI-MS. By this approach, masses are initially separated by LC. The peptide
masses can be identified to determine the glycoprotein candidate. Further, masses can be
selected for collision-induced dissociation (CID) and MS/MS analysis, which provides a
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further fragmentation pattern. In general, glycosidic bonds are weaker than peptide bonds
and fragment more easily allowing glycan sequence information to be obtained by
MS/MS analysis [187]. The MS/MS fragmentation pattern can also decipher the glycan
attachment site. In many cases, final sugar composition and structure is often obtained by
nuclear magnetic resonance (NMR) due to the unusual nature of bacterial glycans [208].
More recently, alternative MS techniques by electron capture dissociation (ECD) and
electron transfer dissociation (ETD) have been applied to glycopeptide analysis [207].
Altogether, MS analysis is typically the ultimate proof of glycosylation and can be used
to analyze the glycan, the attachment site, and the candidate glycopeptides, if the correct
form of analysis is employed.
1.4 Hypothesis and objectives
At the onset of this research, the only glycoproteins fully characterized in H
pylori were the flagellins, flagellin A (FlaA) and flagellin B (FlaB). Both flagellins are
modified with the sugar pseudaminic acid (pse) and flagellin glycosylation is known to be
required for proper flagellum assembly [117-119]. Disruption of pse biosynthesis by
knockout mutations of the first two enzymes in the pse biosynthesis pathway, flaA 1 and
hp0366, resulted in H. pylori that lack flagellum and are non-motile, as expected since
pse glycosylation is interrupted. While the flagellins offlaAl were non-glycosylated, the
flagellins of hp0366 still appeared glycosylated by glycoprotein-specific chemical
labelling, despite disruption of pse biosynthesis. This finding suggests that there is an
alternative protein glycosylation pathway in H pylori, which may be completely
independent of the pse biosynthesis pathway or branch from the pse biosynthesis pathway
(Figure 2). Furthermore, this finding indicates a complex biological role for flagellin
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glycosylation in which there is a strict requirement for pse for proper flagellum
production. The exact role of flagellin glycosylation is unknown, however, the
alternatively glycosylated flagellins of the pse mutants will provide insight to the role of
pse-specific flagellin glycosylation.
In addition, both pse mutants displayed altered LPS profiles. This finding was
surprising as the sugar products from both FlaAl and HP0366 are not precursors for LPS
biosynthesis. As such, additional glycoproteins besides the flagellins are predicted to be
present in H. pylori. In relation to LPS, the products of FlaAl and HP0366 may be
precursors for sugars that glycosylate membrane proteins involved in LPS biosynthesis.
Moreover, the LPS phenotype of hp0366 is O-antigen deficient, which is reminiscent of a
defect in the O-antigen ligase, WaaL, required for LPS biosynthesis. This suggests that
the WaaL of H pylori may require glycosylation by pse or a pse-derivative for proper
function.
Furthermore, an apparent link was observed between protein glycosylation and
LPS biosynthesis in H. pylori. While both FlaAl and HP0366 are dedicated to the pse
biosynthesis pathway and are required for flagellin glycosylation and flagellum assembly,
both pse mutants displayed unexpected altered LPS profiles, as described above.
Similarly, while WaaL, the O-antigen ligase, is conserved in LPS biosynthesis, a
knockout mutation of waaL in H. pylori prevented flagellum assembly. Interestingly,
flagellin glycosylation was not altered in the waaL mutant suggesting that other
components of the flagellar assembly are modified by WaaL. This finding suggests that
WaaL may act as a general glycosyltransferase and may modify both lipid A and

47

proteins. Overall, these discrepancies in established pathways suggest an intimate link
between LPS biosynthesis and protein glycosylation in H. pylori.
Based on the combined observations of the pse and waaL mutants, the following
hypothesis was proposed: Protein glycosylation in H pylori affects several proteins in
addition to the flagellins involving both nse-denendent and pse-independent glycosylation
and plays a key role in virulence factor production.
To address this hypothesis, three main objectives were investigated:
(i)

To elucidate the novel flagellin glycosylation pathway observed in the hp0366
mutant.

(ii)

To demonstrate the presence of novel membrane-associated glycoproteins in H.
pylori, including proteins other than the flagellins modified by pse or by other
sugars.

(iii)

To characterize the link between protein glycosylation and LPS biosynthesis in H
pylori.

CHAPTER 2: Materials and Methods
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2.1 Bacterial strains and growth conditions
Bacterial strains and plasmids used in this study are listed in Table 1. Unless
indicated, all H. pylori strains were grown on brain heart infusion yeast extract (BHI-YE)
agar plates (EMD, BioShop) supplemented with 7.5% horse serum (Gibco), 4.55mM
sodium pyruvate (Alfa Aesear), 4pg/mL amphotericin B (Calbiochem), 5pg/mL
trimethoprim (Sigma), and lOpg/mL vancomycin (BioBasic). When necessary, selection
with 5pg/mL kanamycin (BioBasic), 12pg/mL chloramphenicol (BioBasic) and/or
18pg/mL metronidazole (Biobasic) was applied. All strains were grown under
microaerophilic conditions at 37°C with 5% oxygen, 10% carbon dioxide and 90%
humidity in a tri-gas incubator (NuAire) or in gas jars with Campygen gas packs (Oxoid)
for 36 hour periods until confluent.
All H. pylori strains were maintained as freezer stocks at -80°C containing 25%
glycerol. Freezer stocks were revived on BHI-YE agar plates and cells were expanded in
three stages. After initial revival from freezer stock, bacteria were grown for 36-48 hours
and then harvested with a sterile cotton swab, spread to a new plate and grown for an
additional 36 hours. The confluent lawn was resuspended in lmL of BHI broth
containing no supplements or antibiotics with a sterile cotton swab and distributed to 5-8
BHI-YE agar plates and grown for 36 hours. These plates were then harvested in lOmL
of BHI broth and with sterile cotton swabs were transferred to up to 50 BHI-YE agar
plates and grown for a final 36 hour period. The final 50 plates of growth were harvested
in 3 separate volumes of 45mL of 0.85% saline in sequence to prevent oversaturation of
each resulting suspension and to ensure recovery of the maximum yield of cells. Cells
were pelleted by centrifugation at 3,22Oxg for 30 minutes at 4°C in a clinical
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Table 1: Description of bacterial strains used in this study
Description
Reference
Strain
Helicobacter pylori
Sequenced wild-type strain [209] Lab stock provided
26695
by Dr. D.E. Taylor
SSI

Mouse colonization strain

[210]

NCTC 11637

Wild-type strain

[211] Lab stock provided
by Dr. S. Logan

flaAl::kan

flaAl (hp0840) gene
disrupted in strain NCTC
11637 by a kanamycin
resistance cassette

[118]

hp0366::kan

hp0366 gene disrupted in
strain NCTC 11637 by a
kanamycin resistance
cassette

[174]

waaL::kan

waaL (hpl039) gene
disrupted in strain NCTC
11637 by a kanamycin
resistance cassette

[175]

Escherichia coli
DH5a

JM109

[212]
F’<D80dlacZAM15 recAl
endAl gyrA26 thi-1 hsdR17
supE44 relAl deoRA
(lacZYA-argF)U 169
F' traD36 proA B+lacP
A(lacZ)M15/ A (lac-proAB)
glnV44 el4' gyrA96 recAl
relAl endAl thi hsdR17

[213]
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centrifuge (Eppendorf). The supernatant was discarded and the cell pellets were
resuspended in 15mL of 0.85% saline, combined, and spun again at 3,220xg for 30
minutes at 4°C. The supernatant was removed and the cell pellet was frozen at -20°C for
future protein analysis.
E. coli strains were grown at 37°C in Luria Bertani (LB) Miller broth with
agitation for up to 16 hours. Selection with 100pg/mL of ampicillin and 34pg/mL of
chloramphenicol was applied when necessary.
2.2 Growth of H. pylori in liquid culture and analysis of the secretóme
Wild-type and pse mutant H pylori strains were grown on BHI-YE agar plates
with background and selective antibiotics for 36 hours. After initial growth on solid
medium, the cells were harvested in brucella broth (BD). Brucella broth for liquid
cultures was prepared with 1% (3-cyclodextrin (EMD Millipore) as a protein-free nutrient
source [214,215] with the background antibiotics and supplements used for standard H.
pylori growth conditions (see Section 2.1). Prepared broth was inoculated with each H.
pylori suspension to a final ODéoonm of 0.2, where ODóoonm of 1.0 is equal to
approximately 3X108 cells. Broth cultures were grown with gentle agitation at 37°C in
microaerophilic conditions supplied by growth in anaerobic jars with Campygen gas
packs (Oxoid) for 40 hours. After growth in broth, cells were pelleted by centrifugation at
3,220xg for 30 minutes at 4°C. The supernatant was removed and ultracentrifuged at
100,000xg for 1 hour at 4°C to pellet membrane blebs. The ultracentrifuged supernatant
was removed and concentrated by ammonium sulphate precipitation and membrane bleb
pellets were resuspended in lmL of 50mM ammonium bicarbonate, pH 7.5. Samples
were further concentrated by lyophilization.
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2.3 Phenol red urease activity assay to monitor cell lysis
In order to assess the degree of cell lysis of H. pylori grown in broth, total urease
activity and urease activity in cell pellets and cell supernatants were compared. A 2mL
sample from each H. pylori liquid culture was recovered and normalized to an OD600 of
0.2. Two lmL aliquots were used for analysis; lmL was centrifuged at 2051xg for 10
minutes to pellet cells and separate the supernatant and the other lmL was used to
measure urease activity from total cells. After centrifugation, the supernatants were
removed to a new eppendorf tube and cell pellets were resuspended in lmL of brucella
broth, the original sample volume. Thirty microlitres of each sample were added to the
wells of a 96-well plate in duplicate. To each sample, 200pL of urease reagent (5mM
sodium phosphate pH 7.5, 0.15M NaCl, 0.33M Urea, 0.001% phenol red) were added.
Urease activity was detected by measuring the ODeoonm over time for 1.5 hours at 120
second intervals at 37°C using a Microplate Reader (BioRad). The pH indicator, phenol
red, reflected urease activity as the colour change of phenol red from yellow to red
signified conversion of urea to ammonia and carbon dioxide.
2.4 Supernatant concentration by step-wise ammonium sulphate precipitation
The supernatant of each H. pylori strain was recovered from ultracentrifugation
and split into three 50mL centrifuge tubes in even volumes for concentration. Ammonium
sulphate precipitation was performed at 4°C. Ammonium sulphate (J.T Baker) was added
to the samples to 40% (w/v) gradually over the course of 30 minutes while being mixed
on a nutating platform. After all ammonium sulphate was dissolved, the samples were
mixed for an additional 30 minutes and then centrifuged at 18,514jcg- in a clinical
centrifuge for 20 minutes. The supernatants were removed to new centrifuge tubes and

53

ammonium sulphate was gradually added to 60% (w/v) from 40% with continuous
mixing on a nutator. The samples were mixed for an additional 30 minutes and then spun
at 18,514xg for 20 minutes to pellet protein. The supernatants were removed to new
centrifuge tubes and ammonium sulphate was gradually added to 80% (w/v) from 60%
and mixed overnight. The samples were then centrifuged at 18,514xg for 20 minutes to
pellet remaining protein. The final supernatants were removed to a new centrifuge tubes
and frozen at -20°C. All ammonium sulphate pellets were resuspended in lmL of 20mM
Tris-HCl pH 7.5, lyophilized for further concentration and analyzed by SDS-PAGE (see
Section 2.9). Alternatively, samples were dialyzed overnight in binding buffer, 20mM
Tris pH 7.5, 50mM NaCl, at 4°C prior to further separation by anion exchange
chromatography.
2.5 Supernatant concentration and buffer exchange by ultrafiltration
To limit protein loss by ammonium sulphate precipitation and/or dialysis,
ultrafiltration was used for concentration and buffer exchange of cell supernatants prior to
anion exchange chromatography into binding buffer (20mM Tris pH 7.5, 50mM NaCl).
After ultracentrifugation of cell supernatants, supernatants were processed individually
through a pressurized ultrafiltration stirred cell with a polyethersulfone porous membrane
disc with a 10 kDa molecular weight cut off (MWCO) (Millipore). Operating pressure
was maintained below 70 psi. Diafiltration was performed 5X to remove pepsin and other
contaminating proteins present in the broth culture media. The retentate from each sample
was subsequently separated by anion exchange chromatography.
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2.6 Anion exchange chromatography of cellular supernatants
Supernatants were dialyzed into anion exchange binding buffer by either dialysis
or ultrafilatration (see Section 2.4 or Section 2.5), as described. Anion exchange
chromatography was performed using the AKTA Explorer fast protein liquid purification
system (Amersham) with a 1,04mL AcroSep™ Q Ceramic Hyper D F column (PALL
Life Sciences) according to the manufacturer’s instructions. The system was run with a
constant flow rate of lmL/min with backpressure no greater than 0.3 mPa. The column
was equilibrated with 10 CV (column volumes) of binding buffer before sample injection.
Samples were filtered through a 0.45 pm PVDF membrane filter (Millipore) prior to
sample loading. The protein samples were injected individually with a syringe into a
lOmL super-loop (GE Healthcare). After sample loading, the column was washed with 10
CV of binding buffer to remove all unbound proteins. Bound proteins were eluted over 40
CV of a linear gradient to 100% elution buffer (20mM Tris pH 7.5, 1M NaCl). One
millilitre fractions were collected and directly concentrated by 80% ammonium sulphate
precipitation. Pellets were resuspended in sodium dodecyl sulphate (SDS) loading buffer
and analyzed by 12% SDS-PAGE and anti-FlaA/B Western blot (see Section 2.9 and
refer to Table 2). Following purification and between samples, the column was stripped
with 10 CV of elution buffer and re-equilibrated in 5 CV of binding buffer. The column
was stored in 20% (v/v) ethanol until further use.
2.7 Cell fractionation by differential centrifugation
H. pylori strains were grown on 50 BHI-YE plates, as described (see Section 2.1).
After 36 hours of growth, plates were harvested in 0.85% saline and whole cells were
pelleted by centrifugation at 4,000xg for 30 minutes at 4°C. Pellets were resuspended and
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washed in 25mL of 0.85% saline and pelleted at 4,000xg for 30 minutes at 4°C again.
The final pellet was resuspended in 30-40mL of 0.85% saline to a final OD60o of 6-10.
The cells were subsequently lysed by passage through a French press pressure cell
(GlenMills) four times at 15,000 psi on ice. All centrifugation steps were performed at
4°C. Cellular debris and unlysed cells were pelleted by centrifugation at 5,000xg for 30
minutes. Insoluble proteins were removed from the supemantant by centrifugation at
13,000xg for 1 hour. The insoluble protein pellet was washed in 50mM sodium phosphate
pH 7.2, 0.3M NaCl and pelleted again by centrifugation in a table top microcentrifuge
(Eppendorf). Membrane proteins were pelleted by ultracentrifugation (Optima-XL 100K
ultracentrifuge, Beckman Coulter, 70-Ti rotor) at 100,000xg for 1 hour at 4°C. The
supernatant recovered containing soluble protein underwent a second ultracentrifugation
spin at 100,000xg for 1 hour. The initial membrane pellet was washed in 500pL 50mM
sodium phosphate pH 7.2, 0.3M NaCl and pelleted by ultracentrifugation in a micro
ultracentrifuge (Optimax ultracentrifuge, Beckman Coulter, TLA-110 rotor). The
supernatant was discarded and the total membrane pellet was used for separation of inner
and outer membrane proteins.
2.8 Separation of inner and outer membrane proteins
To solubilize inner membrane proteins, the washed total membrane pellet was
resuspended in 500pL of solubilization buffer (50mM sodium phosphate pH 7.2, 0.3M
NaCl, with 1% N-lauroylsarcosine (w/v) (Sigma-Aldrich)) and mixed on nutator for 1
hour at room temperature followed by incubation overnight at 4°C on the nutator. Outer
membrane proteins were pelleted by ultracentrifugation at 100,000xg (Optimax
ultracentrifuge, Beckman Coulter, TLA-110 rotor) for 1 hour at 4°C. To further enhance
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the separation, the supernatant containing inner membrane proteins was ultracentrifuged
at 100,000xg for 1 hour at 4°C for an additional three times until no pellet was visible.
Similarly, the original outer membrane pellet was resusupended and washed in
solubilization buffer, mixed for 1 hour at room temperature, and pelleted again by
ultracentrifugation at 100,00(kg for 1 hour at 4°C. The final outer membrane pellet was
resuspended in 50mM sodium phosphate pH 7.2, 0.3M NaCl for protein analysis by SDSPAGE.
2.9 SDS-PAGE and Western blot analysis
Bacterial protein fractions or protein purification samples were denatured in SDS
loading buffer (0.625M Tris pH 6.8, 2% SDS, 2% P-mercaptoethanol, 10% glycerol, and
0.002% bromophenol blue) and incubated for 5 minutes at 100°C, unless otherwise
indicated. Proteins were separated on 12% SDS polyacrylamide gels by the Laemmli
system [216] (Bio-Rad, mini-gel system). Electrophoresis was performed at 12mA.
Proteins were visualized by Coomassie blue staining (10% acetic acid, 25% ethanol,
0.001% (w/v) Brilliant Blue R-250), silver nitrate staining (see Section 2.21) or Western
blotting (see below).
LPS preparations (see Section 2.20) were loaded directly on 12% SDSpolyacrylamide gels for separation. Carbohydrates were visualized by silver nitrate
staining (see Section 2.21) or Western blotting.
The antibodies and Western blot conditions used in this study are summarized in
Table 2. Western blotting was performed after electrophoretic transfer of proteins or LPS
to nitrocellulose (Bio-Rad). Wet transfer was performed for 90 minutes for membrane
protein samples and 60 minutes for all other protein and LPS samples in Tris-Glycine
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Table 2: Antibodies and Western blot conditions used in this study
Secondary antibody Wavelength
Primary
Epitope
Blocking
detected
antibody/label and dilution used
detected
buffer
(nm)
and dilution
used
800
Anti-FlaA/B
Anti-rabbit (goat)
H. pylori
2.5% skim
(rabbit) [118],
conjugated to IRDye
milk
flagellins
1/2500
800 (Rockland
(FlaA and
Immunochemicals),
FlaB)
1/5000
Biotin

700
Streptavidin
BHz-labelled
Odyssey
blocking
glycoproteins (see conjugated to
AlexaFluor 680
buffer (Licor) Section 2.10)
(Invitrogen), lpg/mL
or 10% Horse
serum

6XHis-tag

2.5% skim
milk

Anti-mouse (goat) 700
Anticonjugated to IRDye
polyHistidine
(mouse) (Sigma), 680 (Licor), 1/10000
1/3000

Lewis y

2.5% skim
milk

Anti-Lewis y,
Anti-mouse (goat) 700
clone F3 (mouse) conjugated to IRDye
680 (Licor), 1/10000
(Calbiochem),
1/100

Lewis x

2.5% skim
milk

Anti-Lewis x,
clone P12
(mouse)
(Calbiochem),
1/100

Anti-mouse (goat) 700
conjugated to IRDye
680 (Licor), 1/10000
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Transfer buffer (192mM glycine, 25mM Tris, 20% methanol, 0.01% SDS) with a
constant current of 180mA (Bio-Rad transblot system). After transfer, the membrane was
rinsed in distilled water and stained with Ponceau S (0.1% (w/v) Ponceau S (SigmaAldrich) in 1% (v/v) acetic acid) to visualize the transfer of proteins to the membrane.
The Ponceau S stain was removed from the membrane by two 20mL washes with
phosphate buffered saline (PBS) buffer (137mM NaCl, 2.7mM KC1, 8mM Na2 HPC>4 ,
1.46mM KH2P04, pH 7.2). The membrane was blocked overnight at 4°C followed by an
hour at room temperature with gentle shaking on a gel surfer (Dia-med) in 2.5% skim
milk, Odyssey Blocking Buffer (Licor), or 10% Horse Serum (Gibco), as appropriate for
the antibodies to be used (refer to Table 2). After blocking, all steps were performed at
room temperature and with gentle shaking on the gel surfer. The membrane was washed
twice in 20mL PBS-Tween-20 (PBS with 0.1% Tween-20) and once in PBS buffer for 5
minutes each and then incubated with primary antibody for 1 hour at room temperature.
After incubation, the membrane was washed four times in PBS-Tween-20 and once in
PBS for 5 minutes each and then incubated with secondary antibody for 30 minutes in the
dark. The membrane was washed in the dark with PBS-Tween-20 and PBS as above. All
antibodies were centrifuged at 6,300xg for lOminutes prior to use. Proteins or LPS were
detected by the Licor Infrared Imaging system at wavelengths of 700nm or 800nm.
2.10 Glycoprotein-specific chemical labelling
2.10.1 In-solution glycoprotein labelling with biotin-hydrazide
Protein samples of approximately 0.1-0.5 pg/pL, as estimated by Coomassie
staining of membrane protein fractions, were diluted 1:1 in 200mM sodium acetate pH
5.5, for a total starting volume of 20pL. Carbohydrates were mildly oxidized by
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incubation with lOmM sodium periodate (Sigma-Aldrich) for 20 minutes in the dark. The
reaction was quenched by addition of 20mM meta-bisulphite and incubation for 5
minutes. One micromole of biotin-hydrazide (BHz) from a 5mM BHz stock solution
made in DMF (Sigma-Aldrich) was added to label glycoproteins and incubated for 1
hour. All steps were performed at room temperature with gentle shaking on a nutator.
Labelled samples were separated by 12% SDS-PAGE and transferred onto a
nitrocellulose membrane for detection with fluorescent streptavidin. Mock samples were
treated in the same fashion with the exception of incubation with DMF rather than with
the BHz label.
2.10.2 Labelling of immobilized glycoproteins with biotin-hydrazide
Immediately after transfer of protein samples onto a nitrocellulose membrane, the
membrane was washed two times in 20mL of PBS (9mM sodium phosphate pH 7.2,
27mM NaCl) buffer. The membrane was subsequently incubated in the dark with lOmM
sodium periodate in lOOmM sodium acetate pH5.5, 5mM EDTA, for 20 minutes for mild
oxidation of carbohydrates and washed for 5 minutes in 20mL of PBS. The reaction was
stopped by incubation with 20mM meta-bisulphite in lOOmM sodium acetate pH 5.5,
5mM EDTA for 10 minutes and washed 3 times for 10 minutes each with 20mL of PBS.
Glycoproteins were labelled by incubation with 1pM BHz, prepared fresh from a 5mM
BHz stock made in DMF, in lOOmM sodium acetate pH 5.5, 5mM EDTA for 1 hour at
room temperature. The membrane was washed three times for 10 minutes each in 20mL
of PBS and rinsed in distilled water. Total protein was stained with Ponceau S. Ponceau S
stain was removed from the membrane by a wash in 20mL PBS. All incubation steps for
the membrane were conducted with gentle shaking on a nutator. Mock labelling was
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performed on a separate membrane in the same manner with the exception of incubation
with DMF rather than the BHz label.
2.10.3 Detection of biotin-hydrazide labelled glycoproteins with fluorescent
streptavidin
Glycoproteins immobilized on a nitrocellulose membrane, either previously
labelled with BHz in-solution or labelled with BHz after transfer to nitrocellulose, were
detected by incubation with ljjg/mL streptavidin-AlexaFluor-680 (Molecular Probes), a
fluorescent conjugate of streptavidin. The nitrocellulose membrane was blocked
overnight at 4°C and for 1 hour at room temperature with gentle shaking in 10% horse
serum or Odyssey blocking buffer (Licor). The membrane was subsequently washed two
times in 20mL PBS-Tween for 10 minutes each and then incubated for 30 minutes with
lpg/mL streptavidin-AlexaFluor-680 in the dark. After incubation with the fluorescent
probe, the membrane was washed 3 times in PBS-Tween for 10 minutes each and once in
PBS for 10 minutes. The membrane was scanned on a Licor Odyssey Infra-red scanner at
700nm to detect the fluorescent streptavidin conjugate bound to BHz-labelled
glycoproteins.
2.11 In-gel trypsin digestion of proteins for mass spectrometry analysis
Samples for mass spectrometry were prepared according to the procedure outlined
by the University of Western Ontario Biological Mass Spectrometry Laboratory (BMSL).
Briefly, after separation of proteins by SDS-PAGE and protein staining with Coomassie
Blue stain, the protein band of interest was excised from the polyacrylamide gel and cut
into 1mm3 pieces and combined in a 1.5mL eppendorf tube. The gel pieces were washed
with 1 volume of autoclaved and filtered distilled water with occasional vortexing
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throughout. The distilled water was removed and the gel pieces were treated three times
with 1 volume of 1:1 distilled water and acetonitrile for 15 minutes. The liquid was
removed and the gel pieces were incubated with enough acetonitrile to just cover the gel
pieces until the gel pieces visibly shrunk in size, appeared white in colour, and stuck
together (approximately 5-10 minutes). The gel pieces were subsequently spun down in a
microcentrifuge and the acetonitrile was removed. The gel pieces were rehydrated in 1
volume of 0.1 M ammonium bicarbonate for 5 minutes. One volume of acetonitrile was
added, resulting in a 1:1 mixture of acetonitrile and 0.1M ammonium bicarbonate, and
the gel pieces were incubated for an additional 15 minutes. The liquid was removed and
the gel pieces were dried in a vacuum centrifuge (Eppendorf) on the organic phase
setting. Once completely dry, the gel pieces were rehydrated in 1 volume of lOmM DTT,
0.1M ammonium bicarbonate, and incubated for 45 minutes at 56°C to reduce the
protein. The remaining liquid was removed and 1 volume of 55mM iodoacetamide, 0.1M
ammonium bicarbonate was added. The gel pieces were incubated in the dark for 30
minutes and then washed with 1 volume of 0.1 M ammonium bicarbonate for 5 minutes
and 1 volume of 50% acetonitrile in distilled water for 15 minutes. The wash solution
was removed and 1 volume of acetonitrile was added and incubated until the gel pieces
became white and sticky (approximately 5-10 minutes). The liquid was removed and an
additional 0.1M ammonium bicarbonate and acetonitrile washing cycle was performed to
remove residual Coomassie stain. The samples were completely dried in a vacuum
centrifuge. The gel pieces were rehydrated in 1 volume of trypsin digestion buffer
(50mM ammonium bicarbonate, 5mM CaCh, lOng/pL trypsin) and incubated for 45
minutes on ice. The gel pieces were spun down in a microcentrifuge and the supernatant
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removed. The gel pieces were covered with digestion buffer minus trypsin (50mM
ammonium bicarbonate, 5mM CaC^) and incubated overnight at 37°C. To extract
peptides, the gel pieces were spun down in a microcentrifuge and the supernatant
removed to a clean 1.5mL eppendorf tube. One volume of 25mM ammonium bicarbonate
was added to the gel pieces until they were completely covered. The gel pieces were
incubated for 15 minutes with vortexing every 2-3 minutes. One volume of acetonitrile
was added to make a 1:1 solution of 0.1 M ammonium bicarbonate and acetonitrile and
the gel pieces were incubated for an additional 15 minutes. The supernatant was removed
and combined with the initial supernatant following overnight digestion. To the gel
pieces, 1 volume of 5% formic acid was added and incubated for 15 minutes. The same
volume of acteonitrile was added and incubated for an additional 15 minutes. The gel
pieces were spun down and the supernatant was combined with the earlier steps. An
additional extraction cycle with 5% formic acid and acetonitrile was performed and the
supernatant combined. To the pooled supernatant, DTT was added to a final
concentration of ImM. Lastly, the combined supernatant was completely dried in a
vacuum centrifuge and submitted to the BMSL facility for mass spectrometry analysis.
All steps were performed at room temperature unless otherwise stated.
2.12 Construction of pBKS-UreB::RdxA-CAT for chromosomal integration of rdxA
The plasmids and primers used in this study are listed in Table 3 and Table 4,
respectively. The strategy used to construct pBKS-UreB::RdxA-CAT is depicted in
Figure 4. H. pylori ureB (hp0072) was amplified from chromosomal DNA of strain
26695 using primers HP0072P1 and HP0072P2. The resulting PCR product was cloned
into pBlueScriptKS by Xuan Bui Thanh using NotI and Kpnl, generating the initial
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Table 3: Description of plasmids used in this study
Description
Plasmid
pProCompWaaL 2.3kb PCR fragment containing waaL
(hpl039) and upstream promoter region
was digested with BamHl and Kpnl and
cloned into similarly cut pHel2. CatR

Reference
This Study.
Constructed by Dr.
Alexandra MerkxJacques

pHel2

Shuttle vector containing chloramphenicol
resistance cassette. CatR

pET634comp

Derivative of pET21a containing jhp0634 Provided by Dr. Trent
as an insert with flanking regions of rdxA. (University of Texas)
Used for construction of pRF-1 and pRF-2. [218]
AmpR, confers MtzR in H. pylori.

pRF-1

1.75kb PCR fragment containing flaB
(hpOl 15) and 166bp upstream of the gene
was digested with BamHl and EcoBl and
cloned into similarly cut pET634comp.
AmpR, confers MtzRin H. pylori.

This Study

pRF-2

1.66kb PCR fragment containing flaA
(hp0601) and 164bp upstream of the gene
was digested with BamHl and NdeI and
cloned into similarly cut pRF-1. AmpR,
confers MtzRin H. pylori.

This Study

pBlueScriptKS

Suicide vector used for construction of
pBKS-UreB::RdxA-CAT. AmpR

Stratagene

pBKS-UreB

This Study.
1,72kb PCR fragment encoding ureB
(hp0072) was digested with Notl and Kpnl Constructed by Xuan
Bui Thanh.
and cloned into similarly cut
pBlueScriptKS. AmpR

pBKSUreB::RdxA

This Study
950bp PCR fragment encoding rcbcA
(hp0954) and 300bp upstream was digested
with £coRI and BamHl and cloned into
similarly cut 3.55 kb inverse PCR product
of pBKS-UreB. AmpR

1.07kb PCR fragment containing the
pBKSUreB: :RdxA-CAT chloramphenicol resistance cassette from
pHel2 was digested with BamHl and Xbal
and cloned into similarly cut pBKSUreB::RdxA. AmpR, CatR

[217]

This Study
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Table 4: Primers used for this study
Sequence (5’ to 3’)_____________________________________________
Primer Name
GGAATTCC ATATG AAAAAGATTAGCAGAAAAGAA
HP0072P1
GGGGTACCTAGAAAATGCTAAAGAGTTGC
HP0072P2
HP0072P3
CGGAATT CAGTAGC AGGACCTACGC
CGCGGATCCCTACCCCACAACCAG
HP0072P4
CGGAATTCATGAGTTGCGTTAT CCCAGC
HP0954P1
GCGGATCCAGTCTAG ACTACAACCAAGTAATCGCATCAAC
HP0954P2
GCTCTAGACTCAAAACGATGAAATAGGGC
CatHelPl
G
AGGATCCCCGGGTACCG
CatHelP2
CCTTAGCTCCTGAAAATCTCGG
CatHelP3
CAGGG ATCCATGGAACGCCTTTAATAAATG
HPFlagBP5
CACGAATTCTCAGT GGTGGTGGTGGTGGTGACTTCCGGAC ATAT
HPFlagBP7
GTTGTAAAAGCCTTAAGACATTTTG
GACGGGTGTGGAAGCGAGC
HPFlagBP8
GCTCTCCATGGGCAT GAGTTTTAGGATAAATAC
HP0115P1
CACGG ATC CTTATAGCCC ATTTTCATGCTCC
HPFlagAP5
GGAATTCC ATATGAGTTAAAAGCCTTAAGATATTTTG
HPFlagAP6
CCCATTAAGCTCACGCCCATG
HP0954P3seq
CAGGATCCGTTATGGCTTT GAATCTGGAGAAA
HP1039P1
GATTGCAAAAAGC GTTTAAAG
HP1039P7
CGGGATCCTCAGTGGTGGT GGTGGTGG
Ctermhis
CATATTGTGTGGAAACACCGC
PHel2CATl
CACTCATCGCAGTACTGTTG
pHe!2CAT2
*Restriction sites are bolded
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Figure 4: Strategy for construction of pBKS-UreB: :RdxA-CAT. Inverse PCR was
performed on pBKS-UreB containing the full-length ureB gene (A). rdxA and 300bp
upstream of the gene (rdxA+) was amplified from chromosomal DNA of H. pylori strain
26695. The PCR products of pBKS-UreB (from inverse PCR) and rdxA+ were cut with
fscoRI and BamHl to generate pBKS-UreB::RdxA (B). pBKS-UreB::RdxA and the CAT
cassette amplified from the shuttle vector pHel2 were subsequently cut with Xbal and
BamAll resulting in the final construct pBKS-UreB::RdxA-CAT (C). Arrows indicate the
location of the primers used for each stage of cloning.
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construct, pBKS-UreB, containing the full-length ureB gene. pBKS-UreB was verified by
PCR amplification of the ureB fragment using primers HP0072P1 and HP0072P2 and by
restriction digest with Kpnl and BamHl (restriction site within ureB), which generated an
expected fragment of 600bp.
Similarly, rdxA (hp0954) and the sequence 300bp upstream, were amplified from
chromosomal DNA of strain 26695 using primers HP0954P1 and HP0954P2. HP0954P2
contained a linker sequence with an Xbal site to allow insertion of the chloramphenicol
resistance cassette (CAT) from the shuttle vector pHel2 [217] at a later stage of cloning.
Inverse PCR amplification of pBKS-UreB was performed with the primers
HP0072P3 and HP0072P4 to remove the middle portion (1043bp) of UreB containing the
BamHl restriction site. Both rdxA and pBKS-UreB (from inverse PCR) PCR products
were cut with EcoRl and BamHl and allowed to ligate with T4 ligase (NEB) overnight at
room temperature to generate the intermediate construct, pBKS-UreB::RdxA.
The CAT cassette from the shuttle vector pHel2 [217] was amplified with primers
CATHelPl and CATHelP2. The PCR product was cloned into pBKS-UreB::RdxA via
restriction digest with Xbal and BamHl resulting in the final construct, pBKS::UreBRdxA-CAT. All PCR reactions were performed with Expand Long-Range Template
polymerase (Roche) with an annealing temperature of 56°C. Sequencing of rdxA within
pBKS-UreB::RdxA-CAT was performed with primers CatHel3 and HP0954P1.
2.13 Construction of Histidine-tagged flagellin constructs, pRF-1 (FlaB-His) and
pRF-2 (FlaA-His), for expression in H. pylori
The strategy used to construct pRF-1 and pRF-2 is depicted in Figure 5. Refer to
Table 3 and Table 4 for the plasmids and primers utilized. H. pylori flagellin genes, flaA
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Figure 5: Strategy used to construct pRF-1 and pRF-2 for recombinant expression
of the H. pylori flagellins. The vector pET634comp containing flanking regions of rdxA
was cut with BamHI and jEcoRI to remove the previous insert. flaB and its promoter (PrflaB) were PCR amplified from chromosomal DNA of strain 26695 and similarly cut
with BamHl and EcoRl to generate pRF-1, encoding Pr-flaB with a C-terminal hexaHistidine tag (6XHis) (A). To construct pRF-2, flaA and its promoter (Pr-flaA) were PCR
amplified from chromosomal DNA of strain 26695. Both the Pr-flaA PCR product and
the previously constructed pRF-1 vector were cut with BamWl and NdeI to produce pRF2 by replacing the Pr-flaB insert with Pr-flaA (B). Arrows indicate the positions of the
primers used.
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(hp0601) and flaB (hpOl 15), and their respective promoters were amplified from
chromosomal DNA of H pylori strain 26695 using primers HPFlagBP5 and HPFlagBP7
for Pr-flaB, and HPFlagAP5 and HPFlagAP6 for Pr-flaA. A hexa-Histidine tag (6XHis)
was encoded within HPFlagBP7 behind an NdeI site that enabled sequential cloning of
the flagellin constructs and addition of the C-terminal Histidine-tag to both flagellins. The
Pr-flaB PCR product was cloned into the suicide vector pET634comp [218], provided by
Dr. S. Trent (University of Texas), by restriction digest with BamHl and LcoRI and
overnight ligation, generating pRF-1 (flaB-His). pRF-1 was subsequently digested with
BamHl and Ndel to remove Pr-flaB, but leaving the hexa-Histidine tag intact. The PrflaA PCR product was similarly cut with restriction enzymes BamHl and Ndel and cloned
into pRF-1 in place of Pr-flaB, generating pRF-2 (flaA-His). The flagellin constructs
were sequenced with HP0115P1 and HPFlagBP8 for pRF-1, and HPFlagAP5 and
HPFlagAP6 for pRF-2. Both constructs were also sequenced with HP0954P3 to ensure
that the Histidine-tag was in-frame with the gene coding region.
2.14 Transformation of E. coli competent cells
Standard transformation by heat shock was used to transform all plasmid DNA
into DH5a or JM109 CaCE-competent E. coli cells. Briefly, CaCVcompetent E. coli
cells were thawed on ice and divided into 150pL aliquots. One microlitre of purified
plasmid DNA (~25ng/pL) or 15pL of a ligation mixture was added and mixed gently into
the competent cells. The mixture of competent cells and plasmid DNA was incubated on
ice for 30 minutes. The cells were heat shocked for 90 seconds at 42°C and then placed
on ice for 1 minute. Six-hundred microlitres of LB broth were added to the cells,
followed by recovery for 1.5 hours at 37°C in a shaking incubator. After recovery, 50pL
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of the culture were plated on LB agar plates supplemented with the appropriate antibiotic
selection using glass beads. The remaining cells were pelleted by centrifugation at
7,320xg for 2 minutes and the majority of the supernatant removed. The pellet was
resuspended in approximately 70-80pL of the remaining supernatant and 50pL of
concentrated cells were plated on LB agar plates as described. All plates were incubated
at 37°C up to 16 hours. Six-hundred microlitres of LB broth were added to the remaining
cells and incubated at 37°C in a shaking incubator to allow recovery overnight. After
overnight recovery, the cells were plated on LB agar plates with selection as described
and incubated at 37°C for up to 16 hours.
2.15 In vitro site-specific methylation of plasmid DNA with H. pylori cell-free extract
In order to overcome the restriction-modification barrier of H. pylori to
transformation, all plasmid DNA was treated with WT H. pylori cell-free extract (CFE)
as described by Donahue et al. 2000 [219] prior to transformation.
2.15.1 H. pylori cell-free extract (CFE) preparation
WT H. pylori was harvested from 2-5 plates after 36 hours of growth on BHI-YE
agar plates as described. Bacterial pellets were resuspended in up to 5mL of extraction
buffer (20mM Tris-acetate pH7.9, 50mM potassium acetate, 5mM Na2 EDTA, ImM
DTT) and supplemented with protease inhibitor cocktail (Roche) according to the
manufacturer’s instructions. For cell suspensions greater than 3mL, cells were lysed by
passage through a Mini-French Pressure Cell (GlenMills) at 15,000 psi three or four
times until visible clearing of the suspension was observed. For smaller volumes, cells
were lysed with acid-washed glass beads; an approximate 50|a,L volume of neutralized
acid-washed glass beads was added to the cell suspension. The mixture was vortexed for
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30 seconds, followed by incubation on ice for 1 minute and repeated six times until
clearing of the cell lysate was visible. Cellular debris were removed by centrifugation at
13,000xg for 15 minutes at 4°C. The supernatant was removed to a new tube. Protein
content was assessed by the Bradford protein assay (see Section 2.15.2) and used to treat
plasmid DNA.
2.15.2 Determination of protein concentration by Bradford protein assay
Protein concentration of CFE was determined by the Bradford protein assay
[220]. A standard curve was generated using serial dilutions of 1.36g/L BSA in extraction
buffer. The dilutions were added to a 96-well plate in triplicate. CFE was prepared at
three dilutions, 1/25,1/5, and undiluted, by serial diluting and added to the 96-well plate
in triplicate. Protein reagent (Bio-Rad) was added to the samples and ODeoonm was read
by a microplate reader (Bio-Rad). Based on the standard curve, the protein concentration
of the prepared CFE was determined.
2.15.3 Treatment of plasmid DNA with WT H. pylori cell-free extract
Eight to twelve micrograms of plasmid DNA was combined with 300-400p,g of
WT H. pylori CFE in a 150pL reaction containing 20mM Tris-acetate pH 7.9, 50mM
potassium acetate, 5mM Na2 EDTA, and ImM DTT. As the methyl donor for the reaction,
200pM of S-adenosyl-methionine (SAM) (BetaPharma Inc.) were added. The reaction
was incubated at 37°C for 1 hour. Plasmid DNA was extracted by
phenol/chloroform/isoamyl alcohol (25:24:1) extraction. Briefly, 1 volume of
phenol/choloroform/isoamyl alchohol (25:24:1) was added to the reaction tube and
vortexed until an emulsion formed. The mixture was centrifuged at 13,400xg for 1 minute
at room temperature and the aqueous phase was removed to a new tube. Extraction was
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repeated three times until no protein interface was visible. To remove residual phenol, 1
volume of chloroform was added to the final aqueous phase, vortexed, and the aqueous
phase removed to a new tube. Plasmid DNA was recovered by ethanol precipitation; 1/10
volume of 3M sodium acetate pH 7 and 2.5 volumes of anhydrous ethanol were added to
the extracted DNA. The sample was mixed 6-10 times by inversion. DNA was allowed to
precipitate for 2 hours or overnight at -20°C. After incubation, DNA was pelleted by
centrifugation at 13,400xg for 30 minutes at 4°C. The supernatant was removed and the
pellet was washed with 750pL of 70% ethanol. The final pellet was air dried and then
resuspended in 15pL-30pL of autoclaved distilled water.
2.16 Electroporation of H. pylori
One plate of actively growing H. pylori was resuspended in a 15% glycerol, 9%
sucrose solution and pelleted at 5,900xg for 2 minutes. The pellet was resuspended and
washed three times in 750pL of the 15% glycerol, 9% sucrose solution. The final pellet
was resuspended in 200pL of the 15% glycerol, 9% sucrose solution and the volume of
the cell suspension was adjusted to a final ODioonm of 2.5. The cell suspension was
divided into 70pL aliquots. CFE-treated plasmid DNA (1 gig) was mixed gently into the
cells. The mixture was transferred to ice-cold 0.2 cm electroporation cuvettes (Bio-Rad).
The cells were electroporated at 25 pF, 800 Q, and 2.5 kV. After electroporation, lOOpL
of recovery solution (5% Horse serum, 20mM glucose in BHI-YE broth) were added to
the cells. The cell suspension (~160-180pL) was divided into three and spotted on BHIYE agar plates with no antibiotic selection. Cells were allowed to recover for 16-24 hours
in standard conditions. After recovery, cells were resuspended in lmL of BHI-YE broth
and plated on BHI-YE agar plates containing appropriate antibiotic selection.
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Transformants were screened for the presence of plasmid or chromosomal integration by
conventional PCR of the gene of interest.
2.17 Extraction of chromosomal DNA by CTAB
Chromosomal DNA was extracted from total cells using cetyltrimethylammonium
bromide (CTAB) buffer. One millilitre of cell suspension at an ODeoonm of 4 was
centrifuged at 2,000xg for 5 minutes to pellet cells. The cell pellet was resuspended in
0.5mL of CTAB buffer and vortexed. To the cell suspension, 0.5mL of
phenol/chloroform/isoamyl alcohol (25:24:1) were added and vortexed until an emulsion
formed. The lysate was centrifuged at 13,000xg for 5 minutes. The aqueous phase was
removed and treated with 0.5mL of chloroform-isoamyl alcohol (24:1) to remove residual
phenol. The mixture was centrifuged at 13,00(kg for 5 minutes. The aqueous phase was
removed and 0.08 volumes of cold 7.5M ammonium acetate and 0.54 volumes of chilled
isopropanol were added to precipitate the DNA. The contents were mixed by inversion
20-30 times and incubated on ice for 30-40 minutes. The precipitated DNA was collected
by centrifugation at I3,000xg for 10 minutes at 4°C. The DNA pellet was washed once
with cold 70% ethanol and air dried. The final DNA pellet was resuspended in 50pL of
autoclaved distilled water and stored at 4°C.
2.18 Screening of H. pylori transformants by colony PCR
H. pylori transformants were screened by PCR amplification of the gene of
interest. Genomic DNA was isolated using the InstaGene Matrix (Bio-Rad) according to
the manufacturer’s instructions. In brief, the equivalent of the size of a small single
colony of each clone, previously patched on BHI-YE agar plates, was suspended in lmL
of autoclaved distilled water and pelleted by centrifugation at 13,400xg. The supernatant

75

was removed and 200pL of InstaGene Matrix was added. The suspension was incubated
at 56°C for 15 minutes, vortexed, and boiled at 100°C for 8 minutes. The suspension was
vortexed again and the InstaGene Matrix pelleted by centrifugation at 13,400xg for 2
minutes. The supernatant, containing genomic DNA, was used as the template for PCR
with Expand Long-Range template polymerase (Roche) and the PCR products visualized
by separation on a 0.7% agarose gel and imaging using the GelDoc (Bio-Rad). Positive
clones were further expanded on BHI-YE agar plates for protein analysis.
2.19 Protein analysis of H. pylori clones to verify chromosomal integration
Integration of rdxA and disruption of ureB in WT and hp0366 H. pylori strains
was monitored by analyzing the total protein profile of the H. pylori clones for the lack of
UreB production. Total cell pellets of the H. pylori clones were resuspended in SDSPAGE loading buffer and separated on 12% SDS-PAGE. Total protein was stained with
Coomassie Blue.
2.20 LPS sample preparation
LPS samples were prepared via the method described by Marolda et al. 2006
[221] with minor modifications for the preparation of H. pylori LPS. This protocol is
modified from the original LPS sample preparation method [222] as an extra step is
incorporated to remove residual protein content from samples. Approximately 1-2 plates
of actively growing H. pylori were harvested in 1.5mL of IX PBS. The optical density of
the suspension was adjusted to an ODeoonm of 4.0. Cells were pelleted by centrifugation at
5,000xg for 2 minutes and the supernatant removed. The cell pellet was resuspended in
lysis buffer (2% (w/v) SDS, 4% |3-mercaptoethanol, 0.5M Tris-HCl pH 6.8) and boiled
for 10 minutes. Ten microlitres of 20mg/mL proteinase K was added to the cell lysate and
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incubated overnight at 60°C. To remove residual protein and/or peptides, 1 volume of
prewarmed (70°C) phenol solution was added to the cell lysate and incubated at 70°C for
15 minutes with vortexing every 5 minutes. The suspension was incubated on ice for 10
minutes and subsequently centrifuged at 10,000xg for 10 minutes to separate the aqueous
phase. The aqueous phase was transferred to a new tube and 10 volumes of ethyl ether
saturated with Tris-EDTA were added and mixed by inversion 10-15 times. The samples
were centrifuged at 10,000xg for 1 minute and the ether phase (top phase) was discarded
by aspiration. Sample loading buffer (4X) for SDS-PAGE was added and the samples
were stored at -20°C until needed.
2.21 Detection of LPS and protein by silver nitrate staining
After separation of LPS or protein samples by 12% SDS-PAGE, polyacrylamide
gels were stained via a modified ultra-fast silver staining procedure by Fomsgaard et al.
1990 [223]. Samples were oxidized in-gel by incubation for 20 minutes in the oxidation
solution (0.7% periodic acid, 40% ethanol, 5% acetic acid) followed by 4-5 washes with
distilled water for a total of 15 minutes. The gel was subsequently incubated for 10
minutes with freshly prepared staining solution (10% (w/v) silver nitrate, 0.002% NaOH,
0.4% (v/v) NH4 OH). The staining solution was removed and the gel was washed 4-5
times in distilled water for 15 minutes. Developing solution (0.00005% (w/v) citric acid,
0.00054% (v/v) formaldehyde) was added allowing visualization of LPS and protein. The
reaction was stopped by removal of the developing solution, addition of 10% acetic acid
for 5 minutes, and several washes in distilled water. All staining steps were performed at
room temperature with gentle shaking on the Gel Surfer. All solutions were made in
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freshly cleaned glassware to limit contaminants and solutions were removed by vacuum
aspiration.
2.22 Enrichment of WaaL-His by nickel affinity chromatography
H. pylori strains carrying the plasmid pProCompWaaL for WaaL-His expression
or pHel2 as a control were grown on 100 BHI-YE agar plates for 36 hours until
confluent. To confirm the maintenance of each plasmid throughout each stage of growth
(see Section 2.1), 500pL of the cell suspension used to expand cells or from the final cell
suspension, were removed and pelleted by centrifugation at 3,22(bcg for 5 minutes. The
supernatant was discarded and the resulting pellet was used for plasmid purification. Due
to low plasmid yield, plasmid was verified by PCR. Primers specific for WaaL-His,
HP1039P1 and Ctermhis, were used to detect pProCompWaaL and primers specific for
the CAT cassette, pHel2CATl and pHel2CAT2, were used to verify the presence of both
pHel2 and pProCompWaaL.
Once plasmid maintenance was verified, cells were harvested in 0.85% saline,
lysed in the presence of protease inhibitor cocktail (Roche) according to the
manufacturer’s instructions, and separated by differential centrifugation as described in
Section 2.7. Total membrane samples were further fractionated into inner and outer
membrane samples by selective solubilization of inner membrane proteins in 1% Nlauroylsarcosine as outlined in Section 2.8. Inner membrane samples containing WaaLHis were diluted 1:1 in 50mM sodium phosphate pH 7.2, 0.3M NaCl, 5mM imidazole,
and 2% Triton, for a final Triton X-100 concentration of 1%. Samples were mixed gently
on a nutator at 4°C to allow further solubilization of proteins in the detergent for 1 hour.
Gravity flow columns (ThermoFisher) were prepared with lmL of nickel chelation resin
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(Chelating Fast Flow Sepharose; Pharmacia). Columns were loaded with 5 column
volumes (CV) of 0.1 M nickel sulphate, followed by rinsing of the columns with 10 CV of
distilled water, 5 CV of 50mM sodium phosphate pH 7.2, 0.3M NaCl, 5mM imidazole,
and 15 CV of binding buffer (50mM sodium phosphate pH 7.2, 0.3M NaCl, 5mM
imidazole, 1% Triton). Inner membrane samples were loaded on the columns and the
flowthrough loaded two times. Columns loaded with inner membrane samples were
incubated at 4°C for 1 hour to allow proteins to bind to the resin. Unbound proteins were
removed by sequential washes in 10 CV of binding buffer, 20 CV of wash buffer 1
(50mM sodium phosphate pH 7.2, 0.3M NaCl, 5mM imidazole, 0.2% Triton X-100), 12
CV of wash buffer 2 (50mM sodium phosphate pH 7.2, 0.3M NaCl, 50mM imidazole,
0.2% Triton X-100), and 12 CV of wash buffer 3 (50mM sodium phosphate pH 7.2, 0.3M
NaCl, 75mM imidazole, 0.2% Triton X-100). Bound proteins were removed by step-wise
elution with increasing concentrations of imidazole; 2 CV each of 50mM sodium
phosphate pH 7.2, 0.3M NaCl, 0.2% Triton X-100 with 250mM imidazole, 375mM
imidazole, 500mM imidazole, and 1M imidazole. The fractions were screened for the
presence of WaaL-His by SDS-PAGE and detection via anti-Histidine Western blot (refer
to Table 2).
2.23 Treatment of inner membrane protein samples to disrupt protein aggregates
Aggregate removal was performed by modification of the protocol described by
Marani et al. 2006 [224]. Inner membrane samples were diluted 1:1 in PBS containing
10M urea. Samples were mixed for 1 hour on a nutator at 4°C. Insoluble protein was
removed by ultracentrifugation at 100,000xg for 1 hour. Urea treated inner membrane
samples were assessed for the presence of WaaL-His by anti-Histidine Western blot
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(refer to Table 2). No improvement in WaaL-His migration within SDS-PAGE gels was
observed.
2.24 Proteinase K digestion of protein fractions
Samples were digested by sequential treatment with proteinase K to ensure
degradation of the majority of the protein present in the samples. Three-hundred
microlitres of approximately 0.125pg/pL of each cellular protein fraction, as estimated by
Coomassie staining, was split into two equal volumes. The first aliquot was treated with
proteinase K to degrade all protein by addition of 5pL of 20mg/mL proteinase K. The
same volume of autoclaved distilled water was added to the second aliquot as untreated
samples. All samples were incubated overnight (approximately 16 hours) at 60°C for
maximum enzymatic activity. To degrade remaining proteins, an additional 2pL of
20mg/mL proteinase K or autoclaved distilled water were added to treated and untreated
samples respectively. The samples were incubated for an additional 4 hours at 60°C and
stored at -20°C until needed.
2.25 Separation of outer membrane and insoluble protein fractions by 2-DE
Outer membrane or insoluble protein fractions containing 100-250|j.g of protein,
as estimated by Coomassie blue staining, were pelleted by ultracentrifugation at
100,00Oxg or centrifugation at 13,000xg for 1 hour at 4°C, respectively. Samples were
resuspended in the appropriate volume of rehydration sample buffer (7M urea, 2M
thiourea, 4% CHAPS, 30mM Tris-HCl pH 8.8, 0.2% Bio-Lyte 3/10 ampholytes, trace
bromophenol blue) for either 7cm or 11cm isoelectric focusing (IEF) strips. Sample was
dispensed along the length of the rehydration/equilibration tray and the desired
ReadyStrip IPG strip (Bio-Rad) was placed gel-side down on the sample. Initial
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rehydration was allowed to proceed for 30 minutes and then 2-3mL of mineral oil was
overlayed along the strip. The strip was incubated overnight at room temperature to allow
rehydration of the IEF strip and sample loading. After rehydration, the strip was loaded
onto the Protean IEF cell (Bio-Rad). IEF focusing was performed for 11-cm ReadyStrip
IPG strips with a gradient of pH 4-7 as follows: 250V for 20 minutes, 8,000V for 2.5
hours, and 8,000V until 30,000V-hours were reached. For 7-cm ReadyStrip IPG strips
with a non-linear gradient of pH 3-10, IEF focusing was performed as follows: 250V for
20 minutes, 4,000V for 2 hours, and 4,000V until 10,000V-hours were reached. All IEF
steps were conducted at 20°C. After IEF, strips were subjected to disulfide reduction with
DTT by incubation for 10 minutes in equilibration buffer I (6M urea, 2%SDS, 0.375M
Tris-HCl pH 8.8, 20% glycerol, 2% DTT), followed by cysteine alkylation with
iodoacetamide by incubation for 10 minutes in equilibration buffer II (6M urea, 2% SDS,
0.375M Tris-HCl pH 8.8, 20% glycerol, 0.025g/mL iodoacetamide). Proteins were
further separated in the second dimension by standard electrophoresis using 12% SDSPAGE gels. After 2-DE, total protein was visualized by Coomassie Blue staining or
samples were transferred to nitrocellulose for detection of proteins by Western blot.

CHAPTER 3: Results
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3.1 Elucidation of an alternative pse-independent glycosylation pathway in H. pylori
To demonstrate the presence of a novel glycan on the flagellins of the hp0366
mutant, purification of the flagellins from both WT and hp0366 H pylori strains was
required to allow for the analysis of the glycan present on the hp0366 flagellins and
compare it to pse from WT flagellins. Conversely, the flagellins of the flaAl mutant were
non-glycosylated, therefore, further investigation of their glycosylation was not
warranted. However, flaAl may provide insight into the biological requirement for
flagellin glycosylation as the flaAl flagellins represent non-glycosylated flagellin species.
Previous studies have described flagellin purification from WT strains of H. pylori by
mechanical shearing of flagella from cells and acid dissociation of the flagellin subunits
[105, 107], However, both pse mutants lack proper flagellum assembly despite flagellin
production. As such, various new strategies were explored in order to purify flagellins
from different cellular fractions as outlined below.
3.1.1 Disruption of pse glycosylation prevents H. pylori flagellin secretion
Both pse mutants, flaAl and hp0366, produce flagellins but are non-motile and
lack production of proper flagella. This indicates that disruption of pse-glycosylation
interrupts proper flagellum assembly. In general, flagellum assembly in H. pylori is
thought to occur via the prototypical bacterial type III flagellar protein-export system, in
which the structural subunits of the flagellar filament are secreted by an export system
homologous to the type III secretion system identified in several Gram-negative bacteria
[99, 100]. Briefly, in the cytoplasm, the flagellin subunits associate with specific
chaperone proteins that maintain them in their unfolded state and target them to the
flagellar basal body at the cytoplasmic membrane. The flagellin subunits are
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subsequently secreted via the type III export apparatus, composed of the flagellar basal
body and ring structure. This allows the flagellins to transverse the periplasmic space and
travel through the hollow core of the growing flagellar filament to the tip, where they
polymerize and are incorporated in the flagellar filament [100].
Based on this model of flagellum assembly, it is reasoned that flagellin
glycosylation must occur in the cytoplasm, as the flagellins are not exposed to the
periplasm during export and glycosylation is unlikely to occur at the tip of the flagellar
filament [225]. Furthermore, as the H. pylori flagellum is covered by the membranous
sheath, it is unlikely that the flagellin subunits interact with extracellular components.
Therefore, it was proposed that disruption of flagellin glycosylation by pse could alter
production of the flagellar filament in two ways. Firstly, a glycosylation defect could
inhibit protein interactions between the flagellin subunits and their cognate chaperones or
prevent interaction with the flagellar basal body and export apparatus, which would result
in a secretion defect of the flagellins and an accumulation of the flagellins in the
cytoplasm. Secondly, a glycosylation defect could alter protein interactions between
flagellin subunits and prevent polymerization of the flagellins into the flagellar filament,
which would result in the loss of flagellins to the cell supernatant by secretion from the
flagellar export apparatus. Since the biological role of flagellin glycosylation is unknown,
both scenarios are possible. Nevertheless, a defect in flagellin polymerization would be
advantageous for the purification of the hp0366 flagellins for future glycan analysis since
secreted flagellins are predicted to be modified as glycosylation is believed to occur in
the cytoplasm prior to secretion. Both the flagellins offlaAl and hp0366 were
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investigated to assess the effect of non-glycosylated flagellins and alternatively
glycosylated flagellins on flagellum assembly.
To investigate whether pse-glycosylation affects flagellin polymerization or
secretion, WT,flaAl, and hp0366 H. pylori strains were grown in broth and the
supernatants were assessed for the presence of flagellins via anti-FlaA/B Western blots.
Protein-free media was used for this purpose as standard growth medium is supplemented
with serum, which contains various proteins that are difficult to remove from the
extracellular proteins of H. pylori [226]. As well, growth of H pylori in broth required
specific conditions, as when growth conditions are not optimal, H. pylori is known to turn
into a coccoid viable, non-culturable form, or undergo autolysis. This would result in the
release of intracellular content [50, 215, 227, 228]. To ensure that any detection of the
flagellins in the supernatant was due to flagellar secretion and not cell lysis, urease
activity was measured to monitor cell lysis. Urease converts urea to ammonia and carbon
dioxide and is known to largely reside in the cytoplasm [45, 229, 230]. Therefore, by
measuring urease activity, the degree of cell lysis could be inferred. It should be noted
that the total urease activity offlaAl and hp0366 is statistically different from WT as
characterized previously [118, 174, 175]. However, for the purpose of assessing cell lysis
within a particular H. pylori strain, the total urease activity of each strain can be
compared to the urease activity detected in the cell pellets versus the supernatant. By this
method, the majority of urease activity detected over time from total cell suspensions was
found in the cell pellets, which suggests a low degree of cell lysis (Figure 6: A). As
urease activity increases over time due to the conversion of urea to ammonia and carbon
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Figure 6: Measurement of urease activity in total cultures, cell pellets, and cell
supernatants to assess the degree of cell lysis after growth of WT,JlaAl, and hp0366
H. pylori in broth. Cell lysis was monitored by detection of urease, primarily a
cytoplasmic protein, in the total cultures, and separated cell supernatants and cell pellets
of WT,//<x4/, and hp0366 H. pylori strains grown in broth. Urease activity was assessed
by the phenol red assay which detects changes in pH by OD595 nmover time (A). Change
in pH reflects the conversion of urea to ammonia and carbon dioxide by urease. Values
represent the average urease activity from samples evalulated in duplicate for a single
growth period. The total urease activity of WT is statistically different from flaAl and
hp0366 (* indicates p < 0.05). As the urease activity detected by this method increases
over time, a ratio of the urease activity from cell supernatants compared to total urease
activity was determined at 70 minutes once a steady-state had been reached (B). The
minimal level of urease activity detected in culture supernatants compared to the total
urease activity for all H. pylori strains indicates low levels of cell lysis.
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dioxide, the ratio of urease activity from cell supernatants compared to total urease
activity from the cell cultures was determined at 70 minutes, once the urease activity
measured had reached a steady-state (Figure 6: B). Based on the ratios, the cell
supernatants of the WT and hp0366 broth cultures accounted for a minimal level of the
total urease activity with ratios less than 0.25. In the case offlaAl, the ratio of urease
activity of the cell supernatant to the total urease activity was much higher at 0.5. This is
likely a reflection of the overall lower level of urease activity which interfered with the
accuracy of the assay. Regardless, it was clear that the urease activity detected in the
flaAl supernatant was lower than the total urease activity. Thus, any detected flagellins in
cell supernatants were considered to be due to cell secretion and not cell lysis.
In addition to autolysis and release of intracellular contents, H. pylori has been
shown to produce membrane blebs and/or outer membrane vesicles (OMVs) that carry
outer membrane proteins [231-233], While Keenan et al. 2000 demonstrated by electron
microscopy that OMVs of H. pylori lack flagella, the presence of the flagellin subunits in
OMVs has not been investigated. As such, the supernatants obtained from liquid culture
were also investigated for the presence of flagellins within membrane blebs.
After growth in broth, cells were pelleted by centrifugation and the supernatant
recovered. The supernatant was ultracentrifuged to pellet membrane blebs and
subsequently concentrated by step-wise ammonium sulphate precipitation at 40%, 60%,
and 80%. No pellet was observed at 40% ammonium sulphate precipitation in any of the
strains. Both the 60% and 80% supernatant fractions and the membrane bleb pellets were
assessed for the presence of flagellins by Western blot. Immunoblotting was performed
using a polyclonal antiserum raised in rabbits against WT H. pylori FlaA, the major
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flagellin subunit (distinct from FlaAl required for pse biosynthesis), which was
overexpressed in E. coli and purified by nickel affinity chromatography via a Histidinetag. This antiserum is known to cross-react with FlaB, the minor flagellin subunit, due to
the high sequence identity between FlaA and FlaB (57.2%) and therefore detects both
flagellin subunits [118]. As a positive control, H. pylori flagellins cloned with a
Histidine-tag that were overexpressed in E. coli and purified by nickel affinity
chromatography were utilized and loaded with the molecular weight standards.
Based on Ponceau S staining of total proteins in each cell fraction examined, it is
apparent that protein loading of the pse mutants was slightly lower than WT (Figure 7:
A). Nevertheless, the overall protein profile of the WT fractions compared to the fractions
of the pse mutants is similar, which indicates that there is no defect in the general
secretion machinery of the pse mutants. By anti-FlaA/B Western blot, only slight signal
was observed in the membrane bleb and supernatant fractions (Figure 7: B). Two bands
were predominant. The higher migrating band of approximately 66 kDa was previously
identified as the large subunit of urease, UreB. UreB is 54% homologous to FlaA and
contains a 113 amino acid sequence identical to FlaA, which may explain the cross
reactivity observed by the anti-FlaA/B antibody [118]. The lower migrating band of
approximately 54 kDa corresponds with the flagellins. The flagellin band was poorly
abundant compared to other proteins in the H. pylori secretóme as the flagellins were not
visible by Ponceau S stain (Figure 7: A) and only a limited signal was observed by antiFlaA/B Western blot (Figure 7 : B). This finding was expected of the WT secretóme as
the flagellins polymerize into the flagellar filament and are not aberrantly secreted into
the cell supernatant, and is consistent with previous studies of the H. pylori secretóme
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Figure 7: Screening of H. pylori broth culture supernatants for flagellins by antiFlaA/B Western blot. WT, JlaAl, and hp0366 H pylori strains were grown in broth to
detect a defect in the secretion of flagellins from the flagellar export apparatus or a defect
in the polymerization of the flagellin subunits. Membrane bleb proteins and supernatant
proteins concentrated by 60% and 80% ammonium sulphate precipitation were separated
by 12% SDS-PAGE for each WT,flaAl and hp0366. Total protein content in the
supernatant fractions was detected by Ponceau S stain (A). Flagellins were detected by
anti-FlaA/B Western blot (B). Reactive bands correspond to UreB and the flagellin band,
as described in the results. MW+F, molecular weight standard spiked with purified
recombinant H pylori flagellins.
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[226]. Conversely, the low abundance of the flagellins ivi the pse secretóme indicates that
the lack of flagellum production in these mutants is due to a secretion defect from
flagellar apparatus rather than a deficiency for the flagellins to polymerize.
Further, although minimal, greater signal was obtained for the flagellins in the
membrane bleb pellets compared to the concentrated supernatant fractions. The
observation of WT flagellins in membrane blebs may indicate that there is some
incorporation of flagellar components in OMVs. Alternatively, this may indicate potential
shedding of the membranous flagellum sheath as flagellins were shown to remain partly
associated with the sheath even after flagellin dissociation with acid treatment [107]. In
the case of the pse mutants, flagellins detected in the membrane bleb fractions may
indicate an association of the pse flagellins with other flagellar components that are
ultimately incorporated into OMVs.
An additional attempt to purify the flagellins in the supernatant by anion
exchange chromatography was conducted. Ammonium sulphate precipitation fractions
were combined and dialyzed into anion exchange binding buffer prior to loading on the
anion exchange column. No flagellins were detected in the fractions collected or in the
flowthrough, further suggesting low recovery of the flagellins from culture supernatants
(data not shown). Ultrafiltration, rather than ammonium sulphate precipitation, was also
used to concentrate the cell supernatants in order to enhance the recovery of the flagellins
prior to anion exchange chromatography, however low detection of the flagellins was
also observed by anti-FlaA/B Western blot, similar to the results observed by direct
ammonium sulphate precipitation (data not shown).

92

Overall, minimal levels of flagellins were detected in the supernatant and
membrane blebs of liquid cultures of both WT and the pse mutants. The level of
flagellins observed from the pse mutants was similar to WT. This indicates that a defect
in pse flagellin glycosylation, either by the absence of glycosylation or alternative
glycosylation, as demonstrated by the flagellins offlaAl and hp0366, respectively, likely
results in a secretion defect of the flagellins from the flagellar basal body. This finding
suggests that the flagellins of the hp0366 mutant likely reside in the cytoplasm.
Therefore, in order to further assess the observation of alternative glycosylation in the
hp0366 mutant, intracellular fractions were investigated for the presence of flagellins.
3.1.2 H. pylori flagellins are identified intracellularly
As altered glycosylation in the pse mutants resulted in an apparent secretion
defect from the flagellar apparatus, it was necessary to determine the intracellular
localization of the flagellins. In particular, comparing the localization of pse glycosylated
flagellins from WT to the alternatively glycosylated flagellins of the hp0366 mutant
would aid in characterizing the role that pse-specific glycosylation plays in flagellum
assembly. As such, in order to investigate the effect of alternative glycosylation, the
localization of the flagellins in WT and hp0366 was examined.
H. pylori cells were fractionated by differential centrifugation into insoluble,
soluble, and membrane fractions. The total membrane fraction was further separated into
inner membrane (IM) and outer membrane (OM) components by selective solubilization
of the IM by N-lauroylsarcosine [234] and separation by ultracentrifugation (Figure 8).
Each cell fraction was extensively washed to limit protein contaminants between protein
fractions. The cell fractions were screened for the presence of flagellins by anti-FlaA/B
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Figure 8: Fractionation of H. pylori cellular proteins by differential centrifugation.
In order to facilitate the analysis and localization of the flagellins and other glycoproteins
in H. pylori, total H pylori cells were separated into cellular protein fractions by
differential centrifugation. This allowed for enrichment of specific pools of
glycoproteins. H pylori was grown on agar plates and harvested. Total cells were lysed
by French press. Unlysed cells and cellular debris were pelleted by centrifugation at
5000xg. The supernatant was removed and insoluble proteins (I) were separated from
soluble proteins (S) by centrifugation at 13,000xg. Membrane proteins (M) were pelleted
by ultracentrifugation at 100,000xg. Inner membrane proteins (IM) were further separated
from outer membrane proteins (OM) by the differential solubilization of IM proteins in
N-lauroylsarcosine and separation by ultracentrifugation at 100,000xg. Separated cellular
protein fractions were subsequently assessed for the presence of flagellins or
glycoproteins and subjected to further downstream separation to simplify the cell
fractions for MS analysis.
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Western blot. Glycosylated flagellin species were detected by glycoprotein-specific
labelling in-solution with biotin-hydrazide (BHz) and detection of the label with a
fluorescent conjugate of streptavidin after transfer to nitrocellulose. Transferrin, a known
glycoprotein, was used as a positive control for glycoprotein-specific labelling, and the
non-glycosylated recombinant H. pylori flagellins purified from E. coli were run with the
molecular weight standards as a control for the anti-FlaA/B Western blot. No flagellins
were identified by anti-FlaA/B Western blot in the soluble or inner membrane cell
fractions of WT or pse H. pylori strains (data not shown). However, flagellins were
detected in the OM fraction of WT H. pylori (Figure 9). This finding was expected as
flagellins assemble into a proper flagellum in WT and the H. pylori flagellum is known to
be enclosed with a membranous sheath continuous with the outer membrane [107]. Thus,
without further purification, the WT flagellins should remain associated with the flagellar
sheath as part of the OM fraction. Surprisingly, flagellins were also detected in the
insoluble protein fraction of WT. Moreover, in hp0366, flagellins were also identified in
the insoluble protein fraction (Figure 9). No flagellins were identified in the OM of
hp0366, as expected as hp0366 is unable to form proper flagella. By glycoproteinspecific labelling, the WT flagellins in both the OM and insoluble protein fractions
appeared to be glycosylated. As well, the flagellins in the insoluble fraction of hp0366
also appeared glycosylated (Figure 9). Interestingly, by glycoprotein specific-labelling, a
protein band was strongly detected in both the insoluble and OM fractions of WT and
hp0366. As glycosylation is not dependent on hp0366, this glycoprotein candidate may
represent an additional glycoprotein that is glycosylated by a sugar other than pse in H.
pylori. The respective protein band was cut from a Coomassie-stained polyacrylamide gel
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Figure 9: Detection of WT and hp0366 glycosylated flagellins in insoluble and outer
membrane protein fractions by anti-FlaA/B Western blot and glycoprotein-specific
chemical labelling. WT and hp0366 insoluble and outer membrane (OM) cell fractions
obtained by differential centrifugation were labelled in-solution for glycoproteins with
(+) or without (-) BHz and analyzed by SDS-PAGE. Total protein was stained with
Ponceau S (A). Glycoproteins were identified by detection of the BHz label with a
fluorescent conjugate of streptavidin (Red) and flagellins were detected by anti-FlaA/B
Western blot (Green). The arrow indicates the flagellin band. Overlap of the signals
obtained by anti-FlaA/B Western blot and by detection of glycoproteins with streptavidin
indicate the presence of glycosylated flagellin species. The asterisk indicates the
glycoprotein band sent for analysis. MW = molecular weight standards, T = transferrin, F
= purified recombinant H. pylori flagellins (non-glycosylated).
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and sent for glycopeptide analysis by our collaborator, Dr. Anne Dell (Imperial College,
London). Results are pending.
To verify the presence of flagellins in the WT OM and in the WT and hp0366
insoluble protein fractions, the flagellin band was cut from ID SDS-PAGE gels, trypsin
digested, and analyzed by mass spectrometry (MS). Unfortunately, the samples were
found to be too complex to detect the flagellins. By MS analysis, over 30 proteins were
identified in the single cut band with high confidence (data not shown). As such, it is
likely that the flagellins were recovered in low amounts by differential centrifugation,
which prevents further glycopeptide analysis. Regardless, the additional evidence of
glycosylated flagellins in hp0366 further suggests that there is a pse-independent
glycosylation pathway in H. pylori. This observation warranted the development of new
strategies to assess the insoluble protein fraction of WT and hp0366. Therefore, new
approaches were utilized in order to simplify the protein fractions containing glycosylated
flagellins for further purification and glycan analysis.
3.1.3 Separation of WT H. pylori insoluble flagellins by 2-D gel electrophoresis
In order to identify the flagellins in the insoluble protein fraction of both WT and
hp0366 strains of H. pylori, it was necessary to separate the flagellins from other protein
content present in the samples. For this purpose, 2-dimensional gel electrophoresis (2DE) was investigated as a potential preparative method. 2-DE separates proteins based on
charge in one dimension and based on molecular mass in the second dimension, resulting
in distinct protein spots. 2-DE has previously been used to resolve different glycoforms
of glycoproteins [188].
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To determine if 2-DE would provide enough resolution to obtain purified
flagellins from the insoluble protein fractions, the WT insoluble sample was assessed by
2-DE. Previous characterization of the H. pylori flagellins indicated that WT flagellins
exhibited a pi of 5.2 [105]. As such, the pH range of 4.5 to 6.5 was chosen for analysis.
Total protein was visualized by Ponceau S stain and the flagellins were detected by antiFlaA/B Western blot (Figure 10). By anti-FlaA/B Western blot, flagellins were detected
as a series of several protein spots rather than a single protein spot. While the detection of
multiple protein spots may be due to flagellin degradation or non-specificity of the antiFlaA/B antibody, horizontal streaking by 2-DE is typically indicative of post-translational
modifications, such as glycosylation [188]. Thus, the detection of multiple protein spots
by anti-FlaA/B Western blot could reflect the presence of several flagellin glycoforms.
This was anticipated as previous analysis of the WT flagellins has indicated that they are
heterogeneously glycosylated [117]. In the present analysis, the flagellin spots of the WT
insoluble protein fraction appear as two populations. This likely represents the separation
of FlaA and FlaB and/or the separation of the different glycoforms of each flagellin. As
evident by 2-DE, the WT flagellins are poorly abundant compared to other proteins in the
insoluble protein fraction and are not visible by Ponceau S. The low abundance of the
flagellins in the insoluble fraction may explain why the flagellins could not be
conclusively identified by MS analysis from ID SDS-PAGE.
Overall, 2-DE of the WT insoluble fraction allowed for the separation of the WT
flagellins from more abundant proteins that would otherwise contaminate MS analysis.
As such, the protein spots corresponding to the flagellins could be excised and used for
MS analysis. However, the flagellin spots are not detectable by Ponceau S. Thus, it is
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Figure 10: Analysis of WT insoluble flagellins separated by 2-DE and detected via
anti-FlaA/B Western blot. Total protein in the WT insoluble protein fraction was
separated by 2-DE and stained with Ponceau S (A). Flagellins were detected by antiFlaA/B Western blot (B). By 2-DE, several flagellin protein spots were observed. These
likely represent the various glycoforms of FlaA and FlaB. All flagellin spots were poorly
abundant compared to other proteins in the WT insoluble protein fraction. Thus, a
different method to obtain purified flagellins for glycoprotein analysis was investigated.
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unlikely that enough flagellins could be recovered for complete glycoprotein analysis by
2-DE preparative gels. Therefore, methods to recover more of the flagellins, which would
be applicable to hp0366 as well, were investigated.
3.1.4 Purification of recombinant flagellins via affinity chromatography
As it was evident by ID SDS-PAGE and 2-DE that the flagellins were of low
abundance compared to other proteins in the insoluble protein fraction, another strategy
was required in order to purify the flagellins for complete analysis of the glycosylation
observed.
In order to enable purification of the flagellins, both of the flagellin subunits,
FlaA and FlaB, were tagged with a C-terminal hexa-Histidine tag to allow purification
from H. pylori by affinity chromatography. Expression of the flagellins from H pylori,
rather than a different bacterial host, was required in order to assess the effect of pse
glycosylation versus alternative glycosylation. However, genetic manipulation of H.
pylori is hindered by the availability of minimal gene transfer systems. Although some
shuttle vectors have been designed, problems are encountered with plasmid stability and
the occurrence of recombination events [235]. In addition, limited strategies for
chromosomal integration have been described in H pylori. A shuttle vector based
strategy was employed for expression of the glycoprotein candidate WaaL in H pylori, as
described in Section 3.3.2, however, problems with plasmid stability were encountered.
Therefore, to express tagged versions of the flagellins in H. pylori, a chromosomal
integration strategy was utilized.
The flagellins were integrated into the chromosome in the rdxA gene as
previously reported [218, 236]. Few other sites for chromosomal integration have been
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reported for H. pylori. RdxA (hp0954) is a nitroreductase that converts the antibiotic
metronidazole (Mtz) from its inactive pro-drug form to its active form [237], to which
most laboratory strains of H. pylori are susceptible. This site of integration is
advantageous as rdxA is dispensable for H pylori viability; Mtz-resistant strains exhibit
no metabolic or growth differences from isogenic Mtz-susceptible strains [237]. As well,
inactivation of rdxA allows for positive selection without incorporation of additional
resistance markers as disruption of rdxA prevents conversion of Mtz to its active form
and results in H. pylori that is resistant to Mtz [236]. The vector used for chromosomal
integration in rdxA is a pET21a (Novagen) derivative that contains flanking regions of
rdxA around a gene of interest for chromosomal integration [218]. This vector,
pET634comp, was obtained from Dr. S. Trent (University of Texas) and was modified to
contain either flagellin gene with their native promoter, hp0601 (Pr-flaA) and hpOl 15
(Pr-flaB), and a C-terminal hexa-Histidine tag, to be used for chromosomal integration of
the flagellins in rdxA and subsequent expression of the tagged flagellins in H. pylori.
However, our laboratory WT H. pylori strain is naturally resistant to Mtz, due to
insertion of the mini-IS605 transposon and deletion of the flanking regions of rdxA [238].
The truncated and non-functional copy of rdxA in the WT chromosome prevented the use
of the flagellin pET634comp derivatives for chromosomal integration into rdxA.
Therefore, in order to utilize this system for flagellin expression in WT and hp0366
strains, an additional integration step was required to introduce a full-length functional
copy of rdxA into WT and the isogenic mutant hp0366.
In order to introduce a functional copy of rdxA, a new site of integration within
the WT chromosome was required. For this purpose, ureB (hp0072), which encodes for
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urease subunit B (UreB), was chosen. Disruption of ureB was chosen as deletion of ureB
in H. pylori has been widely characterized with no observed defect in growth and motility
or effect on glycosylation [118, 239]. In addition, disruption of ureB is advantageous for
the purification of the flagellins as UreB has been found by several different methods to
cross-react with the anti-FlaA/B antibody, including during attempts to purify the
flagellins from cell fractions as described in Section 3.1.2. This co-migration has
hindered past MS analysis of samples as UreB is highly abundant in the cell and likely
masks detection of the flagellins, which are present at lower levels. Upon incorporation of
rdxA within ureB, rdxA could be subsequently inactivated with the tagged flagellin genes
for the expression of tagged flagellins in WT and hp0366 and the purification of the
flagellins by affinity chromatography. This strategy is outlined below.
3.1.4.1 Integration of rdxA into WT and hp0366 H. pylori
Incorporation of rdxA into WT and hp0366 H. pylori strains will convey Mtz
susceptibility and allow for the use of the pET634comp derivatives for chromosomal
integration of the cloned flagellin genes for flagellin expression in H pylori. ureB was
chosen as the site of integration for a full-length copy of rdxA. A suicide vector, pBKSUreB::RdxA-CAT, containing rdxA in-frame with a chloramphenicol antibiotic resistance
cassette (CAT) with flanking regions of ureB was constructed (refer to Figure 4). For
transformation into H. pylori, the vector was treated with WT H pylori cell-free extract
(CFE). CFE treatment of foreign DNA is advantageous for transformation into H. pylori
as the presence of multiple restriction-modification systems act as a barrier to
transformation [219]. Treatment with CFE results in specific in vitro site-specific
méthylation of foreign DNA with the “signature” of H. pylori DNA by endogenous
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methyltransferases. This allows for the restriction-modification barrier to be overcome
[219, 240]. Without CFE treatment of foreign DNA, H. pylori strains are often resistant
to transformation or exhibit extremely low transformation efficiencies. After CFE
treatment, pBKS-UreB::RdxA-CAT was transformed into WT and hp0366 by
electroporation. Clones were selected on BHI-YE agar plates supplemented with
12pg/mL chloramphenicol and were apparent after 3-5 days of incubation in
microaerophilic conditions.
Successful integration of rdxA-CAT was screened by conventional PCR of
chromosomal DNA for the upstream and downstream regions of ureB. PCR amplification
of a 2.7kb band indicated that rdxA-CAT had properly integrated within ureB and not
elsewhere in the genome (Figure 11: A). Furthermore, the disruption of ureB was
confirmed by analysis of the total protein profiles of select clones (Figure 11: B).
Compared to WT and hp0366 strains, clones with successful integration of rdxA into
ureB, lacked the abundant UreB band of approximately 66 kDa.
To verify the integration of a functional copy of rdxA, clones were patched onto
BHI-YE agar plates supplemented with 6pg/mL, 12pg/mL, and 18pg/mL of Mtz. In all
cases, WT and hp0366 clones containing rdxA were unable to grow in the presence of
Mtz (data not shown). Therefore, a full-length functional copy of rdxA was successfully
integrated into both WT and hp0366 H pylori strains.
3.1.4.2 Inactivation of rdxA via chromosomal integration of the tagged flagellins
Representative clones of WT and hp0366 with verified integration of rdxA-CAT
were used for subsequent inactivation of rdxA by tagged versions of the H. pylori
flagellin genes. As described previously, suicide vectors containing either Pr-flaA-His
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Figure 11: Verification of chromosomal integration of a functional copy of rdxA in
WT and hp0366 H. pylori rdxA-CAT was integrated into the chromosome of both WT
and hp0366 H. pylori strains by electroporation with the suicide vector pBKSUreB::RdxA-CAT. Successful integration of rdxA-CAT was confirmed by PCR
amplification with primers specific for ureB from chromosomal DNA of WT, hp0366,
and representative clones containing rdxA-CAT from each strain. Clones of both WT and
hp0366 that had undergone successful chromosomal integration of rdxA-CAT
demonstrated a size increase of-l.Okb. 1 = pBKS-UreB (plasmid control), 2 = pBKSUreB::RdxA-CAT (plasmid control), 3 = WT, 4 = WT-rdxA-CAT, 5 = hp0366, 6 =
hp0366-rdxA-CAT {A). The disruption of ureB was verified by the loss of UreB
production as seen by analysis of the total protein content of the rdxA-CAT clones. Total
protein from WT, hp0366, and representative rdxA-CAT clones from each strain were
separated by 12% SDS-PAGE and visualized by Coomassie Blue staining (B). A
noticeable loss of UreB (~66 kDa) in the clones containing rdxA-CA T indicated the
successful disruption of ureB. MW = molecular weight standards.
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(hp0601) or Pr-flaB-His (hp0115) were constructed by modification of the vector
pET634comp (see Figure 5). In these vectors, both flagellins were cloned with their
native promoter as the flagellins are known to be differentially regulated by alternative
promoters [112]. The constructs, pRF-2 (Pr-flaA-Hisj and pRF-1 {Pr-flaB-His), were
treated with WT CFE and transformed into WT-rdxA-CATand hp0366-rcbcA-CAT strains
by electroporation. Clones were selected on BHI-YE agar plates supplemented with
12pg/mL chloramphenicol and 18pg/mL of Mtz.
Several clones were obtained after transformation of WT-rdxA-CA T and hp0366rdxA-CAT with both pRF-2 and pRF-1. The appearance of clones on agar plates
supplemented with Mtz indicated that the tagged flagellin genes had properly integrated
within rdxA as they were resistant to Mtz. Verification of the clones for each strain is
underway via PCR amplification using primers that flank the ureB gene. Compared to the
WT-rdxA-CAT and hp0366-rdxA-CAT strains, the PCR product obtained from clones
with the appropriate insertion of either Pr-flaA-His or Pr-flaB-His is expected to exhibit
an approximately 1.7kb size increase of the PCR product.
Moreover, it appeared that the mini-IS605 transposon, responsible for the
disruption of the endogenous copy of rdxA in our WT strain, was able to jump into the
newly integrated copy of rdxA as several clones were obtained from negative control
transformation plates transformed with distilled water (no vector). These false-positive
clones were observed at a lower frequency than clones that were disrupted by the tagged
flagellin genes. The presence of false-positive clones indicates the requirement for
routine screening of colonies before the use of the rdxA-CAT strains for chromosomal
integration in the future. Regardless, once clones for each WT and hp0366 expressing Pr-
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flaA-His and Pr-flaB-His are confirmed, the expression of the tagged flagellins will be
verified by an anti-Histidine Western blot from total cell lysates.
Overall, once fully characterized, the generation of WT and hp0366 strains that
express the flagellins with a Histidine-tag will enable purification of large amounts of the
flagellins from both H pylori strains by affinity chromatography. Purified flagellins can
then be analyzed by MS. The ultimate goal is to identify the glycan present on the hp0366
flagellins and compare it to that of pse on the WT flagellins. The demonstration that a
glycan distinct from pse is present on the hp0366 flagellins will definitively reveal the
presence of an alternative glycosylation pathway in H. pylori.
3.2 Detection of additional glycoproteins besides the flagellins in H. pylori
Pse is known to only modify the flagellins of H. pylori. However, both pse
mutants, flaA 1 and hp0366, displayed unexpected altered LPS profiles in addition to a
defect in flagellum production. flaAl exhibited an altered O-antigen compared to WT
[118, 175], while hp0366 was completely O-antigen deficient [174]. This observation
was surprising as pse is not involved in LPS biosynthesis [69-71]. Further, the effect
observed on LPS production was not due to joint transcriptional regulation of LPS and
flagella biosynthesis as quantitative real-time PCR demonstrated no significant changes
in the expression of LPS biosynthetic genes in the hp0366 mutant (Creuzenet Lab,
unpublished). In flaAl, a slight upregulation of the O-antigen ligase, WaaL, involved in
LPS biosynthesis was observed, however, this would not contribute to the altered Oantigen profile observed.
Overall, the unexpected effect by the disruption offlaAl and hp0366 on LPS
production indicated that other proteins, such as those involved in LPS biosynthesis, may
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require glycosylation for proper function. The proposed presence of additional
glycoproteins in H. pylori is supported by recent data from our laboratory in which
soluble glycoprotein candidates in H. pylori were identified [176]. The following section
describes detection of additional glycoproteins in the membrane protein fraction of H.
pylori. The identification of glycoproteins in the membrane protein fraction of H. pylori
may exemplify a link between protein glycosylation and LPS biosynthesis as LPS
biosynthetic enzymes are known to be integral IM proteins. As well, surface-associated
glycoproteins in the OM of H. pylori could represent a pool of novel virulence factors.
3.2.1 Pleiotropic effects on membrane stability do not account for the LPS defects
observed in flaAl and hp0366
Pse glycosylation of the flagellin subunits is well-established as a component
required for flagellum production [117, 225], Moreover, the flagellar apparatus is a prime
component of the bacterial membrane that transverses both the IM and OM [104], Thus,
interruption of flagellum production by disruption of pse biosynthesis may have
pleiotropic effects on the stability of the cell membrane, which may result in the LPS
defects observed in the flaAl and hp0366 mutants. To investigate if the LPS profiles
observed in flaAl and hp0366 could be due to a general effect on membrane stability,
rather than a link between protein glycosylation and LPS biosynthesis, the cell
membranes of WT and the pse mutants were analyzed.
For this purpose, total membrane fractions of WT, flaAl, and hp0366 were
separated into IM and OM components by differential solubilization of the IM proteins
by 1% N-lauroylsarcosine and the protein profiles were analyzed by 12% SDS-PAGE. In
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general, by Coomassie stain, the IM and OM protein profiles of WT, flaAl, and hp0366
were similar (Figure 12). The similar protein pattern observed indicates that the LPS
defects observed in flaAl and hp0366 are gene-specific and not the result of pleiotropic
effects on membrane stability. Of interest are the reduced levels of a ~15 kDa band in the
membrane fractions offlaAl. This protein could represent a potential pse-dependent
glycoprotein in the membrane of H pylori that follows a similar pattern to that observed
for the flagellins; when flaAl is disrupted, the flagellins are non-glycosylated and
expressed at reduced levels [175]. Comparatively, the flagellins of hp0366 are
alternatively glycosylated and are expressed at levels close to WT [174]. The
corresponding ~15 kDa protein band observed by Coomassie staining was cut from the
polyacrylamide gel and sent for protein identification by MS analysis. Results are
pending.
3.2.2 Demonstration of novel membrane glycoproteins in H. pylori
The alteration of LPS production in flaAl and hp0366 was unexplained by
transcriptional regulation and potential pleiotropic effects on membrane stability,
indicating that the effect on LPS production was gene-specific. Thus, the defect observed
in LPS production in the pse mutants suggests that LPS biosynthetic enzymes in H. pylori
may require glycosylation for function. As such, glycoproteins are likely present in the
membranes of H. pylori.
To investigate whether the LPS defect observed in the pse mutants was due to the
presence of membrane glycoproteins in H pylori, total membrane samples of WT, flaAl,
and hp0366 were chemically labelled with BHz to specifically label glycoproteins, and
separated by 12% SDS-PAGE. Glycoproteins were detected with a fluorescent conjugate
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Figure 12: Inner membrane and outer membrane protein profiles of WT,JlaAl, and
hp0366. WT, flaAl, and hp0366 total membrane samples were separated into inner and
outer membrane components by differential solubilization of inner membrane proteins in
1% N-lauroylsarcosine. The protein profiles of the inner membrane and outer membrane
fractions were analyzed by 12% SDS-PAGE and stained with Coomassie Blue. The
protein profiles of WT, flaAl, and hp0366 are similar, indicating no pleiotropic effects on
membrane stability caused by the disruption of flagellin glycosylation and flagellum
production in flaAl and hp0366. Interestingly, a ~15 kDa protein appeared dependent on
flaAl but not hp0366. This protein band of interest is indicated by the arrow. MW =
molecular weight standards.
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of streptavidin. By this method, several glycoprotein bands were observed in the total
membrane fraction of WT H pylori that were absent from the membrane fractions of the
pse mutants, indicating that pse-dependent glycoproteins are present in the membranes of
H. pylori and that pse glycosylation is not limited to the flagellins (Figure 13). These
novel pse-dependent membrane glycoproteins and the absence of glycosylation in the pse
mutants may contribute to the altered LPS profiles observed in the mutants. Moreover,
several glycoprotein bands were detected in the membrane fractions of the pse mutants
(Figure 13), indicating the presence of pse-independent glycoproteins as well. The
potential glycoproteins observed in the total membrane were visualized at two intensities,
high (Figure 13: B) and low (Figure 13: C), for optimal resolution of the glycoprotein
bands. For the purpose of this study, only the predominant bands were considered as
candidates for further investigation. This likely underestimates the number of
glycoproteins found in the membranes of H pylori as several additional bands are
observed upon visualization at a higher intensity.
Overall, the observation of pse-independent glycoproteins further demonstrates
the presence of a novel glycosylation pathway in H. pylori, which corresponds with the
alternative glycosylation of the hp0366 flagellins. As well, the detection of several psedependent glycoproteins demonstrates that additional proteins besides the flagellins are
glycosylated with pse. Together, these findings go against the current dogma of protein
glycosylation in H pylori in which only the flagellins are believed to be glycosylated by
pse.
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Figure 13: Detection of membrane glycoproteins in WT,JlaAl, and hp0366 H. pylori.
WT, flaAl, and hp0366 total membrane samples were subjected to chemical labelling in
solution, which specifically labels glycoproteins with BHz. Samples were treated with (+)
or without (-) BHz to demonstrate specific detection of labelled proteins, separated on
12% SDS-PAGE gels, and transferred to a nitrocellulose support. Total protein on the
nitrocellulose membrane was stained with Ponceau S (A). BHz-labelled glycoproteins
were detected with a fluorescent conjugate of streptavidin. Detection of glycoproteins
was performed at high intensity (B) and at a low intensity (C) to resolve the distinct
glycoprotein bands. It is evident that several pse-dependent glycoprotein bands are
present in the WT membrane. These distinct bands are clearly evident by detection of
glycoproteins at low intensity. Moreover, several pse-independent glycoprotein bands are
also evident in the membrane fractions offlaAl and hp0366. M = molecular weight
standards, T = transferrin (glycoprotein control).
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3.3 Investigation of H. pylori LPS biosynthetic enzymes as novel glycoproteins
The observation of a defect in LPS biosynthesis by both pse mutants is suggestive
of a link between protein glycosylation and LPS biosynthesis in H pylori, such that
disruption of pse glycosylation results in the altered activity of LPS biosynthetic
enzymes. Both flaAl and hp0366 exhibited altered O-antigen profiles; flaA I displayed a
modified O-antigen [118, 175] while hp0366 lacked O-antigen production completely
[174], which suggests that there is a defect in the assembly or translocation of the Oantigen to the lipid A core upon disruption of pse glycosylation. As a result, investigation
of the H pylori LPS biosynthetic machinery and the potential role of protein
glycosylation on protein function was warranted.
The LPS biosynthesis pathway in H. pylori was recently characterized and was
shown to exhibit both classical components of model LPS biosynthesis and novel
components not previously associated with LPS production [93]. The identification of the
flippase required for LPS biosynthesis, Wzk, as a homolog of protein glycosylation [93]
further supports a direct connection between LPS biosynthesis and protein glycosylation
in H pylori. In general, the function of any of the identified enzymes involved in LPS
biosynthesis, and more specifically, the production and translocation of the O-antigen
chain to the lipid A core, may be affected by pse glycosylation and result in the LPS
defects observed in the pse mutants.
Overall, a clear connection between LPS biosynthesis and protein glycosylation is
evident. Nevertheless, the extent of the link between LPS biosynthesis and protein
glycosylation has not been defined. More specifically, whether the LPS biosynthetic
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enzymes are glycosylated themselves and if they require glycosylation for function has
not been previously investigated. This is examined in the following sections.
3.3.1 Glycoprotein candidates are present in the inner membrane of H. pylori
The LPS biosynthetic machinery responsible for the assembly and attachment of
the O-antigen to the lipid A core is localized to the IM. As such, in order to explore
whether LPS biosynthetic enzymes are glycosylated, it was first necessary to determine
whether glycoproteins are present in the IM of H. pylori. As described in Section 3.2.2,
several membrane glycoprotein candidates were detected via glycoprotein-specific
labelling in total membrane samples (Figure 13). This represents potential glycoproteins
in both the IM and OM. To determine if any of the labelled glycoproteins could be LPS
biosynthetic enzymes, WT total membrane samples were separated into IM and OM
components by differential solubilization of IM proteins in 1% N-lauroylsarcosine. The
IM and OM fractions were subsequently labelled for glycoproteins in-solution with BHz
and glycoproteins were detected with a fluorescent conjugate of streptavidin.
Several glycoprotein bands were detected in both the IM and OM protein
fractions (Figure 14). The observation of glycoprotein bands in the IM fraction indicates
that LPS biosynthetic enzymes may be glycosylated as all enzymes involved in LPS
biosynthesis for the attachment and translocation of the lipid A core are integral IM
proteins. Nevertheless, it is difficult to ascertain if any of the detected glycoprotein bands
correspond to LPS biosynthetic enzymes based on molecular mass alone, as anomalous
migration within SDS-PAGE gels has been reported for several integral IM proteins
[241-243].
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Figure 14: Detection of H. pylori inner membrane glycoproteins. WT total membrane
samples were separated into IM and OM components by selective solubilization of IM
proteins in 1% N-lauroylsarcosine. IM and OM proteins were labelled in-solution for
glycoproteins with BHz (+) or without (-), separated by 12% SDS-PAGE, and transferred
to nitrocellulose. Total proteins were stained with Ponceau S (A). Glycoproteins were
detected by affinity of the BHz-label with a fluorescent conjugate of streptavidin (B).
Several glycoprotein bands are evident in both the IM and OM fractions. The presence of
IM glycoproteins corresponds with the hypothesis that LPS biosynthetic IM enzymes
may be glycosylated and require glycosylation for function. M = molecular weight
standards, T = transferrin (glycoprotein control), F = purified recombinant flagellins.
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In order to further investigate whether LPS biosynthetic enzymes are
glycosylated, a candidate glycoprotein, WaaL, was chosen based on the LPS profile of
the hp0366 mutant. While all the enzymes involved in LPS biosynthesis could rely on
glycosylation and be responsible for the defect observed in hp0366, the LPS profile of
hp0366 is O-antigen deficient. This is reminiscent of a defect in the O-antigen ligase, or
WaaL, in which the O-antigen is not attached to the lipid A core prior to export of LPS
tothe OM. Thus, efforts were focused on assessing the glycosylation status of WaaL in H.
pylori.
3.3.2 Characterization of the candidate glycoprotein WaaL
Previous work in the Creuzenet Laboratory identified the WaaL in the sequenced
H. pylori strain 26695 as hpl039 based on a homology search to known WaaLs and
comparison of hydrophobicity profiles [175]. In general, known WaaLs lack sequence
similarity, but demonstrate similar secondary structures and membrane topology [67],
Comparison of the H. pylori WaaL, hpl039, to characterized WaaLs in E. coli K12 and
Salmonella enterica indicated that they are similar in both the distribution and size of
transmembrane domains [175], As well, hpl039, possesses a Wzy_C domain (Pfam
domain PF04932), which is annotated as an O-antigen polyermerase motif, but has in
practice been found among O-antigen ligases. The hydrophobicity profile of hpl039
indicated that the H. pylori WaaL contains 12 transmembrane domains with a large
periplasmic loop of approximately 90 amino acids. This secondary structure is consistent
with known WaaLs in which the large periplasmic loop has been shown to possess the
catalytic site for ligase activity [244]. As such, if glycosylation does affect the activity of
WaaL, it is likely to occur within the periplasmic loop. In fact, based on the sequence and
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membrane topology of hp!039, several serine and threonine amino acid residues for Olinked glycosylation as well as one putative eukaryotic N-linked glycosylation sequence
are present within the periplasmic loop [175].
The identification of hpl039 as a true WaaL was further demonstrated by
construction of a knockout mutant of hpl039 [175], The mutant displayed an O-antigen
deficient LPS profile as expected of an O-antigen deficient strain and will be referred to
as waaL. As anticipated, the O-antigen deficient profile matched that of hp0366, which
supports the proposed theory that WaaL is non-functional in hp0366 due to a
glycosylation defect.
In order to investigate WaaL as a candidate glycoprotein, several obstacles needed
to be overcome. Firstly, as an integral inner membrane protein, WaaL is expressed at low
levels. To date, all WaaL proteins that have been characterized have been studied after
overexpression [244, 245], No WaaL has been purified from endogenous levels.
However, in order to study glycosylation of WaaL in H. pylori, expression in another host
was not possible. As well, overexpression of WaaL in H. pylori was updesired as the
effects on glycosylation are unknown, such that overexpression may congest the
glycosylation machinery resulting in detection of non-glycosylated forms of the protein.
As well, the LPS machinery acts as a complex and may require strict stoichiometric
interactions between complex components for proper function. Furthermore, likely due to
difficulties in purification, no WaaL-specific antibody is available to detect WaaL. To
accommodate these barriers, WaaL, under its native promoter, was tagged with a Cterminal hexa-Histidine tag on the shuttle vector pHel2 by Dr. Alexandra Merkx-Jacques.
The Histidine-tag was incorporated to serve a dual purpose; to allow enrichment of WaaL
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by nickel affinity chromatography and for its subsequent detection by anti-Histidine
Western blot. Using this strategy, attempts to purify WaaL-His from H pylori in order to
assess its glycosylation status were performed.
3.3.2.1 Expression and localization of WaaL-His to the WT inner membrane
The shuttle plasmid encoding H. pylori WaaL (hpl039) under its native promoter
with a C-terminal Histidine-tag, pProCompWaaL, was previously constructed by Dr.
Alexandra Merkx-Jacques. The shuttle plasmid was treated with WT cell-free extract
(CFE) for in vitro site-specific méthylation of plasmid DNA in order to overcome the
restriction-modification barrier present in H pylori, as described in Section 3.1.4. The
CFE-treated plasmid was transformed into WT H. pylori by electroporation. In tandem,
WT H. pylori was also transformed with the backbone vector, pHel2, treated with WT
CFE. This WT strain, carrying pHel2, was used as a negative control for WaaL-His
expression in all experiments to verify that the signal detected by anti-Histidine Western
blot was specific to WaaL-His expression and not from the plasmid backbone.
Transformants were screened by colony PCR using primers specific for the promoter
region of WaaL (HP1039P1) and for the C-terminal Histidine-tag (Ctermhis) (data not
shown - see Figure 15). The primer specific for the C-terminal Histidine-tag was used to
distinguish the foreign copy of WaaL-His from the endogenous waaL. To screen for
pHel2 transformants, colony PCR for amplification of the CAT cassette from the vector
was performed using primers pHel2CATl and pHel2CAT2.
As discussed in Section 3.1.4, limited gene transfer systems are available in H.
pylori. While shuttle plasmids have been used with success, problems are encountered
with plasmid stability in which plasmid loss can occur over time. To limit the occurrence
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of plasmid loss, H. pylori strains carrying each plasmid were grown in a strict timeline
with two cell expansions. Each growth period did not exceed 36 hours. As well, to further
verify plasmid maintenance in each strain, after each expansion of WT strains carrying
pProCompWaaL (+WaaL-His) or pHel2 (-WaaL-His), an aliquot of cells was used for
plasmid purification and PCR amplification of WaaL-His or of the CAT cassette to
ensure that each plasmid was retained during growth. PCR amplification from purified
plasmid was necessary to assess the presence of the plasmid as pHel2 is a low copy
vector [217] and very limited plasmid recovery is obtained from H. pylori. The presence
of a 1.7kb band from PCR amplification of WaaL-His from pProCompWaaL extracted
from H. pylori at each stage of growth verified that the plasmid was not lost (Figure 15).
Similarly, a 750bp band from PCR amplification of the CAT cassette from pHel2 or
pProCompWaaL extracted from H. pylori after each stage of growth indicated that both
plasmids were not lost during growth (data not shown).
After validation of the presence of plasmid by PCR amplification, cell pellets of
WT H. pylori carrying pProCompWaaL and WT pHel2 were lysed and the cell lysate
separated by differential centrifugation. The total membrane pellet was further separated
into IM and OM fractions. The initial cell separation acted to enrich samples in WaaLHis prior to purification by affinity chromatography as WaaL was expected to be
localized to the IM. After separation, expression of WaaL-His was assessed in the IM
fractions. Total IM samples of both WT pProCompWaaL (+WaaL-His) and WT pHel2 (WaaL-His) were denatured by various conditions before separation by SDS-PAGE;
incubation at 45 °C for 30 minutes, 56°C for 10 minutes, 65 °C for 10 minutes or 100°C
for 5 minutes. Several denaturing conditions were tested as membrane proteins have
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Figure 15: Verification of pProCompWaaL maintenance in WT H. pylori by PCR
analysis of purified plasmid. To verify the presence of pProCompWaaL in WT H.
pylori after each stage and round of growth for 36 hours on BHI-YE agar plates, plasmid
was extracted from H. pylori by plasmid purification. Recovery of plasmid DNA from H.
pylori is too low to ascertain the presence of the plasmid after plasmid purification alone.
Therefore, purified plasmid DNA was used for PCR amplification of WaaL-His to detect
pProCompWaaL. The 3’primer was specific for the C-terminal Histidine-tag to ensure
amplification of WaaL-His from the vector rather than the endogenous copy of WaaL.
Detection of a 1.7kb band from H. pylori at each stage of growth after each cell harvest
indicated that pProCompWaaL was retained throughout each growth period. PCR
amplification of WaaL-His was also conducted on the original pProCompWaaL vector
extracted from E. coli as a PCR control at two dilutions (undiluted and 1/10). Lane 1:
pProCompWaaL from E. coli undiluted, Lane 2: pProCompWaaL from E. coli 1/10
dilution, Lane 3: pProCompWaaL from H. pylori, final harvest, round 1, Lane 4:
pProCompWaaL from H. pylori, final harvest, round 2, Lane 5: pProCompWaaL from H.
pylori, first expansion, round 1, Lane 6: pProCompWaaL from H. pylori, first expansion,
round 2.
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previously been reported to aggregate upon standard boiling for protein denaturation due
to their high hydrophobic nature [243]. In fact, other integral IM proteins involved in LPS
biosynthesis have been undetectable if boiled before SDS-PAGE due to protein
aggregation which prevents migration of the protein within SDS-PAGE gels [241, 242].
After denaturation, total IM samples were separated by SDS-PAGE and transferred to
nitrocellulose for immunodetection of WaaL-His by an anti-Histidine Western blot. Total
IM protein profiles of WT pProCompWaaL (+WaaL-His) and WT pHel2 (-WaaL-His)
samples, as visualized by Ponceau S stain of the nitrocellulose membrane, were similar
(Figure 16: A). There was no evidence of an additional band that would represent WaaLHis in the strain carrying pProCompWaaL (+WaaL-His) compared to the control strain.
This was expected since WaaL-His is under its native promoter and therefore is expressed
at low levels which are below the detection level of typical protein stains, including
Ponceau S. As well, no apparent difference in protein profile was observed from the
various denaturing conditions. In order to detect expression of WaaL-His, an antiHistidine Western blot was conducted (Figure 16: B). Reactivity of a ~50.0 kDa doublet
was observed to be more intense in the samples containing pProCompWaaL (+WaaLHis) when denatured at 56°C, 65°C, or 100°C, compared with the control strain. This
doublet was later found to be due to non-specific signal from the secondary antibody
alone and was not investigated further. However, a highly reactive, high molecular
weight band was also detected in the IM samples from the strain with pProCompWaaL
(+WaaL-His), but not from the control strain. This high molecular weight band was
thought to be WaaL-His as it was specific to the WT strain carrying pProCompWaaL by
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Figure 16: WaaL-His is expressed and localized to the inner membrane of WT H.
pylori after expression in trans. IM samples of WT H. pylori carrying pProCompWaaL
(+WaaL-His) or pHel2 (-WaaL-His) were denatured at various conditions; 45°C for 30
minutes, 56°C for 10 minutes, 65°C for 10 minutes, and 100°C for 5 minutes. Denatured
samples were separated by 12% SDS-PAGE. Total protein was stained with Ponceau S
(A). WaaL-His was detected by anti-Histidine Western blot (B). WaaL-His was apparent
as a high molecular weight aggregate in samples containing pProCompWaaL (+WaaLHis). MW = molecular weight standards, C= control Histidine-tagged protein.
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anti-Histidine Western blot. The detection of WaaL-His indicated that WaaL-His was
expressed from the shuttle plasmid and was properly localized to the IM.
The observation of strong reactivity as a high molecular band indicates that the majority
of WaaL-His is found within high molecular weight aggregates that are unable to migrate
within the SDS-PAGE gel. The observation of protein aggregates or oligomers at the
edge of the separating gel is common among integral IM proteins. Studies on the LPS
biosynthesis machinery of E. coli have demonstrated the presence of both oligomeric and
monomeric bands after mild denaturation conditions (45 °C for 30 minutes) [241, 242]. It
has been proposed that the mild denaturation conditions used to detect membrane
proteins are insufficient to fully denature all protein aggregates resulting in the presence
of high molecular weight oligomers [90, 242]. On the contrary, upon harsher denaturation
by boiling, no protein monomers can be detected. In the case of WaaL-His, no monomers
were observed, which suggests that the denaturing conditions tested were unable to fully
denature protein aggregates containing WaaL-His.
Various strategies were employed in order to disrupt the aggregates. Firstly, IM
samples were treated with 5M urea to remove aggregates as described previously for OM
proteins by Marani et al. 2006 [224], however, no difference in the migration of WaaLHis was observed (data not shown). As well, IM samples were also denatured in a
modified sample buffer containing urea as previously described for the detection of Wzx
in E. coli [242], however, no difference in the detection of WaaL-His as a high molecular
weight aggregate was observed (data not shown). In all cases, WaaL-His was detected as
a high molecular weight aggregate, which suggests that the denaturation conditions tested
for WaaL-His were insufficient to disperse protein aggregates from the IM.

131

3.3.2.2 Enrichment of WaaL-His by nickel affinity chromatography
Although WaaL-His could not be resolved by SDS-PAGE, the presence of WaaLHis in the IM was observed as high molecular weight aggregates that were present in H.
pylori containing pProCompWaaL (+WaaL-His) and not the control strain. In order to
assess whether WaaL was glycosylated, nickel affinity chromatography was employed to
further purify WaaL-His from the total IM samples.
IM samples containing WaaL-His from H pylori carrying pProCompWaaL
(+WaaL-His), as well as the control samples from H. pylori carrying pHel2 (-WaaL-His)
were processed through a gravity flow column of chelating sepharose resin loaded with
nickel sulphate. Both samples were subjected to step-wise elution with increasing
concentrations of imidazole. Fractions were analyzed by SDS-PAGE and detection of
WaaL-His was performed by immunoblot for the Histidine-tag. WaaL-His was detected
in the flowthrough and appeared to primarily elute with 250mM imidazole as a high
molecular weight aggregate as observed by anti-Histidine Western blot (Figure 17). The
high molecular weight band was not detected in the fractions collected from the control
strain.
To determine the purity of WaaL-His, the 250mM elution fraction from WT
pProCompWaaL (+WaaL-His) and the 250mM elution fraction from the control strain,
were separated by SDS-PAGE and were stained with silver nitrate (Figure 18). Multiple
protein bands were detected in samples with pProCompWaaL (+WaaL-His) indicating
that WaaL-His was not purified by nickel affinity chromatography. However, the 250mM
elutions containing WaaL-His from WT pProCompWaaL (+WaaL-His) was much
simpler in protein content compared to the total IM fraction. Thus, although WaaL-His
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Figure 17: Detection of WaaL-His in nickel affinity chromatography fractions. Total
IM samples with pProCompWaaL (+WaaL-His) or pHel2 (-WaaL-His) were processed
through gravity flow columns containing chelating sepharose resin charged with nickel
sulphate. The flowthrough (FT), wash, and elution at 250mM fractions were analyzed on
12% SDS-PAGE gels. Total protein was stained with Ponceau S (A). WaaL-His was
detected by anti-Histidine Western blot (B). WaaL-His was detected specifically in the
flowthrough and 250mM imidazole elution from the WT pProCompWaaL (+WaaL-His)
strain as a high molecular weight aggregate. MW = molecular weight standards, C =
control Histidine-tagged protein.
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Figure 18: Analysis of WaaL-His purified by nickel affinity chromatography. To
assess the purity of WaaL-His after nickel affinity chromatography, the 250mM
imidazole elution fractions from WT pProCompWaaL (+WaaL-His) and WT pHel2 (WaaL-His) were separated by 12% SDS-PAGE and total protein was stained with silver
nitrate. Several protein bands were evident in both the elution from WT pProCompWaaL
(+WaaL-His) and WT pHel2 (-WaaL-His) indicating that WaaL-His was only enriched
by nickel affinity chromatography. MW = molecular weight standards, C = control
Histidine-tagged protein.
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could not be fully purified by nickel affinity chromatography, this method allowed for
enrichment of WaaL-His.
In order to verify the presence of WaaL-His within the high molecular weight
aggregates and determine the extent of protein contaminants, the high molecular weight
region on a 1-well SDS-PAGE gel was excised and subjected to trypsin digestion. The
extracted peptides were sent to the University of Western Ontario Biological Mass
Spectrometry Laboratory (BMSL) for protein identification by MS analysis.
Unfortunately, no WaaL identification was obtained. Instead, several protein complexes
were identified, including UreA and UreB. UreA and UreB are not known to be present
in the IM and are predominantly cytoplasmic or surface associated [230]. Thus, their
identification from IM preparations suggests that the region containing WaaL-His does
consist of protein aggregates that were not solubilized by treatment with detergent, in
addition to the insufficient protein denaturation of samples prior to SDS-PAGE. As well,
it is possible that WaaL-His was expressed at levels too low for detection by MS.
Furthermore, as WaaL-His was only enriched by affinity chromatography, the protein
contaminants present may have a greater ability to be ionized. In particular, it is known
that glycosylated peptides are much harder to detect because they are more difficult to
ionize [187]. Thus, if WaaL-His was poorly expressed and our hypothesis is correct that
WaaL is glycosylated, WaaL peptides would be masked by more abundant, well-ionized
peptides, such as those of UreA and UreB. As well, peptides were extracted from SDSPAGE gels by trypsin digestion. Trypsin is commonly used to prepare samples for MS
analysis and cleaves the C-terminus of lysine and arginine residues [246]. Proximity to
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post-translational modifications has been shown to inhibit protease activity [247], Thus, if
WaaL is glycosylated, trypsin may have been inadequate for peptide digestion.
Overall, it is evident that expression by this system was not sufficient to purify
WaaL-His from WT H. pylori. It is likely that expression from the shuttle plasmid was
poor. Moreover, problems with plasmid stability remain a problem. Although the
presence of the shuttle plasmid was verified by PCR amplification for WaaL-His at each
stage of growth, it is possible that the plasmid was highly unstable. Since purified
plasmid is difficult to recover from H. pylori, PCR amplification was used to ascertain its
presence. However, this does not provide quantitative information regarding the
percentage of cells that still harbour the plasmid in the whole cell population and
therefore, this may over-represent the number of cells that are carrying the plasmid. Thus,
in order to investigate the potential glycosylation of WaaL, it will be beneficial to use a
chromosomal integration system. As such, the expression system derived for expression
of the recombinant flagellins via integration in rdxA in H pylori may be used for the
expression of WaaL-His.
3.4 Investigation of WaaL as a general glycosyltransferase
Bothpse mutants demonstrated an altered LPS profile in which the O-antigen of
the flaAl mutant was altered compared to WT and the LPS of the hp0366 mutant was Oantigen deficient. The disruption of LPS biosynthesis in the pse mutants indicated that a
connection exists between protein glycosylation and LPS biosynthesis in H. pylori. This
prompted investigation of the direct glycosylation of LPS biosynthetic enzymes in H.
pylori as described in Section 3.3. In particular, WaaL, the O-antigen ligase, was chosen
as a candidate glycoprotein based on the O-antigen deficient profile of hp0366. For this
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study, a waaL (hpl039) knockout mutant that was constructed previously was used [175].
Upon characterization of the waaL mutant, it was observed that in addition to an Oantigen deficient LPS profile, as expected of a waaL mutant, the mutant was also nonmotile and lacked production of a proper flagellum [175]. This finding was surprising as
WaaL is considered to function exclusively in LPS biosynthesis in H. pylori. No
additional role of WaaL in H. pylori has been described previously. As such, the
observation that inactivating WaaL abrogated flagellum production suggested that WaaL
function is necessary for proper flagellum production.
Given the known function of WaaL as the O-antigen ligase, which amounts to
saccharyltransferase activity similar to that of the oligosaccharyltransferases (OTases)
found to be involved in protein glycosylation, it was theorized that WaaL could act as an
OTase for glycosylation of the flagellins. However, a prior study demonstrated that while
WaaL affects flagellum production, it is not involved in the glycosylation of the flagellins
since the waaL flagellins were demonstrated to be glycosylated by glycoprotein-specific
labelling [175]. Thus, this suggested that WaaL may be necessary for the glycosylation of
other flagellar components required for proper flagellum assembly, and that WaaL may
serve as a general OTase for these components.
The proposal of WaaL as a general OTase in H. pylori is further supported by the
finding that WaaL is similar to the pilin glycosyltransferase of Neisseria meningitidis,
PglL. PglL and WaaL exhibit similar hydrophobicity profiles in which both exhibit
several transmembrane domains and a large periplasmic loop. Furthermore, WaaL is 46%
similar to PglL, which is the same degree of similarity exhibited between the H. pylori
WaaL and known WaaLs from other species [175], As well, PglL was originally
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identified as a ligase by homology with the Wzy_C domain (PFAM04932) [184]. Wzy_C
domains are common among O-antigen ligases, including the H. pylori WaaL [175],
however they have also been identified in transferases involved in protein glycosylation
pathways including PilO, which is required for the O-glycosylation of pilin subunits in P.
aeruginosa [153]. PilO and PglL have been classified as a new family of OTases, OOTases, which mediate O-linked protein glycosylation [248], A search conducted by Dr.
Alexandra Merkx-Jacques for other proteins besides WaaL in H. pylori that encode a
Wzy_C domain was unsuccessful, indicating that if an OTase for protein glycosylation
was present in H. pylori the most likely candidate is WaaL. Interestingly, both PilO and
PglL exhibit relaxed glycan specificity [249, 250]. In particular, PilO was demonstrated
to transfer different O-antigens to the pilin subunits [249] while PglL has been shown to
have extreme substrate promiscuity in which potentially any glycan can be transferred to
the pilin subunits [250]. As such, if the H. pylori WaaL acts similarly as a general OTase,
it may have relaxed glycan specificity for both the O-antigen chain and other glycans for
protein glycosylation.
Nevertheless, if WaaL functions as an OTase in addition to the O-antigen ligase,
the structure of the glycan transferred to potential glycoproteins is unknown. Therefore,
to investigate whether WaaL could act as an OTase, it was examined whether the H.
pylori WaaL could transfer its natural glycan, the Ley O-antigen chain, to proteins in
addition to lipid A.
3.4.1 Detection of H. pylori O-antigen
In order to deduce whether O-antigen was present on H. pylori proteins it was
necessary to develop a reliable method to detect H. pylori O-antigen. The O-antigen of H.
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pylori strains are known to be decorated by sugars that mimic the Lewis blood group
antigens found on human epithelial cells. This enables detection of H. pylori LPS by
Western blot with antibodies specific for the Lewis antigens [86]. Previously, our
laboratory WT strain was found to be Ley-positive [118]. However, Lewis antigen
expression is known to be phase variable in H. pylori and expression of Lewis antigens
can be switched on or off within populations derived from a single cell [251]. Therefore,
the expression of Lewis antigens needs to be validated consistently after H pylori growth
to account for potential phase variation. Furthermore, LPS samples with known Lewis
antigen expression were required as positive controls for anti-Lewis Western blots to
ensure that the antibodies were specific for O-antigen chains decorated by the different
Lewis antigens.
As such, in order to confirm the Lewis expression of our strains and obtain
reliable LPS controls for Lewis Western blots, LPS samples were prepared from a panel
of H. pylori strains expressing the Lewis antigens, Leyand Lex, relevant to our study and
assessed for the presence of the Lewis antigens by Western blot. The H. pylori strains
examined included the WT laboratory strain, NCTC 11637, and the isogenic mutants
flaAl, hp0366, and waaL, as well as WT H. pylori strains 26695 [209] and SSI [210].
LPS was extracted from total cell pellets by solubilization of total cell lysates with SDS,
removal of proteins by proteinase K treatment, and the subsequent removal of residual
proteins and peptides by phenol/chloroform extraction [221]. Each LPS sample was
separated by 12% SDS-PAGE and visualized by silver nitrate staining (Figure 19: A,
Figure 20: A). By silver stain, it was evident that the different WT strains of H. pylori,
NCTC 11637, 26695, and SSI, exhibited different O-antigen patterns, which is a
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Figure 19: SDS-PAGE analysis of H. pylori O-antigen with detection by anti-Ley
Western blot. LPS samples from the WT laboratory strain NCTC 11637 and the isogenic
mutants, flaAl, hp0366, and waaL, as well as other WT strains of H. pylori, 26695 and
SSI, were separated by SDS-PAGE. LPS was visualized by silver nitrate staining (A).
The LPS of strain 26695 was highly reactive by silver nitrate staining and residual
amounts from sample spill-over are apparent in the empty lane to the left side of the
26695 sample. The production of Ley O-antigen was examined by anti-LeyWestern blot
(B). All of the WT H. pylori strains were detected, indicating that the O-antigen of all of
the WT strains tested were decorated with Ley motifs. The isogenic mutants of the WT
laboratory strain were not detected by anti-Ley Western blot, as expected, since they are
either O-antigen deficient or produce an altered O-antigen. The detection of only the LPS
of the WT strains is consistent with known results indicating that the anti-Ley Western
blot was successful in detecting H pylori Ley O-antigen.
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Figure 20: SDS-PAGE analysis of H. pylori O-antigen with detection by anti-Le*
Western blot. LPS samples from the WT laboratory strain NCTC 11637 and the isogenic
mutants, jlaA 1, hp0366, and waaL, as well as other WT strains of H. pylori, 26695 and
SSI, were separated by SDS-PAGE. LPS was visualized by silver nitrate staining (A).
The production of Lex O-antigen was examined by anti-LexWestern blot (B). Only the
strain 26695 was detected, indicating that the O-antigen of this strain carries Lex motifs.
It is apparent that some of the signal from strain 26695 spilled over into the WT NCTC
11637 lane due to the high level of reactivity. The lack of reactivity of the LPS of the
other H. pylori strains is consistent with previous observations indicating that the anti-Lex
Western blot was successful in specifically detecting H. pylori Lex O-antigen.
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reflection of the different degrees of O-antigen capping and variation of the Lewis
antigens present. Moreover, it is evident that the amount of O-antigen apparent by silver
stain is much less compared with the lipid A core. As expected, the mutants, flaA 1,
hp0366, and waaL, did not exhibit any O-antigen as flaAl is known to produce lower
levels of an altered O-antigen compared to WT [118] and both hp0366 and waaL are Oantigen deficient [174, 175]. Thus, due to the different degrees of O-antigen present in
each sample, the amount of lipid A core was utilized as a loading control to ensure that
approximately the same amount of LPS was examined for each strain.
The presence of Leyand Lex Lewis antigens was assessed by anti-Ley and anti-Lex
Western blots. By anti-Ley Western blot, all WT strains were reactive, indicating the
presence of Ley O-antigen in each strain (Figure 19: B). The reactivity of the WT strains
by anti-Ley Western blot is consistent with previous observations [69, 252]. Conversely,
despite similar LPS loading for the mutants, flaAl, hp0366, and waaL, no Ley O-antigen
was detected by anti-Ley Western blot. This was expected as hp0366 and waaL lack Oantigen and flaAl produces an altered O-antigen that was previously shown to exhibit
limited reactivity by anti-LeyWestern blot [118]. The ability to detect Lex O-antigen by
anti-Lex Western blot was also examined by testing the reactivity of the LPS from each
strain via an anti-Lex Western blot. By anti-Lex Western blot, only the WT strain 26695
was reactive (Figure 20: B). This is consistent with previous observations for each of the
H. pylori strains [69, 174,175, 252]. Indeed, the presence of both Ley and Lex is well
established in strain 26695 due to the lower relative activities of the FucTs that mediate
Lewis antigen expression that limit the conversion of Lex structures to Ley [84, 85]. The
apparent reactivity observed for the LPS of the WT NCTC strain is due to sample spill
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over from the 26695 sample as the LPS of 26695 reacts very strongly by anti-Lex
Western blot. For the NCTC signal to be real, a ladder-like pattern would be evident as
observed by anti-Ley Western blot for the same strain. The lack of reactivity by anti-Lex
Western blot from our WT strain is consistent with previous observations in the
laboratory [118].
Overall, the consistency of Lewis antigen detection on the LPS of the various H.
pylori strains screened with known or previously observed Lewis antigen expression,
demonstrates that immunoblotting is a reliable method to detect O-antigen. As well,
screening of the panel of laboratory H. pylori strains for Lewis antigen reactivity by
Western blot verified that the O-antigen of our laboratory WT strain, NCTC 11637, is
Ley-positive, while strain 26695 exhibits both Ley and Lexantigens, making it an
adequate control for anti-Ley and anti-Lex Western blots. Thus, anti-Leyand anti-Lex
Western blots provide a means to examine the presence of O-antigen on proteins.
3.4.2 Demonstration of glycoproteins modified with O-antigen in H. pylori cell
fractions
Once detection of the Lewis antigens on the O-antigen of H. pylori LPS by
Western blot was optimized, it was possible to assess whether H. pylori proteins were
modified with the O-antigen chain by WaaL. It is predicted that WaaL only has
periplasmic activity since its catalytic site is present within a large periplasmic loop
[244], therefore, if WaaL acts as a general OTase, only periplasmic and membrane
proteins would be accessible to WaaL for modification. Thus, to investigate if
periplasmic or membrane proteins were modified with O-antigen, the soluble cell
fraction, which contains both cytoplasmic and periplasmic proteins, and the membrane
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cell fractions of H. pylori, were examined for the presence of proteins that react by antiLey and anti-Lex Western blots.
WT H. pylori cellular proteins were separated by differential centrifugation into
soluble, insoluble, total membrane, IM, and OM fractions, as outlined previously (refer to
Figure 8). The membrane protein fraction was fractionated into IM and OM components
to allow detection of modified proteins in each membrane. The total membrane fraction,
and separated IM and OM protein fractions were separated by 12% SDS-PAGE and
analyzed by immunoblotting. Total proteins transferred to the nitrocellulose membrane
were stained with Ponceau S (Figure 21: A). O-antigen was detected by anti-Ley (Figure
21: B) and anti-Lex (Figure 21: C) Western blots. LPS from strain 26695 was used as a
control for the anti-Leyand anti-Lex Western blots and was detected as expected.
By anti-Ley Western blot, several bands were detected in the total membrane
fraction and in the IM and OM fractions (Figure 21: B). The bands detected by anti-Ley
Western blot in the total membrane fraction appear to be separated between the IM and
OM fractions. This is most evident with the principal reactive band of approximately 31.0
kDa in the total membrane fraction that appears to represent at least two proteins, one in
the OM and one in the IM, that migrate slightly differently by SDS-PAGE. The IM
reactive protein appears to migrate slightly slower than that of the band present in the
OM. To determine if the signal observed by anti-Ley Western blot in each membrane
fraction was due to the presence of LPS in the samples or from proteins modified with Oantigen, each membrane fraction was treated with proteinase K to degrade all of the
proteins present in the samples. Significantly, the predominant band of approximately
31.0 kDa detected in each membrane fraction was absent upon proteinase K digestion of
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Figure 21: Demonstration of WT H. pylori membrane proteins modified with Ley Cl
antigen by anti-Leyand anti-Lex Western blots and by glycoprotein-specific
labelling. WT cellular fractions of total membrane and separated IM and OM
components were treated with (+) and without (-) proteinase K (+/- PK) to specifically
degrade all proteins in the samples. The treated and untreated samples with proteinase K
were separated by 12% SDS-PAGE. Total proteins transferred to nitrocellulose were
stained with Ponceau S (A). A representative membrane stained with Ponceau S is shown
for all Western blots. O-antigen was detected by anti-Ley(B) and anti-Lex (C) Western
blots. To ensure that detection was specific to O-antigen, a mock secondary only Western
blot was performed (D). Glycoproteins were detected by glycoprotein-specific labelling
with BHz (E). The specificity of glycoprotein labelling was determined by performing a
mock labelling without BHz (F). Total proteins and LPS in each of the fractions were
detected by silver stain (G). It is evident that proteinase K treatment degraded all of the
proteins from each sample, revealing a distinct LPS pattern in treated samples, detected
by both anti-Ley Western blot and silver nitrate staining. Two independent glycoprotein
candidates were observed by anti-Ley Western blot and glycoprotein labelling, one each
in the IM and OM that migrate slightly differently by SDS-PAGE at approximately 31.0
kDa (indicated by arrows). The glycoprotein candidates migrate slightly higher than the
abundant 31.0 kDa protein denoted with an asterisk for reference to compare Western
blots and total protein detected by Ponceau S and silver stain. No specific bands were
detected by anti-Lex Western blot, indicating that no WT membrane proteins were
modified with Lex O-antigen. A sample of strain 26695 LPS was run as a control for all
Western blots.
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proteins. This indicates that the signal obtained by anti-Ley Western blot in each of the
untreated membrane fractions originated from proteins and suggests that they are
modified with Ley O-antigen. Based on the higher migration of the band detected in the
IM compared to the band detected in the OM by SDS-PAGE, it appears that there are at
least two potential glycoprotein candidates that may be modified by Ley O-antigen.
Moreover, treatment of the membrane fractions with proteinase K degrades
proteins but leaves LPS intact. As such, upon proteinase K digestion, LPS is detected as
expected in the total membrane and OM samples of the WT strain as a ladder-like pattern
typical of LPS by anti-Ley Western blot (Figure 21: B). Minor detection of O-antigen is
evident in the IM sample treated with proteinase K as well. This is due to the presence of
assembled LPS in the IM that has yet to be exported to the OM. The signal obtained from
the WT LPS in proteinase K treated membrane fractions is distinct from the signal
observed in the untreated membrane samples, which further supports that the signal
obtained at approximately 31.0 kDa is the result of membrane proteins that are modified
with Ley O-antigen.
H. pylori cell extracts have previously been observed to react non-specifically
with the goat anti-mouse secondary antibody used for Lewis antigen detection. Therefore,
to ascertain that the results seen by the anti-Ley Western blot were genuine, a mock
Western blot was performed with only the secondary antibody (Figure 21: D). The band
detected by the anti-Ley Western blot in the WT OM fraction was not observed by the
mock Western blot, which indicates that signal obtained by the anti-Ley Western blot is
real and that the detected protein is modified with O-antigen. Conversely, a band was
detected at approximately 31.0 kDa in the WT total membrane fraction and IM fraction in
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the mock Western blot. However, the band was detected at a lower intensity compared to
the bands observed in these fractions by anti-LeyWestern blot. This non-specific band
appears to migrate similarly to the band reactive in the total membrane fraction, but
slightly lower than the band detected in the IM fraction by anti-Ley Western blot.
Together, the lower reactivity in the mock Western blot and the slightly lower migration
of the non-specific band suggests that the protein band detected in the IM by anti-Ley is
distinct from the non-specific signal observed by the mock Western blot and also
represents a glycoprotein modified with Ley O-antigen. Comparatively, the non-specific
band detected by the mock Western blot in the total membrane fraction likely results
from non-specific binding of the secondary antibody to an unknown IM protein as the
same signal is observed in the IM fraction but not the OM fraction.
The membrane fractions were also assessed for the presence of O-antigen
decorated with Lex antigens. This was conducted to determine whether the same Ley Oantigen chain was attached to both lipid A and proteins or if a modified O-antigen, such
as Lex, could be attached to glycoproteins even if it is not present on the WT LPS.
Interestingly, the ability to attach different O-antigen chains to proteins has been
observed for the pilin OTase PilO of P. aeruginosa [249]. By anti-Lex Western blot, a
number of faint bands were detected in the membrane fractions in addition to the WT
26695 LPS control (Figure 21: C). However, it is apparent that the bands detected by
anti-Lex Western blot are the same bands that are detected by the mock secondary only
Western blot (Figure 21: D) and therefore are due to non-specific binding of the
secondary antibody to H. pylori membrane proteins. Thus, this data establishes that no
glycoproteins in the WT strain are modified by Lex O-antigen.
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To further demonstrate the presence of carbohydrates on the Ley-reactive
glycoproteins, the WT membrane fractions were assessed for glycosylation by
glycoprotein-specific labelling of carbohydrates with BHz. Labelling was performed on
the nitrocellulose membrane and labelled glycoproteins were detected with a fluorescent
conjugate of streptavidin (Figure 21: E). LPS was detected by BHz labelling, which is
expected given that this method of chemical labelling relies on the oxidation of
carbohydrates. Despite detection of LPS, a distinct signal was observed at approximately
31.0 kDa in each of the membrane fractions that was absent upon proteinase K digestion.
The bands detected correspond to the migration of the protein bands detected by anti-Ley
Western blot (Figure 21: B). Further, the detected bands were demonstrated to be specific
to BHz labelling as a nitrocellulose membrane that was mock labelled in the same
manner, but without BHz, did not show the same protein bands (Figure 21: F).
Lastly, total proteins and LPS were stained by silver nitrate (Figure 21: G). Again,
it is evident that upon proteinase K treatment of each membrane fraction, the distinct
ladder-like pattern of LPS can be observed, similar to the control LPS preparations of WT
and strain 26695.
Together, the demonstration of a specific band reactive by both anti-Ley Western
blot (Figure 21: B) and by glycoprotein-specific labelling (Figure 21: E) in each of the IM
and OM fractions indicates that at least two membrane glycoproteins are present in H.
pylori that are modified with Ley O-antigen. As such, this suggests that WaaL may be
acting as a general OTase that transfers its natural substrate, Ley O-antigen, onto these
proteins.
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To investigate whether WaaL can also modify periplasmic proteins in addition to
membrane proteins, the soluble protein fraction was separated by 12% SDS-PAGE and
immunoblotting was performed with anti-Ley and anti-Lexantibodies and a mock
Western blot with the secondary antibody only. However, by both anti-Ley and anti-Lex
Western blots no proteins were specifically detected compared to the mock Western blot
(data not shown). This indicates that no periplasmic or soluble proteins are modified by
Ley O-antigen and that only membrane proteins appear to be targeted by WaaL.
3.4.3 Examination of the dependence of the O-antigen-modified membrane
glycoprotein candidates on WaaL and pse biosynthesis
Several findings indicate that LPS biosynthesis and protein glycosylation in H.
pylori are interconnected. As well, it is proposed that the WaaL ligase of H. pylori
functions as both the O-antigen ligase and as a general OTase that is able to modify
proteins. Firstly, the pse mutant, hp0366, is O-antigen deficient, suggesting that WaaL
activity is abrogated upon disruption of pse. As well, the H. pylori waaL mutant lacks
proper flagellum production in addition to being O-antigen deficient. This unexpected
role of WaaL on flagellum production is suspected to be due to the modification of
flagellar components by WaaL. The presence of H pylori membrane proteins modified
with Ley O-antigen was demonstrated by the specific detection of Ley O-antigen on
proteins by anti-LeyWestern blot. However, the dependence of the glycosylation of these
proteins on WaaL and pse biosynthesis could not be established from the WT alone.
Therefore, based on the above hypotheses and findings, it is proposed that if WaaL acts
as a general OTase and is responsible for the modification of the WT membrane proteins
with Ley O-antigen, the Ley O-antigen should be absent from the membrane protein
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fractions of the waaL mutant. Similarly, if WaaL function is dependent on pse-specific
glycosylation, the modification of proteins with O-antigen should not occur in the pse
mutants.
To investigate the reliance of the Ley O-antigen modified membrane glycoprotein
candidates on WaaL and pse glycosylation, the total membrane fractions of lLT,flaAl,
hp0366, and waaL H. pylori strains were separated into OM and IM components. While
both OM and IM will need to be analyzed to assess the glycoprotein candidate in each
membrane fraction, initial analyses were performed on the OM. The OM fraction of each
strain was treated with and without proteinase K, separated by 12% SDS-PAGE, and
assessed for the presence of O-antigen as described above for the WT membrane
fractions.
The presence of the OM glycoprotein candidate modified with the Ley O-antigen
in the OM of WT, JlaAl, hp0366, and waaL was assessed by anti-Ley Western blot
(Figure 22: B). The same approximately 31.0 kDa protein-dependent band was observed
in the WT OM fraction as observed previously. By the separation obtained by this
Western blot, two potential reactive bands are evident in the WT OM. One of the bands
may correspond to the protein detected by Ponceau S stain at approximately 31.0 kDa and
the other migrates slightly higher which is not detected by Ponceau S (Figure 22: A).
Alternatively, the glycoprotein of interest may appear as a doublet to reflect the
modification with O-antigen in which O-antigen is typically visualized as a ladder-like
pattern. The same doublet was not detected in the OM fractions of the pse mutants and
waaL. This indicates that the modification of the OM glycoprotein candidate with Oantigen is dependent on both WaaL and pse glycosylation. This observation matches the
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Figure 22: Demonstration of the dependence and specificity of the Ley O-antigen
modification of the WT OM glycoprotein candidate on WaaL and pse biosynthesis.
The OM fractions ofW7, flaAl, hp0366, and waaL were treated with (+) and without (-)
proteinase K (+/- PK) to degrade all proteins in the samples. The treated and untreated
samples with proteinase K were separated by 12% SDS-PAGE. Total proteins transferred
to nitrocellulose were stained with Ponceau S (A). A representative membrane stained
with Ponceau S is shown for all Western blots. O-antigen was detected by anti-Ley(B)
and anti-Lex (C) Western blots. To ensure that detection was specific to O-antigen, a
mock secondary only Western blot was performed (D). Glycoproteins were verified by
glycoprotein-specific labelling with BHz (E). Specificity of glycoprotein detection by
glycoprotein labelling was controlled for by performing a mock labelling without BHz
(F). Total proteins and LPS in each of the fractions were detected by silver stain (G). It is
evident that proteinase K treatment was incomplete as low molecular weight proteins are
evident in treated samples by silver stain. Regardless, a distinct protein-dependent band
of approximately 31.0 kDa was detected by anti-Ley Western blot and glycoprotein
labelling as expected in the WT OM (indicated by an arrowhead). The OM glycoprotein
candidate migrates slightly higher than the abundant 31.0 kDa protein denoted with an
asterisk for reference. A similar band was not detected in the pse and waaL mutants,
indicating that Ley O-antigen modification of the OM glycoprotein candidate is
dependent on pse biosynthesis and WaaL. A sample of strain 26695 LPS was run as a
control for all Western blots.
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results expected if WaaL is a general OTase that can modify proteins in addition to lipid
A and is dependent on pse glycosylation for function. In order to determine whether pse
biosynthesis or WaaL have an effect on the specificity of the O-antigen modification
observed, the OM fractions of WT,y7<x47, hp0366, and waaL were also analyzed by antiLex Western blot (Figure 22: C). Similar to the WT OM, no signal distinct by anti-Lex
Western blot was observed compared to the mock Western blot in any of the mutants
(Figure 22: D). Therefore, the disruption of pse biosynthesis and inactivation of WaaL in
the pse and waaL mutants does not alter the type of O-antigen that can be attached to
proteins, but rather appears to completely prevent the modification of the OM
glycoprotein candidate with O-antigen. This also indicates that both WaaL and potential
pse-specific glycosylation of WaaL is required for Ley O-antigen modification of the OM
glycoprotein candidate.
To further demonstrate the dependence of the LeyO-antigen modification of the
OM glycoprotein candidate on WaaL and pse glycosylation, the OM fractions of the pse
and waaL mutants were analyzed by glycoprotein-specific labelling with BHz (Figure 22:
E) . As expected, a diffuse band at approximately 31.0 kDa was detected in the WT OM
fraction and its presence was abolished upon proteinase K digestion, indicating it was a
potential glycoprotein candidate. As observed previously, this band was specific to BHz
labelling as it was not detected by mock glycoprotein labelling without BHz (Figure 22:
F) . Importantly, this Ley O-antigen modified glycoprotein candidate was not evident by
BHz labelling in the OM fractions of the pse and waaL mutants. This also suggests that
the glycoprotein candidate observed to be modified with Ley O-antigen in the WT OM is
dependent on both WaaL and pse glycosylation.
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Total proteins and LPS from the OM fraction of WT and the pse and waaL
mutants were stained by silver nitrate (Figure 22: G). It is evident that proteinase K
digestion of all proteins in the samples was not complete as similar low molecular weight
bands are present in the proteinase K treated fractions of all H. pylori strains. However,
the majority of proteins in the samples have been degraded, especially in the range of
molecular weight greater than 31.0 kDa around the glycoprotein candidate of interest.
WT LPS was detected in the WT OM sample treated with proteinase K by both silver
staining (Figure 22: G) and anti-Ley Western blot (Figure 22: B). No LPS was detected in
the OM fractions offlaAl, hp0366, and waaL as expected since hp0366 and waaL are Oantigen deficient and flaAl produces an altered O-antigen that is only visible upon much
higher loading than present on this gel. By silver stain, it was apparent that the
approximately 31.0 kDa region where the Ley O-antigen modified OM glycoprotein
candidate is observed is quite complex and therefore will require further separation for
MS analysis and its identification.
In addition, the dependence of the Ley O-antigen modification of the IM
glycoprotein candidate on WaaL and pse glycosylation was assessed in the same manner
(data not shown). Interestingly, this glycoprotein candidate appears to be dependent on
strict growth conditions and further optimization of the conditions required for its
production is required before its production in the pse and waaL mutants can be
determined.

159

3.4.4 Analysis of the Ley O-antigen modified membrane glycoprotein candidates by
2-dimensional gel electrophoresis (2-DE)
Two membrane glycoprotein candidates modified with Ley O-antigen were
observed in the membrane fraction of WT H. pylori: one in the IM and one in the OM.
As the waaL mutant was previously shown to exhibit a defect in flagellum production, it
was proposed that WaaL may act as a general OTase to modify components of the
flagellar apparatus required for flagellum assembly. To determine if the membrane
glycoprotein candidates modified with Ley O-antigen are part of the flagellar apparatus,
identification of the glycoprotein candidates is required. Since the H. pylori flagellar
apparatus is similar to the prototypical type III secretion flagellar machinery described
among Gram-negative bacteria and transverses both the cytoplasmic and outer
membranes [99], it is possible that both glycoprotein candidates may be flagellum
components.
Unfortunately, the IM and OM fractions of H. pylori appear complex by ID SDSPAGE with several proteins visible that migrate similar to the glycoprotein candidates.
Therefore, before the glycoprotein candidates can be identified by MS analysis, the IM
and OM fractions need be simplified in order to enhance detection of the glycoprotein
candidates over non-glycosylated proteins. Thus, 2-DE was employed to separate the
glycoprotein candidates from non-glycosylated proteins.
Efforts were first focused on identifying the OM glycoprotein candidate as no
growth requirements were observed for its production and OM proteins are believed to be
more compatible with the conditions used for isoelectric focusing for the first dimension
of 2-DE compared to IM proteins [253, 254], As such, the WT OM fraction was
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Figure 23: Detection of the OM glycoprotein candidate modified with Ley O-antigen
by anti-Ley Western blot and glycoprotein labelling after separation by 2-DE. The
WT OM fraction containing the OM glycoprotein candidate modified with Ley O-antigen
was separated by 2-DE with a broad pH range of 3-10. Total proteins transferred to
nitrocellulose were detected by Ponceau S (A). A representative membrane stained with
Ponceau S is shown for all Western blots. The Ley O-antigen modified OM glycoprotein
candidate was detected by anti-Ley Western blot (B) and by glycoprotein-specific
labelling with BHz (C). A distinct protein spot with a molecular weight of approximately
14.5 kDa was detected by both methods. The same spot was not evident by Coomassie
Blue staining of total protein despite high protein loading (D). This indicates that the
glycoprotein candidate of interest modified with Ley O-antigen is of too low abundance to
be detected by MS analysis. The location of the protein spot detected is indicated by an
arrow.
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separated by 2-DE. As the pi of the glycoprotein candidate was unknown and the effect
of Ley O-antigen modification on the pi of proteins has not been established, a broad pH
range of 3-10 was utilized for analysis. Total proteins transferred to nitrocellulose were
visualized by Ponceau S staining of the membrane (Figure 23: A). The Ley O-antigen
modified glycoprotein was detected by anti-Ley Western blot (Figure 23: B) and by
glycoprotein-specific labelling with BHz (Figure 23: C). Surprisingly, no protein spot
was detected by either anti-Ley Western blot or by glycoprotein-specific labelling with a
molecular weight of approximately 31.0 kDa as anticipated for the OM glycoprotein
candidate based on its migration by ID SDS-PAGE. However, a predominant spot was
detected by anti-Ley Western blot at approximately 14.5 kDa. A similar spot was detected
by glycoprotein-specific labelling. The remaining signal observed by anti-Ley Western
blot was present at a molecular weight too high to be the OM glycoprotein candidate of
interest and appears as a smear in the second dimension, which suggests that this residual
signal is an artefact of the high protein loading used for 2-DE. Similarly, by glycoproteinspecific labelling, additional spots are detected, however, they also exhibit a molecular
weight that is too high to be the OM glycoprotein candidate. As well, due to the high
protein loading used for 2-DE, several spots are detected by negative staining. These
spots are likely detected due to the high abundance of these proteins. Therefore, as no
other common signal between the anti-LeyWestern blot and glycoprotein-specific
labelling was observed, the detected protein spot of approximately 14.5 kDa is likely the
OM glycoprotein candidate of interest that is modified with Ley O-antigen.
The identification of a 14.5 kDa protein spot rather than the expected molecular
weight of approximately 31.0 kDa suggests that the original 31.0 kDa protein detected by
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ID SDS-PAGE in the OM fraction may have been a dimer of the 14.5 kDa protein
detected by 2-DE. It is possible that the denaturing conditions used for ID SDS-PAGE
were insufficient to disrupt oligomers. This is consistent with the fact that OM proteins
are known to be resistant to SDS solubilization [255]. Comparatively, the conditions used
for 2-DE involve additional chaotropes and detergents which may be more capable of
disrupting protein oligomers and results in the detection of the OM glycoprotein
candidate at the lower molecular weight of approximately 14.5 kDa.
The WT OM fraction separated by 2-DE was also stained by Coomassie Blue for
total proteins (Figure 23: D). Unfortunately, the protein spot detected by anti-Ley Western
blot and glycoprotein-specific labelling was not apparent by Coomassie Blue staining,
even upon the high protein loading utilized. This indicates that the Ley O-antigen
modified glycoprotein candidate is of low abundance. The inability to detect the
glycoprotein candidate by Coomassie Blue staining prevents the protein spot from being
excised and sent for MS analysis for protein identification. Although the protein spot may
be visualized by other staining methods that are more sensitive, such as by silver nitrate
staining, to obtain the recommended amount of protein for MS analysis, multiple 2-DE
spots would likely be required, which is impractical for both protein identification and
further glycopeptide analysis. Therefore, due to the low abundance of the glycoprotein
candidate, additional enrichment and purification strategies need to be performed before
identification of the OM glycoprotein candidate can be obtained.
Although the Ley O-antigen modified OM glycoprotein candidate was found to be
poorly abundant, the same is not necessarily true for the IM glycoprotein candidate
modified with Ley O-antigen. Thus, once growth conditions for the production of the IM
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glycoprotein candidate are optimized, the same methodology will be applied to separate
the IM glycoprotein candidate from non-glycosylated proteins to allow for eventual
identification of the glycoprotein candidate by MS analysis.
In general, once MS identification of the Ley O-antigen modified glycoprotein
candidates can be obtained and glycopeptide analysis performed, this data will provide
conclusive evidence of the existence of both additional glycoproteins in H. pylori and
verification that a second protein glycosylation pathway exists in H. pylori. Furthermore,
confirmation of the modification of the glycoprotein candidates with Ley O-antigen by
glycopeptide analysis will implicate WaaL in both LPS biosynthesis and protein
glycosylation pathways. These findings will undoubtedly change the current dogma of
protein glycosylation in H pylori in which only the flagellins are believed to be
glycosylated and only the pse glycosylation pathway is thought to be present.

CHAPTER 4: Discussion
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4.1 Deciphering the biological role of pse-glycosylation of the flagellins in H. pylori
At the onset of this research, the flagellins of H pylori were known to be
glycosylated with pse [117]. Glycosylation of the flagellins with pse is required for
production of proper flagella as mutations in the genes responsible for pse biosynthesis
results in H pylori that are non-motile and lack formation of flagella [117, 118, 174,
175], Thus, protein glycosylation in H pylori is considered a virulence factor as it is
required for motility - a key factor in H pylori’s colonization and overall pathogenesis
[111, 256]. However, the biological role of flagellinglycosylation inH pylori and other
bacteria has yet to be elucidated.
Previous studies by the Creuzenet Laboratory characterized the first two enzymes
required for pse biosynthesis in H pylori, FlaAl [118, 175] and HP0366 [174]. Knockout
mutants for each enzyme lacked flagella and were non-motile, as expected, since pse
biosynthesis is inactivated. However, preliminary evidence obtained by glycoproteinspecific labelling suggested that the flagellins of the hp0366 mutant were glycosylated,
despite disruption of pse biosynthesis. This alluded to the presence of an alternative
glycosylation pathway in H pylori in addition to the pse glycosylation pathway and
suggests that the hp0366 flagellins are modified with a sugar other than pse.
Comparatively, the flagellins of the flaAl mutant were non-glycosylated as expected. As
such, the flagellins of the flaAl and hp0366 mutants represent variations of flagellin
glycosylation compared to the flagellins from WT H pylori and provide a useful tool to
investigate the biological requirement for the flagellins to be glycosylated specifically
with pse.
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Based on the requirement for flagellin glycosylation on flagellum assembly [117,
118, 174, 175], it was proposed that glycosylation could be required for the interaction or
polymerization of the flagellin subunits to form the flagellar filament, or that
glycosylation could be required for the secretion of the flagellins from the flagellar type
III secretion apparatus. Both defects were investigated by analyzing the supernatants of
H. pylori liquid cultures of WT and the pse mutants for flagellins. No evidence of the
flagellins was found in the supernatants of the pse mutants, whereas the secreted
flagellins of WT H. pylori are known to assemble into the flagellar filament (Figure 7).
This indicates that the flagellins of the flaAl and hp0366 mutants, which do not form
proper flagella and are not glycosylated by pse, were unable to be secreted from the cell.
This finding demonstrates that the defect in flagellum production, due to the
inactivation of pse-specific glycosylation in the flaAl and hp0366 mutants, is a result of a
defect in the secretion of the flagellins from the flagellar apparatus. Further, a defect in
secretion implies that flagellin glycosylation likely occurs at the base of the flagellar
basal body as opposed to within the flagellar ring structure or filament during flagellum
assembly. This is consistent with the recent observation that components of the flagellin
glycosylation machinery of C. jejuni are localized to the flagellar basal body [163].
Interestingly, the same secretion defect was observed in both flaAl and hp0366. This
■ implies that specific glycosylation of the flagellins by pse is required for their secretion as
the flagellins of hp0366 are believed to be alternatively glycosylated.
Overall, this study provides the first known evidence that flagellin glycosylation
is required for the secretion of the flagellin subunits by the flagellar export system and
that the H pylori glycosylation machinery is likely present at the flagellar basal body.
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4.2 The implication of alternative flagellin glycosylation in H. pylori
As described, the flagellins of the hp0366 mutant appeared unexpectedly
glycosylated by glycoprotein-specific labelling of total cell lysates, despite the lack of pse
biosynthesis [175]. Moreover, the hp0366 mutant was unable to form proper flagella,
indicating that the hp0366 flagellins are modified with a sugar distinct from pse. As such,
a novel alternative glycosylation pathway for the glycosylation of the hp0366 flagellins
was predicted.
As the hp0366 flagellins are unable to assemble into proper flagella, the
glycosylated flagellins could not be present in the OM cell fraction as in WT, where the
flagellins associate with the OM cell fraction due to the flagellar membrane sheath.
Instead, glycosylated flagellins were observed in the insoluble protein fraction (Figure 9).
This further indicates that the flagellin glycosylation machinery is likely present at the
flagellar basal body as opposed to within the flagellar filament during flagellum assembly
since the glycosylated flagellins were identified intracellularly in a mutant that does not
produce flagella.
Moreover, the hp0366 glycosylated flagellins were identified in the insoluble
protein fraction rather than the cytoplasmic fraction. The absence of cytoplasmic
glycosylated flagellins is consistent with the first report of glycosylated flagellins in H
pylori in which the neuA/flmD gene cluster was investigated for its involvement in
flagellar biosynthesis or flagellin glycosylation [119]. In this study, it was suggested that
the lack of cytoplasmic glycosylated flagellins implied that glycosylated flagellin species
were only present in their polymerized state as a part of the assembled flagellar filament
and that glycosylation must be coupled to flagellin secretion. As such, the observation of
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glycosylated flagellins in the hp0366 mutant and their localization to the insoluble protein
fraction demonstrates that contrary to the speculation from this initial study, glycosylated
flagellins are present intracellularly.
The demonstration of glycosylated flagellins of the hp0366 mutant as insoluble
proteins rather than soluble proteins suggests that when the flagellins are alternatively
glycosylated with a sugar other than pse, the flagellins are unstable and may aggregate.
Furthermore, this indicates that pse-specific glycosylation of the flagellins may be
required for proper protein folding, such that when the flagellins are alternatively
glycosylated with a sugar different from pse, as in the case of the hp0366 flagellins, the
flagellins are mis-folded, aggregate, and pellet as insoluble proteins. The role of protein
glycosylation on protein folding and stability has been characterized in-depth, in which
protein glycosylation has been shown to mediate final protein conformation [257].
Interestingly, glycosylated flagellins were also observed in the WT insoluble
protein fraction (Figure 9). This suggests that some WT flagellins may also be
alternatively glycosylated by the alternative glycosylation pathway proposed for the
hp0366 flagellins. This may indicate that glycosylation could act as a quality control or
feedback mechanism for flagellin secretion, such that when they are improperly folded or
not required by the cell, they are alternatively glycosylated and cannot be secreted from
the flagellar basal body. This is reminiscent of the well-characterized role of protein
glycosylation on eukaryotic proteins in which proper glycosylation is required for protein
folding and stability [121]. Conversely, the production of WT insoluble flagellins could
be due to an interaction between non-glycosylated and pse-glycosylated flagellins. In this
case, it is hypothesized that non-glycosylated flagellins act similarly to the alternatively
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glycosylated flagellins of hp0366 and are unstable, resulting in their aggregation and
insolubility. It could be reasoned that the presence of WT insoluble glycosylated
flagellins is the result of pse-glycosylated flagellins aggregating with non-glycosylated
flagellins. Thus, glycosylation could be acting as a feedback mechanism to control the
secretion of the flagellins and potentially the length of the flagellum. In fact, although the
overall structure of the H. pylori flagellar apparatus is believed to be similar to the
general model of the type III flagellar export system of the Enterobacteriaceae, notable
differences have been observed in regards to the regulation of the flagellar assembly. In
particular, no master control regulator has been identified [112] and posttranscriptional
regulation of the major flagellin subunit, flaA, has been reported [258], both of which
indicate the presence of unique regulatory mechanisms in H. pylori for flagellum
assembly. The current study may indicate that flagellin glycosylation also acts as a
regulatory mechanism for flagellar assembly. Overall, the impact of the proposed
alternative flagellin glycosylation pathway in hp0366 highlights the need to fully
characterize this novel glycan to further elucidate the function of flagellin glycosylation.
4.3 Difficulties associated with the purification of the insoluble glycosylated
flagellins
In order to definitively demonstrate the presence of an alternative flagellin
glycosylation pathway in H pylori, identification of the glycan present on the
glycosylated hp0366 flagellins was necessary. Therefore, purification of the hp0366
flagellins was required. However, in order to purify the flagellins from the insoluble
protein fraction, several difficulties were encountered.
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Firstly, the insoluble protein fraction of H. pylori is very complex. The single
flagellin protein band cut from a ID SDS-PAGE gel contained over 30 positive protein
identifications by MS (refer to Section 3.1.2). The inherent complexity of the insoluble
protein fractions thereby hindered sample preparation for glycopeptide analysis and sugar
identification of the glycan present on the hp0366 flagellins. In general, glycopeptide and
sugar analyses by MS are difficult due to the poor abundance of glycosylated peptides
compared to non-glycosylated peptides, and the existence of multiple glycoforms which
dilutes the pool of glycopeptides available for analysis [187]. As well, glycosylated
peptides are less efficiently ionized compared to non-glycosylated peptides [186].
Therefore, the low level of the flagellins in the insoluble protein fractions and the co
migration of the flagellins with unglycosylated proteins by ID SDS-PAGE, prevented the
detection of the flagellins by MS and subsequent glycopeptide and sugar analyses.
Thus, 2-DE was utilized to further separate and simplify the insoluble protein
fractions to obtain purified WT and hp0366 glycosylated flagellins. 2-DE is often used to
separate complex protein samples and has been used to analyze glycoproteins, making it
a suitable technique to examine the flagellins [188]. By 2-DE, the WT insoluble flagellins
did separate into distinct protein spots, however, the flagellins were found to be poorly
abundant in the insoluble protein fraction (Figure 10). In addition, several glycoforms
were evident. As such, the availability of glycopeptides for MS analysis from 2-DE was
anticipated to be too low for complete glycopeptide analysis.
Overall, the complexity of the insoluble protein fractions and poor abundance of
the flagellins prevented the purification of the hp0366 flagellins and identification of the
hp0366 flagellin glycan by standard protein preparation methods from cell lysates for MS

172
analysis. To overcome this limitation of the sample preparation, a strategy was designed
to express recombinant H. pylori flagellins cloned with a C-terminal Histidine-tag in WT
and hp0366 H. pylori strains to enable purification of the flagellins from the insoluble
protein fraction. This strategy is advantageous as it overcomes both barriers to the
analysis of the glycosylated flagellin species: it allows the flagellins to be purified away
from other contaminating proteins, which would otherwise hinder glycopeptide analysis,
and it enables samples to be enriched with high levels of the flagellins. In general,
analysis on purified flagellin samples is expected to allow identification of the
glycosylated flagellin peptides, the attachment site, and most importantly, the
identification of the alternative glycan present on the hp0366 flagellins.
4.4 The impact of the presence of an alternative glycan on the hp0366 flagellins
Glycosylated flagellins were identified in the insoluble protein fraction of hp0366
by glycoprotein-specific labelling with BHz (Figure 9). The demonstration of
glycosylated flagellins in the hp0366 mutant is surprising as pse biosynthesis has been
inactivated, suggesting that an alternative glycosylation pathway is present in H. pylori.
The strategy developed to express recombinant H. pylori flagellins with a C-terminal
Histidine-tag to enable their purification by affinity chromatography will allow complete
characterization of the glycan present on the hp0366 flagellins as indicated above.
Ongoing characterization of these recombinant H pylori strains, of both WT and hp0366
expressing tagged versions of the flagellins, both FlaA and FlaB, will allow a direct
comparison between the flagellin glycan on the WT flagellins to that identified on the
hp0366 flagellins. Importantly, the verification of an alternative sugar on the hp0366
flagellins will demonstrate the presence of a novel glycosylation pathway in H pylori.
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The occurrence of multiple glycan structures on the H. pylori flagellin subunits would not
be unique as the flagellins of C. jejuni are known to be modified with a variety of
carbohydrates including pse, pse derivatives, and legionaminic acid [156, 158].
Moreover, the identification of the alternative glycan on the hp0366 flagellins
may provide insight into the biological role of flagellin glycosylation in H. pylori. It can
be reasoned that the size or charge of the alternative sugar identified compared to that of
pse may allow inference regarding the potential role for flagellin glycosylation, such that
pse-specific glycosylation of the flagellins may be required for proper flagellin folding or
be more amenable to flagellin secretion from the export flagellar basal body.
Furthermore, the identification of the alternative glycan present on the hp0366
flagellins will lead to additional studies regarding the elucidation of the sugar
biosynthesis pathway and the sugar nucleotide modifying enzymes involved in its
production.
Lastly, the identification of an alternative glycosylation pathway, based on the
novel glycan on the hp0366 flagellins, would be consistent with the observation of pseindependent glycoproteins by glycoprotein-specific labelling detected in the membrane
fractions of H. pylori in this study (Figure 13) and previously in the soluble protein
fraction [176]. Thus, identification of the alternative glycan on the hp0366 flagellins will
also reveal new information that can be used to design further approaches to characterize
the glycoprotein candidates detected by glycoprotein-specific labelling. For example,
when the glycan is identified, lectin affinity may be utilized, if an appropriate lectin is
available, to determine if any of the detected glycoproteins are modified by the same
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sugar. Thus, identification of the hp0366 flagellin glycan is crucial to assess whether this
alternative glycosylation pathway also targets other proteins in H pylori.
4.5 The significance of membrane glycoproteins in H. pylori
The accepted view regarding protein glycosylation in H pylori is that only the
flagellins are modified with pse. Nevertheless, increasing evidence suggests that
additional glycoproteins are present in H pylori. A recent study demonstrated the
presence of additional glycoproteins in H. pylori by metabolic labelling, however, no
analysis of the sugars involved or identification of the glycosylated proteins was
performed [177]. Moreover, the metabolic labelling technique used in this study has only
been previously applied to detect glycoproteins in eukaryotic systems, thus, optimization
of this labelling technique in prokaryotes is required before direct conclusions regarding
the presence of protein glycosylation can be made. Comparatively, a more comprehensive
study conducted by our laboratory, demonstrated the presence of additional glycoproteins
besides the flagellins in the soluble protein fraction of H. pylori by chemical
glycoprotein-specific labelling [176]. In addition to the detection of multiple soluble
glycoproteins by glycoprotein labelling, this study identified and verified the presence of
sugars other than pse from the soluble protein fraction and identified potential
glycoprotein candidates. Thus, this study provided the first clear evidence that both
additional glycoproteins and alternative glycosylation pathways are present in H. pylori.
The present study investigated whether membrane glycoproteins are present in H.
pylori in addition to the soluble glycoprotein candidates observed in the previous study
[176]. Indeed, several membrane glycoprotein candidates were detected by glycoproteinspecific labelling with BHz in both the WT and pse mutants (Figure 13) and by anti-Ley
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Western blot in WT H. pylori (Figure 21). In general, the identification of additional
glycoproteins in the membranes of H. pylori goes against the current dogma of protein
glycosylation in H. pylori and indicates that protein glycosylation likely plays a variety of
functions in this organism. Furthermore, the observation of pse-dependent and pseindependent glycoproteins suggests that there are both additional glycoproteins besides
the flagellins that are modified with pse as well as one or several alternative pseindependent glycosylation pathways that act to modify proteins with sugars distinct from
pse. In particular, the clear loss of the approximately 15-17 kDa protein in the membranes
offlaAl, but not hp0366, is consistent with a requirement for the alternative glycosylation
pathway proposed for the hp0366 flagellins for the glycosylation of other protein targets
(Figure 12). This protein appears to be dependent on flaAl and thereby pse biosynthesis,
but can overcome a defect in hp0366, which is similar to the pattern observed for the
glycosylation of the hp0366 flagellins. Identification of this protein by MS analysis may
uncover a glycoprotein modified with a glycan similar to that of the hp0366 flagellins.
Moreover, the presence of several membrane glycoproteins suggests the presence of a
potential general glycosylation pathway in H. pylori similar to H. pullorum, N.
gonorrhoeae, or B. fragilis, as these systems are mediated by the cytoplasmic membrane
[147, 166, 169],
More specificially, glycoproteins were evident in both the IM and OM by
glycoprotein-specific labelling with BFfz (Figure 14). The presence of IM glycoproteins
corresponds with the hypothesis that LPS biosynthetic enzymes may be glycosylated, as
investigated in Section 3.3, and suggests that protein glycosylation has important
intracellular functions. The observation of IM glycoproteins in H. pylori is compatible
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with the identification of IM glycoproteins in B.fragilis [169]. To date, the IM
glycoproteins characterized in B. fragilis include multiple proteins involved in cell
division and a sensor histidine kinase. Thus, protein glycosylation may affect similar
proteins in H. pylori.
Comparatively, the presence of glycoproteins in the OM suggests that protein
glycosylation may have important implications regarding host-pathogen interactions,
such that OM glycoproteins may be involved in H. pylori colonization or mediating the
host immune response. Thus, OM glycoproteins may represent a novel virulence factor in
H. pylori’s pathogenesis that has yet to be explored.
While the glycan present on the majority of the membrane glycoproteins
visualized by glycoprotein-specific labelling is unknown, two candidates were found to
be modified with the Ley O-antigen chain typically characteristic of LPS; one
glycoprotein candidate in the IM and one glycoprotein candidate in the OM of WT H
pylori (Figure 21). The modification of these glycoprotein candidates with Ley O-antigen
represents a second alternative glycosylation pathway in H pylori, distinct from the
protein glycosylation pathway proposed for the hp0366 flagellins. Interestingly,
glycosylation of the OM glycoprotein candidate by this alternative glycosylation pathway
was still dependent on pse biosynthesis as it was not observed in the pse mutants (Figure
22 ). Thus, the requirement for pse biosynthesis suggests that the two glycosylation
pathways are intertwined, such that modification of proteins with Ley O-antigen is
dependent on the previous pse-specific glycosylation of proteins which mediate this
alternative glycosylation pathway. In general, the identification of membrane
glycoproteins in both WT and the pse mutants demonstrates that alternative glycosylation
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pathways are indeed present in H. pylori and shows that other proteins besides the
flagellins are glycosylated.
4.6 Difficulties associated with the purification of the membrane glycoprotein
candidates
Several membrane glycoproteins were observed by glycoprotein-specific labelling
with BHz (Figure 13 and Figure 14) and by detection of proteins modified with Ley Oantigen by anti-Ley Western blot (Figure 21). Thus, the ongoing priority of this study is to
identify the membrane glycoproteins observed and characterize their glycosylation by
glycopeptide and sugar analyses to definitively demonstrate the presence of novel protein
glycosylation in H pylori. However, many difficulties are associated with the purification
of these candidates for verification of their glycosylation by MS analysis.
In particular, the membrane fractions containing the glycoprotein candidates are
quite complex, such that excision of the glycoprotein bands for trypsin digestion and
subsequent MS analysis would likely result in the identification of a large array of
proteins. It is predicted that the majority of the identified proteins by I D SDS-PAGE
would originate from contaminating non-glycosylated peptides that are more efficiently
ionized compared to glycosylated peptides, as observed for the ID SDS-PAGE protein
band containing the insoluble flagellins (Section 3.1.2).
As such, 2-DE is commonly employed to separate membrane proteins [188],
However, membrane proteins are more difficult to solubilize compared to soluble or
insoluble proteins due to their highly hydrophobic nature. In general, the use of the
chaotropes, urea and thiourea, and the zwitterionic detergent CHAPS is required [253].
However, it cannot be determined if the solubilization and rehydration buffer will be
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adequate to solubilize the membrane protein of interest. IM proteins are particularly
notorious as being difficult to solubilize due to the number of transmembrane spanning
domains mediated by alpha helices [254]. This may hinder analysis of the IM
glycoprotein candidate modified with Ley O-antigen. Comparatively, OM proteins are
believed to be more soluble in the conditions used for isoelectric focusing, as the
transmembrane domains of OM proteins are generally composed of beta-barrel sheets
that can be fully denatured in the conditions typically used for 2-DE [253]. However,
optimization of 2-DE conditions for OM proteins is still required. In fact, the poor
abundance of the OM glycoprotein candidate modified by Ley O-antigen, as seen by
Coomassie staining (Figure 23: D), may have partly been due to the limited solubilization
of the glycoprotein candidate by the conditions used for 2-DE. The poor abundance of
glycoproteins after 2-DE separation for glycopeptide analysis was also reported for the
identification of the glycoprotein candidates targeted by the general glycosylation system
of A. gonorrhoeae. In this prior study, not enough protein was recovered by 2-DE from
endogenous protein levels for complete analysis of the glycoproteins detected [166].
Thus, although the complexity of the membrane protein fractions can often be remedied
by separation of the glycoprotein candidates from other non-glycosylated proteins by 2DE, the poor abundance of the glycoprotein candidates has prevented the analysis of their
glycosylation directly from cell fractions thus far.
In addition to difficulties associated with the characterization of the unidentified
glycoprotein candidates, obstacles were also encountered with investigation of the known
glycoprotein candidate WaaL. WaaL was selected as a glycoprotein candidate based on
the O-antigen deficient profile of the hp0366 LPS. As well, the hypothesis that WaaL is a
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glycoprotein is consistent with the observation that the modification of the LeyO-antigen
glycoprotein candidates are dependent on both WaaL and pse biosynthesis since
disruption of pse biosynthesis appears to prevent the modification of proteins with Oantigen, which is believed to be mediated by WaaL. Problems associated with analysis of
the glycosylation of WaaL highlight potential downstream barriers to the detection of
other membrane glycoproteins. In particular, WaaL could not be visualized accurately by
SDS-PAGE despite the examination of several denaturing conditions. In all cases, WaaL
was observed as a high molecular aggregate in total IM samples and after enrichment of
WaaL by nickel affinity chromatography, indicating that the denaturing conditions used
for SDS-PAGE were unable to disperse oligomer formation. The inability of WaaL to
migrate within SDS-PAGE gels prevented WaaL from being separated from other high
molecular weight or aggregated proteins. This further prevented subsequent MS analysis
of WaaL for glycosylation as purified WaaL could not be obtained. Therefore, to
overcome this barrier for the detection of WaaL and for the detection of other membrane
glycoprotein candidates, additional electrophoresis techniques should be investigated to
improve the separation and visualization of membrane proteins. As such, the use of
deoxycholate gels [259] or SDS-PAGE gels supplemented with urea [243] may be
advantageous for the dénaturation of membrane proteins and their separation.
Furthermore, even after enrichment of WaaL by affinity chromatography, WaaL
was of too low abundance to be detected by MS analysis (Section 33.2.2). Apart from the
low expression of WaaL from its native promoter, the poor abundance of WaaL is likely
a reflection of the instability of the shuttle vector used for WaaL expression. However,
expression of membrane glycoprotein candidates, including WaaL, from their native
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promoters is desired, instead of an overexpression strategy, as the effect of
overexpression on the glycosylation machinery is unknown. Thus, future studies to
investigate other membrane glycoprotein candidates as well as to further examine the
glycosylation of WaaL will require the development of a stable expression system in H.
pylori.
In general, these obstacles in membrane protein analysis have hindered the
identification and characterization of the glycoprotein candidates revealed in this study.
Thus, optimization of standard purification and protein analysis techniques for membrane
proteins will be advantageous for the future directions of this study. Nevertheless, the
eventual identification and purification of the membrane glycoprotein candidates will
pave the way for additional studies to investigate the role of glycosylation on these
proteins. It is possible, that similar to the general glycosylation system of B. fragilis,
identification of several of the proposed glycoproteins and analysis of their glycopeptides
and glycan attachment sites by MS may reveal a common consensus sequence for protein
glycosylation in H. pylori and thereby may expose the presence of a general
glycosylation system in H pylori. This could lead to the identification of even more
glycoproteins in H. pylori.
4.7 The demonstration of a connection between protein glycosylation and LPS
biosynthesis in H. pylori
An obvious link between protein glycosylation and LPS biosynthesis was
observed in H. pylori, such that disruption of pse-specific glycosylation in the pse
mutants altered LPS production and mutation of the O-antigen ligase, waaL, required for
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LPS biosynthesis, prevented flagellum production. This study is the first to characterize
the interconnection between the two distinct glycosylation pathways in H. pylori.
This link was first examined by investigating the possibility that LPS biosynthetic
enzymes may require pse glycosylation for function (Section 3.3). WaaL was chosen as a
glycoprotein candidate to explore this connection based on the O-antigen deficient LPS
profile of hp0366, however, due to difficulties in its purification, it remains to be
determined whether WaaL is glycosylated. It is possible that other LPS biosynthetic
enzymes are glycosylated instead of, or in addition to WaaL, to account for the LPS
defect observed in the pse mutants.
As described in Section 4.6, the expression system used for WaaL expression in
this study was likely not stable and thereby hindered purification of WaaL due to its poor
abundance. The development of a stable expression system will undoubtedly improve the
ability to purify larger amounts of WaaL for analysis of its glycosylation. Once WaaL is
purified, the glycosylation status of WaaL can be determined via glycoprotein-specific
labelling with BHz and further characterization by MS analysis.
In addition, if WaaL is shown to be glycosylated after a stable expression system
is achieved, the same system can be used to determine the dependence of WaaL
glycosylation on pse biosynthesis. It is predicted that if WaaL is glycosylated with pse,
glycosylation will not occur in the pse mutants. Moreover, if WaaL is glycosylated with
pse, the biological role of WaaL glycosylation can be investigated by examination of
WaaL purified from the pse mutants. It is theorized that pse glycosylation may directly
affect the ligase activity of WaaL. As such, the ability to purify WaaL from both WT and
pse mutant strains of H. pylori will allow differences in the O-antigen ligase activity to be
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investigated by the in vitro assay previously used to assess the WaaL O-antigen ligase
activity of H pylori [93] and other species [244]. Alternatively, it is possible that pse
glycosylation of WaaL could affect its cellular localization, similar to pse glycosylation
of the flagellins. In this sense, WaaL would not be properly targeted to the IM in the pse
mutants and would likely be observed in the soluble or insoluble protein fractions. Thus,
analysis of the cellular protein fractions obtained by differential centrifugation from WT
and pse strains expressing WaaL can be examined for the cellular localization of WaaL.
Further, by comparing the glycosylation status of WaaL from WT to that of the
pse mutants it can be determined whether the alternative glycosylation pathway observed
for the hp0366 flagellins is common among other pse-dependent glycoproteins, such as
WaaL. In this scenario, WaaL would be glycosylated with pse in WT H pylori, nonglycosylated in flaAl, and alternatively glycosylated in hp0366. As such, demonstration
of the differential glycosylation of WaaL in the pse mutants may explain the variation in
the LPS profiles observed between flaAl and hp0366, such that complete abrogation of
WaaL glycosylation results in reduced O-antigen ligase activity in the flaAl mutant,
while when WaaL is alternatively glycosylated in hp0366, ligase activity is completely
inactivated. Thus, establishment of a stable expression system for WaaL and analysis of
its glycosylation could initiate an array of studies to characterize the requirement of pse
glycosylation on WaaL and LPS biosynthesis.
In addition, generation of a stable expression system in H. pylori for membrane
glycoprotein expression and glycosylation analysis can also be used to examine the other
glycoprotein candidates once they are identified. It is possible that the IM glycoprotein
candidates observed by glycoprotein-specific labelling with BHz (Figure 14) include one
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or several proteins that are involved in LPS biosynthesis which may or may not be WaaL.
Thus, identification of the observed IM glycoprotein candidates by glycoprotein labelling
will contribute to the exploration of the functional requirement for pse glycosylation for
the activity of LPS biosynthetic enzymes.
Nevertheless, the system used in the present study was unable to indicate whether
WaaL was glycosylated by pse and if its glycosylation was required for function. It
remains possible that WaaL is not glycosylated and that a different component of the LPS
machinery may be affected in the pse mutants. Despite this caveat, another connection
between LPS biosynthesis and protein glycosylation via WaaL was observed, which
highly supports that WaaL has a role in both glycosylation pathways and may be
glycosylated by pse.
A second connection between LPS biosynthesis and protein glycosylation was
evident due to a defect in flagellum production upon waaL inactivation. This suggested
that WaaL could be acting as a general OTase in addition to its known role as the Oantigen ligase, and may modify proteins required for proper flagellum assembly. Flagellin
glycosylation was not affected in the waaL mutant [175] suggesting that other flagellar
components may be glycosylated by WaaL. Thus, this observation is consistent with the
proposal that additional glycoproteins besides the flagellins are glycosylated in H. pylori.
As such, it was theorized that in addition to the direct glycosylation of WaaL for LPS
biosynthesis, WaaL may mediate an alternative glycosylation pathway in H pylori.
Together, the dual role of WaaL in protein glycosylation and its direct glycosylation
resolve the obvious link between LPS biosynthesis and protein glycosylation in H. pylori.
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The general OTase activity of WaaL was explored through the detection of Oantigen on proteins by immunblotting. By this method, two membrane glycoprotein
candidates modified with Ley O-antigen were observed; one OM protein and one IM
protein (Figure 21). Importantly, the OM glycoprotein candidate was absent in the waaL
mutant (Figure 22). This supports the hypothesis that WaaL is a general OTase and can
modify proteins. This is similar to the protein glycosylation pathway observed in A.
actinomycetemcomitans in which the glycosylation of the collagen adhesin EmaA is
dependent on WaaL [185]. To further demonstrate that the modification of the
glycoprotein candidates with Ley O-antigen are dependent on WaaL, complementation of
the waaL mutant and re-appearance of the modified glycoprotein bands by
immunoblotting would be ideal. However, all previous attempts to complement the waaL
mutant with the shuttle vector designed for WaaL expression have been unsuccessful
(data not shown). The inability to complement a waaL defect has been reported by other
groups as well [93]. This suggests that there is an inherent property of WaaL that
interferes with its complementation. It is proposed that WaaL may function under strict
stoichiometric ratios with other components of the LPS biosynthesis or protein
glycosylation machineries that may be refractory to its complementation in trans.
Nevertheless, upon establishment of a stable expression system for waaL,
complementation can be attempted in the waaL mutant again, which may be more
successful. Alternatively, if complementation of waaL remains unattainable, but
purification of WT WaaL can be achieved, the in vitro assay previously proposed to
monitor the O-antigen ligase activity of WaaL can be adapted to monitor the ability of
purified WaaL to attach O-antigen to the membrane glycoprotein candidates. Thus, using
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these methods, the dependence of the modification of membrane proteins with Ley Oantigen can be firmly established.
Significantly, the Ley O-antigen-modified OM glycoprotein candidate was also
absent in the membrane fractions of the pse mutants (Figure 22), indicating that the Ley
O-antigen modification observed is dependent on pse biosynthesis despite pse not being
involved in O-antigen synthesis. In order to demonstrate that the Ley O-antigen
modification of the membrane glycoprotein candidates is dependent on pse biosynthesis,
analysis of the membrane fractions of the complemented flaAl and hp0366 H pylori
strains previously constructed in the laboratory [174, 175] is underway. The production
of the Ley O-antigen-modified glycoprotein candidates in the complemented strains, but
not in the mutant strains, will directly demonstrate that the modification of these
glycoproteins with Ley O-antigen is dependent on pse biosynthesis. It is proposed that the
dependence of the Ley O-antigen modification of proteins on pse biosynthesis indirectly
demonstrates that WaaL is glycosylated with pse and requires pse-glycosylation for
function, as speculated. To definitively demonstrate this connection, purification of WaaL
remains a priority in order to assess its glycosylation directly. Overall, based on the
results presented thus far, it is observed that inactivation of pse biosynthesis appears to
affect both the O-antigen ligase activity of WaaL, as seen by the defect of LPS
production in the pse mutants, and its potential OTase activity, as observed by the
absence of the Ley O-antigen-modified glycoproteins in the pse mutants. Therefore, the
data presented in this study establishes a clear link between protein glycosylation and
LPS biosynthesis in H. pylori. It is evident that at least two membrane proteins are
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modified with Ley O-antigen, indicating that WaaL has general OTase activity and can
modify both lipid A and proteins and that WaaL is likely glycosylated by pse.
4.8 Future directions
The present study demonstrated the presence of novel protein glycosylation in H.
pylori, in terms of both the detection of membrane glycoproteins and the elucidation of
uncharacterized glycosylation pathways. As a result, the future direction of this study is
to further characterize the novel membrane glycoproteins identified for the eventual
characterization of the protein glycosylation pathways present in H. pylori.
As described, the major obstacle that prevents identification of the unknown
membrane glycoprotein candidates observed in this study is their poor abundance. As
such, the next step in the characterization of these glycoprotein candidates is to develop
strategies to enrich samples in the glycoprotein candidates for MS analysis and
identification.
It is proposed that enrichment of all membrane glycoprotein candidates can be
performed using a similar mechanism to that used for glycoprotein-specific labelling. For
enrichment of glycoproteins, the membrane fractions containing the glycoprotein
candidates of interest can be chemically labelled with BHz, as used for glycoprotein
detection. The BHz-labelled glycoproteins can then be isolated from other membrane
proteins by selective affinity for streptavidin-coated beads. The use of streptavidin-coated
beads to purify biotinylated glycoproteins has previously been utilized to purify both bl
and O-linked glycoproteins [260], Thus, this provides a suitable means to purify the
membrane glycoproteins without any prior knowledge of the type of linkage or the
identity of the glycan. In addition, since chemical labelling with BHz was previously
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employed to detect the glycoprotein candidates in the membranes of H. pylori, the use of
streptavidin-coated beads is a suitable method to enrich these candidates. Moreover, the
BHz-tag incorporated on the modified carbohydrates can further be used as a signature to
identify glycopeptides apart from non-glycosylated peptides, which will be useful in
identifying the glycoproteins, glycosylation attachment sites, and the glycans involved,
by MS analysis.
In the case of the Ley O-antigen-modified glycoprotein candidates, affinity for the
anti-Leyantibody can be utilized to purify the glycoprotein candidates from unmodified
membrane proteins. For this method, the anti-Ley IgM antibody could be coupled to a
matrix containing Protein L, which has affinity for the Ig light chain and has previously
been shown to bind IgM antibodies [261]. Subsequently, the anti-Ley antibody, which has
been coupled to a support via Protein L, can be used to purify the Ley O-antigen-modified
glycoproteins via affinity chromatography. Once purified by this method, the Ley Oantigen-modified glycoprotein candidates can be sent for MS analysis for identification.
Alternatively, a fucose-specific lectin that can detect the fucose of the Ley O-antigen can
be used to similarly capture the Ley O-antigen-modified glycoprotein candidates. These
approaches target identification of the membrane glycoproteins modified by the Ley Oantigen only.
Moreover, the present study focused on the identification of glycoproteins
modified with the known substrate of WaaL, the Ley O-antigen. However, several WaaL
homologues, such as the pilin glycosyltransferase PglL of N. meningitidis, exhibit
substrate promiscuity [250]. Thus, additional investigations are required in order to study
the substrate specificity of the H. pylori WaaL. It is possible that WaaL may modify
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proteins with carbohydrates other than O-antigen and that the protein glycosylation
pathway mediated by WaaL represents a major source of protein glycosylation
uncharacterized in H. pylori.
It is anticipated that enrichment of the unknown membrane glycoprotein
candidates by the methods described above will allow for their identification by MS.
However, in order to completely characterize their glycosylation, glycopeptides and sugar
analyses are required. These forms of analyses are most accurate with large amounts of
pure glycoproteins. Thus, as many of the membrane glycoprotein candidates observed
were of low abundance, a further strategy may be required to purify the candidates prior
to complete characterization of their glycosylation.
The strategy most commonly utilized to purify glycoprotein candidates is to
express recombinant versions of the glycoprotein candidates with a tag to enable the
specific purification of each candidate. This strategy was most recently used to confirm
the glycosylation of glycoprotein candidates from the general protein glycosylation
system of B.fragilis [169]. Moreover, the use of this strategy was also applied for the
purification of two glycoprotein candidates in this study: the hp0366 flagellins and WaaL,
in which each candidate was tagged with a C-terminal Histidine-tag to allow their
purification by affinity chromatography. Purification of the flagellins from WT and
hp0366 is underway, but no problems are anticipated as the flagellins are present in the
insoluble protein fraction and a stable expression system was used for expression of the
tagged flagellin genes via chromosomal integration. Comparatively, purification of WaaL
was met with several obstacles due to the use of a shuttle vector for expression that was
unstable. Therefore, in order to allow complete characterization of the glycoprotein
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candidates, including WaaL, a stable expression system needs to be designed. In fact, the
strategy utilized for the chromosomal integration of the tagged flagellins into rdxA can be
employed for expression of the membrane glycoprotein candidates and will allow for the
stable expression of each of the glycoprotein candidates. Thus, by this method, each
glycoprotein candidate can be purified, which will allow for the glycosylation of these
proteins to be fully characterized by both glycopeptide analysis and identification of the
glycan by MS.
4.9 General significance and applications
In general, the study of bacterial protein glycosylation has received a lot of
attention in recent years for both therapeutic development and biotechnological
applications. In particular, bacterial protein glycosylation has been demonstrated to have
significant applications in glycoengineering. In particular, the ability to transfer the C.
jejuni N-glycosylation system to E. coli [128] has opened the doors for the production of
glycoproteins for medical and industrial use. It has been proposed that sugar biosynthetic
enzymes from additional glycosylation pathways may be used for glycoengineering
purposes, which can be used for the glycosylation of antibiotics or anti-cancer drugs
[262] and the production of recombinant peptide antigens [263]. The elucidation of
additional glycosylation pathways in H. pylori will add to the available sugar biosynthetic
enzymes for these purposes.
Moreover, protein glycosylation pathways in bacteria are considered innovative
targets for therapeutic development as the sugars typically incorporated in bacterial
glycoproteins are distinct from those of their host. Thus, small-molecule inhibitors of the
glycosyltransferases or other biosynthetic enzymes involved in sugar biosynthesis and
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protein glycosylation provide a new pool of therapeutic targets. In the case of H pylori
and the data presented in this study, the inhibition of pse biosynthesis could potentially
inhibit the production of several virulence factors - flagella, LPS, and IM and OM
glycoproteins - which implicate pse glycosylation as a prime target for therapeutic
development. In fact, a previous investigation has identified CMP-pse as a natural
inhibitor of pse biosynthesis for both H. pylori and C. jejuni [264]. The need to develop
new therapeutics to treat H. pylori infections is evident given the rise of antibiotic
resistance in H. pylori strains [41].
4.10 Summary
Overall, this study explored the presence of novel protein glycosylation in H.
pylori, including both novel glycoproteins and glycosylation pathways and demonstrated
their existence. The results of this study challenge the current dogma regarding protein
glycosylation in H pylori on several accounts. In particular, only the pse glycosylation
pathway is believed to modify the flagellins of H. pylori. However, this study
demonstrates that there is an alternative glycosylation pathway that branches from the pse
biosynthesis pathway that can also modify the flagellins. Further, the observation of the
flagellins as intracellular insoluble proteins provides the first evidence that the biological
role of flagellin glycosylation may be related to the stability, proper folding, or regulation
of the flagellin subunits. In addition, this study revealed the presence of several
membrane glycoproteins in H. pylori. The glycosylation of several of these glycoproteins
appears independent of pse biosynthesis, indicating that a pse-independent glycosylation
pathway is also present in H. pylori. Moreover, it was demonstrated that at least two of
these membrane glycoproteins are modified with the Ley O-antigen typically found on H.
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pylori LPS. This form of glycosylation involving the O-antigen ligase, WaaL, directly
demonstrates the presence of another glycosylation pathway in H. pylori and a novel
glycan involved in H pylori protein glycosylation.
Furthermore, this study is the first to characterize a link between protein
glycosylation and LPS biosynthesis in H. pylori. It was demonstrated that WaaL
functions as a general OTase and can modify both lipid A and proteins. Moreover, the
evidence presented in this study suggests that WaaL is glycosylated by pse and requires
pse-glycosylation for function.
Overall, the data presented here implicates protein glycosylation in the
production of multiple virulence factors. It was shown that pse-specific glycosylation is
required for flagellum assembly, LPS production, and the modification of both IM and
OM glycoproteins. As well, the OM glycoproteins detected may have direct roles in
virulence, such as in H. pylori colonization and protection from host defences, while the
IM glycoproteins detected may play pivotal roles in virulence factor production, such as
that predicted for the production of LPS via pse-glycosylation of WaaL,
In general, this study has contributed to the further understanding of bacterial
protein glycosylation. Overall, much less is known regarding bacterial protein
glycosylation compared to eukaryotic protein glycosylation. However, given the
important cellular roles of protein glycosylation in eukaryotes, and the increasing number
of reports of bacterial protein glycosylation, it is anticipated that bacterial protein
glycosylation has many more implications than previously believed. Therefore, continued
investigation of bacterial protein glycosylation is warranted in order to fully understand
the extent and importance of this phenomenon in bacteria.
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